[
  {
    "id": 53569,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9016,
      "drug_code": 61562,
      "updated_date": "2025-05-15T03:57:19-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8326212,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02238171",
      "brand_name": "MYLAN-AMOXICILLIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131314001"
    },
    "created_date": "2018-07-03T17:49:18-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02238171",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J01CA04",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "discontinuation_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Last lot 161574 Expires 31-Oct-18",
    "fr_discontinuation_comments": "Last lot 161574 Expires 31-Oct-18",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-04T05:00:45-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-AMOXICILLIN",
    "en_drug_common_name": "AMOXICILLIN",
    "fr_drug_brand_name": "MYLAN-AMOXICILLIN",
    "fr_drug_common_name": "AMOXICILLIN",
    "en_ingredients": "AMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "250MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53603,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24332,
      "drug_code": 86923,
      "updated_date": "2025-05-15T04:20:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351486,
          "ingredient": {
            "id": 2942,
            "ingredient_code": 12538,
            "en_name": "BOSENTAN",
            "fr_name": "Bosentan (Monohydrate de bosentan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "62.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02383497",
      "brand_name": "MYLAN-BOSENTAN",
      "brand_name_fr": "",
      "descriptor": "FILM COATED TABLET",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145922001"
    },
    "created_date": "2018-07-03T18:15:20-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02383497",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C02KX01",
    "atc_description": "OTHER ANTIHYPERTENSIVES",
    "discontinuation_date": "2018-07-03T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 23157",
    "fr_discontinuation_comments": "Discontinued in shortage ID 23157",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-04T05:00:47-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-BOSENTAN",
    "en_drug_common_name": "BOSENTAN",
    "fr_drug_brand_name": "MYLAN-BOSENTAN",
    "fr_drug_common_name": "BOSENTAN",
    "en_ingredients": "BOSENTAN",
    "fr_ingredients": "bosentan",
    "drug_strength": "62.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "56 BL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53608,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24334,
      "drug_code": 86924,
      "updated_date": "2025-05-15T04:20:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351487,
          "ingredient": {
            "id": 2942,
            "ingredient_code": 12538,
            "en_name": "BOSENTAN",
            "fr_name": "Bosentan (Monohydrate de bosentan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02383500",
      "brand_name": "MYLAN-BOSENTAN",
      "brand_name_fr": "",
      "descriptor": "FILM COATED TABLET",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145922002"
    },
    "created_date": "2018-07-03T18:18:04-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02383500",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C02KX01",
    "atc_description": "OTHER ANTIHYPERTENSIVES",
    "discontinuation_date": "2018-07-03T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 22010",
    "fr_discontinuation_comments": "Discontinued in shortage ID 22010",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-04T05:00:48-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-BOSENTAN",
    "en_drug_common_name": "BOSENTAN",
    "fr_drug_brand_name": "MYLAN-BOSENTAN",
    "fr_drug_common_name": "BOSENTAN",
    "en_ingredients": "BOSENTAN",
    "fr_ingredients": "BOSENTAN",
    "drug_strength": "125.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "56 BL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53611,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23826,
      "drug_code": 86501,
      "updated_date": "2025-05-15T04:19:48-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351193,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379120",
      "brand_name": "MYLAN-CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220001"
    },
    "created_date": "2018-07-03T18:21:06-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02379120",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09CA06",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "discontinuation_date": "2018-07-03T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 13190. Last lot 3065384 Expires 31-Mar-19",
    "fr_discontinuation_comments": "Discontinued in shortage ID 13190. Last lot 3065384 Expires 31-Mar-19",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-04T05:00:49-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN",
    "fr_drug_brand_name": "MYLAN-CANDESARTAN",
    "fr_drug_common_name": "CANDESARTAN",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53616,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23828,
      "drug_code": 86502,
      "updated_date": "2025-05-15T04:19:48-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351194,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379139",
      "brand_name": "MYLAN-CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220002"
    },
    "created_date": "2018-07-03T18:25:49-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02379139",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09CA06",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "discontinuation_date": "2018-08-10T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-08-10T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Last lot 3075845 Expires 30-Nov-19",
    "fr_supply_disruption_mitigation": "Last lot 3075845 Expires 30-Nov-19",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-08-11T05:00:07-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN",
    "fr_drug_brand_name": "MYLAN-CANDESARTAN",
    "fr_drug_common_name": "CANDESARTAN",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53621,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23830,
      "drug_code": 86503,
      "updated_date": "2025-05-15T04:19:48-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351195,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379147",
      "brand_name": "MYLAN-CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220003"
    },
    "created_date": "2018-07-03T18:30:23-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02379147",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09CA06",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "discontinuation_date": "2018-07-03T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in ID 14695. Last lot 3076973 Expires 30-Nov-19",
    "fr_discontinuation_comments": "Discontinued in ID 14695. Last lot 3076973 Expires 30-Nov-19",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-04T05:00:50-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN",
    "fr_drug_brand_name": "MYLAN-CANDESARTAN",
    "fr_drug_common_name": "CANDESARTAN",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53628,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23832,
      "drug_code": 86504,
      "updated_date": "2025-05-15T04:19:48-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351196,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "32",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379155",
      "brand_name": "MYLAN-CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220004"
    },
    "created_date": "2018-07-03T18:34:24-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02379155",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09CA06",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "discontinuation_date": "2018-07-03T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 16246. Last lot 3066425 Expires 31-Mar-19",
    "fr_discontinuation_comments": "Discontinued in shortage ID 16246. Last lot 3066425 Expires 31-Mar-19",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-04T05:00:51-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN",
    "fr_drug_brand_name": "MYLAN-CANDESARTAN",
    "fr_drug_common_name": "CANDESARTAN",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "32MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53714,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24828,
      "drug_code": 87368,
      "updated_date": "2025-05-15T04:20:17-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351734,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8351733,
          "ingredient": {
            "id": 1472,
            "ingredient_code": 7490,
            "en_name": "LEVONORGESTREL",
            "fr_name": "Lévonorgestrel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388138",
      "brand_name": "ESME 21",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0220415005"
    },
    "created_date": "2018-07-03T19:15:47-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02388138",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "G03AA07",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "discontinuation_date": "2018-07-03T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in ID 51450. Last lot F5037001C Expires 31-Mar-19",
    "fr_discontinuation_comments": "Discontinued in ID 51450. Last lot F5037001C Expires 31-Mar-19",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-04T05:00:42-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ESME 21",
    "en_drug_common_name": "Ethinylestradiol / Levonorgestrel",
    "fr_drug_brand_name": "ESME 21",
    "fr_drug_common_name": "Ethinylestradiol / Levonorgestrel",
    "en_ingredients": "ETHINYL ESTRADIOL\r\nLEVONORGESTREL",
    "fr_ingredients": "Éthinylestradiol\r\nLévonorgestrel",
    "drug_strength": "20MCG\r\n100MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "21 BL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53722,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24830,
      "drug_code": 87369,
      "updated_date": "2025-05-15T04:20:17-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351736,
          "ingredient": {
            "id": 1472,
            "ingredient_code": 7490,
            "en_name": "LEVONORGESTREL",
            "fr_name": "Lévonorgestrel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8351735,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388146",
      "brand_name": "ESME 28",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0220415005"
    },
    "created_date": "2018-07-03T19:18:21-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02388146",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "G03AA07",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "discontinuation_date": "2018-07-03T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 51453. Last lot F5047002C Expires 31-Mar-19",
    "fr_discontinuation_comments": "Discontinued in shortage ID 51453. Last lot F5047002C Expires 31-Mar-19",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-04T05:00:42-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ESME 28",
    "en_drug_common_name": "Ethinylestradiol / Levonorgestrel",
    "fr_drug_brand_name": "ESME 28",
    "fr_drug_common_name": "Ethinylestradiol / Levonorgestrel",
    "en_ingredients": "ETHINYL ESTRADIOL\r\nLEVONORGESTREL",
    "fr_ingredients": "Éthinylestradiol\r\nLévonorgestrel",
    "drug_strength": "20MCG\r\n100MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28 BL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53727,
    "drug": {
      "current_status": "MARKETED",
      "id": 20838,
      "drug_code": 8275,
      "updated_date": "2025-05-15T02:30:41-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8251077,
          "ingredient": {
            "id": 3628,
            "ingredient_code": 6212,
            "en_name": "SODIUM TETRADECYL SULFATE",
            "fr_name": "Tétradécyl sulfate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00511234",
      "brand_name": "TROMBOJECT 1%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "66606",
      "number_of_ais": "1",
      "ai_group_no": "0107541001"
    },
    "created_date": "2018-07-03T19:20:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00511234",
    "company_name": "OMEGA LABORATORIES LTD",
    "atc_number": "C05BB04",
    "atc_description": "ANTIVARICOSE THERAPY",
    "anticipated_start_date": "2018-07-12T00:00:00-04:00",
    "actual_end_date": "2019-02-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-05T06:00:09-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TROMBOJECT 1% INJ 10MG/ML",
    "en_drug_common_name": "Sodium Tetradecyl  Sulfate Injection",
    "fr_drug_brand_name": "Tromboject",
    "fr_drug_common_name": "Injection de tétradécyl sulfate de sodium",
    "en_ingredients": "SODIUM TETRADECYL SULFATE",
    "fr_ingredients": "Tétradécyl sulfate de sodium",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 x 2mL vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53729,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22790,
      "drug_code": 85324,
      "updated_date": "2025-05-15T04:18:37-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8350212,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02368277",
      "brand_name": "MYLAN-LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971001"
    },
    "created_date": "2018-07-03T19:21:30-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02368277",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09CA01",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "discontinuation_date": "2018-08-10T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-08-10T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Last lot 3078107 Expires 31-Dec-19",
    "fr_supply_disruption_mitigation": "Last lot 3078107 Expires 31-Dec-19",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-08-11T05:00:08-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "MYLAN-LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BL, 100 BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53735,
    "drug": {
      "current_status": "MARKETED",
      "id": 20836,
      "drug_code": 8274,
      "updated_date": "2025-05-15T02:30:41-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8251076,
          "ingredient": {
            "id": 3628,
            "ingredient_code": 6212,
            "en_name": "SODIUM TETRADECYL SULFATE",
            "fr_name": "Tétradécyl sulfate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00511226",
      "brand_name": "TROMBOJECT 3%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "66605",
      "number_of_ais": "1",
      "ai_group_no": "0107541002"
    },
    "created_date": "2018-07-03T19:24:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00511226",
    "company_name": "OMEGA LABORATORIES LTD",
    "atc_number": "C05BB04",
    "atc_description": "ANTIVARICOSE THERAPY",
    "anticipated_start_date": "2018-07-20T00:00:00-04:00",
    "actual_end_date": "2019-02-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-05T06:00:09-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TROMBOJECT 3% INJ 30MG/ML",
    "en_drug_common_name": "Sodium Tetradecyl Sulfate Injection",
    "fr_drug_brand_name": "Tromboject",
    "fr_drug_common_name": "Injection de tétradécyl sulfate de sodium",
    "en_ingredients": "SODIUM TETRADECYL SULFATE",
    "fr_ingredients": "Tétradécyl sulfate de sodium",
    "drug_strength": "30MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 x 2mL vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53737,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22792,
      "drug_code": 85325,
      "updated_date": "2025-05-15T04:18:37-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8350213,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02368285",
      "brand_name": "MYLAN-LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971003"
    },
    "created_date": "2018-07-03T19:24:58-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02368285",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09CA01",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "discontinuation_date": "2018-08-10T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-08-10T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Last lot 8071927 Expires 31-Dec-19",
    "fr_supply_disruption_mitigation": "Last lot 8071927 Expires 31-Dec-19",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-08-11T05:00:08-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "MYLAN-LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BL, 100 BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53745,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22794,
      "drug_code": 85326,
      "updated_date": "2025-05-15T04:18:37-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8350214,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02368293",
      "brand_name": "MYLAN-LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971002"
    },
    "created_date": "2018-07-03T19:29:08-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02368293",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09CA01",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "discontinuation_date": "2018-08-10T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-08-10T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Last lot 3078483 Expires 31-Dec-19",
    "fr_supply_disruption_mitigation": "Last lot 3078483 Expires 31-Dec-19",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-08-11T05:00:09-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "MYLAN-LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BL, 100 BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53748,
    "drug": {
      "current_status": "MARKETED",
      "id": 20836,
      "drug_code": 8274,
      "updated_date": "2025-05-15T02:30:41-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8251076,
          "ingredient": {
            "id": 3628,
            "ingredient_code": 6212,
            "en_name": "SODIUM TETRADECYL SULFATE",
            "fr_name": "Tétradécyl sulfate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00511226",
      "brand_name": "TROMBOJECT 3%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "66605",
      "number_of_ais": "1",
      "ai_group_no": "0107541002"
    },
    "created_date": "2018-07-03T19:29:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00511226",
    "company_name": "OMEGA LABORATORIES LTD",
    "atc_number": "C05BB04",
    "atc_description": "ANTIVARICOSE THERAPY",
    "anticipated_start_date": "2018-10-31T00:00:00-04:00",
    "actual_end_date": "2019-02-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-05T06:00:09-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TROMBOJECT 3% INJ 30MG/ML",
    "en_drug_common_name": "Sodium Tetradecyl Sulfate Injection",
    "fr_drug_brand_name": "Tromboject",
    "fr_drug_common_name": "Injection de tétradécyl sulfate de sodium",
    "en_ingredients": "SODIUM TETRADECYL SULFATE",
    "fr_ingredients": "Tétradécyl sulfate de sodium",
    "drug_strength": "30MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "5 x 5mL vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53757,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3160,
      "drug_code": 18058,
      "updated_date": "2025-05-15T03:44:10-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8299984,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02148765",
      "brand_name": "MYLAN-METFORMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80272",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2018-07-03T19:33:04-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02148765",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "A10BA02",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2018-07-03T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in ID 3935",
    "fr_discontinuation_comments": "Discontinued in ID 3935",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-04T05:01:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-METFORMIN",
    "en_drug_common_name": "METFORMIN",
    "fr_drug_brand_name": "MYLAN-METFORMIN",
    "fr_drug_common_name": "METFORMIN",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT, 360 BT, 500 BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53765,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7038,
      "drug_code": 47631,
      "updated_date": "2025-05-15T03:50:19-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8313771,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "850",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02229656",
      "brand_name": "MYLAN-METFORMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773002"
    },
    "created_date": "2018-07-03T19:36:31-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02229656",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "A10BA02",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2018-07-03T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 5025. Last lot 4680005A Expires 31-Aug-20",
    "fr_discontinuation_comments": "Discontinued in shortage ID 5025. Last lot 4680005A Expires 31-Aug-20",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-04T05:01:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-METFORMIN",
    "en_drug_common_name": "METFORMIN",
    "fr_drug_brand_name": "MYLAN-METFORMIN",
    "fr_drug_common_name": "METFORMIN",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "850MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT, 500 BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53770,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20604,
      "drug_code": 82351,
      "updated_date": "2025-05-15T04:15:41-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8347987,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337878",
      "brand_name": "MYLAN-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783001"
    },
    "created_date": "2018-07-03T19:39:22-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02337878",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2018-07-03T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "discontinued in shortage ID 51475. Last lot 3063170 Expires 31-Dec-19",
    "fr_discontinuation_comments": "discontinued in shortage ID 51475. Last lot 3063170 Expires 31-Dec-19",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-04T05:01:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "MYLAN-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53775,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20606,
      "drug_code": 82352,
      "updated_date": "2025-05-15T04:15:41-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8347988,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337886",
      "brand_name": "MYLAN-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783003"
    },
    "created_date": "2018-07-03T19:41:55-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02337886",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2018-07-03T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 51478. Last lot 3071257 Expires 31-Jul-20",
    "fr_discontinuation_comments": "Discontinued in shortage ID 51478. Last lot 3071257 Expires 31-Jul-20",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-04T05:01:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "MYLAN-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53780,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20608,
      "drug_code": 82353,
      "updated_date": "2025-05-15T04:15:41-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8347989,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337894",
      "brand_name": "MYLAN-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783004"
    },
    "created_date": "2018-07-03T19:44:31-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02337894",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2018-07-03T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 51481 . Last lot 3065965 Expires 28-Feb-20",
    "fr_discontinuation_comments": "Discontinued in shortage ID 51481 . Last lot 3065965 Expires 28-Feb-20",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-04T05:01:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "MYLAN-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "7.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53783,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20610,
      "drug_code": 82354,
      "updated_date": "2025-05-15T04:15:41-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8347990,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337908",
      "brand_name": "MYLAN-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783002"
    },
    "created_date": "2018-07-03T19:46:13-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02337908",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2018-07-03T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 51484. Last lot 3077339 Expires 28-Feb-2020",
    "fr_discontinuation_comments": "Discontinued in shortage ID 51484. Last lot 3077339 Expires 28-Feb-2020",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-04T05:01:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "MYLAN-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53790,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20612,
      "drug_code": 82355,
      "updated_date": "2025-05-15T04:15:41-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8347991,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337916",
      "brand_name": "MYLAN-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783005"
    },
    "created_date": "2018-07-03T19:49:07-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02337916",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2018-07-03T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 51489 . Last lot 3077338 Expires 30-Nov-2020",
    "fr_discontinuation_comments": "Discontinued in shortage ID 51489 . Last lot 3077338 Expires 30-Nov-2020",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-04T05:01:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "MYLAN-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 53867,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 578,
      "drug_code": 11254,
      "updated_date": "2025-05-15T03:37:49-04:00",
      "company": {
        "id": 140,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 4835,
        "mfr_code": "ODN07",
        "name": "ODAN LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "325 STILLVIEW AVENUE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "POINTE-CLAIRE",
        "postal_code": "H9R 2Y6",
        "post_office_box": "",
        "contact_information": "info@odanlab.com\r\nTel.: 1-800-387-9342\r\nFax: 1-800-329-6326"
      },
      "drug_ingredients": [
        {
          "id": 8287718,
          "ingredient": {
            "id": 358,
            "ingredient_code": 5019,
            "en_name": "NICOTINIC ACID",
            "fr_name": "Acide nicotinique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00779806",
      "brand_name": "NIODAN 500 MG TIME RELEASE TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71832",
      "number_of_ais": "1",
      "ai_group_no": "0108396003"
    },
    "created_date": "2018-07-03T20:42:38-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00779806",
    "company_name": "ODAN LABORATORIES LTD",
    "atc_number": "C04AC01",
    "atc_description": "PERIPHERALVASODILATORS",
    "discontinuation_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Inventory depleted",
    "fr_supply_disruption_mitigation": "inventaire écoulé",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-04T05:01:22-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "NIODAN 500 MG TIME RELEASE TABLETS",
    "en_drug_common_name": "Niacin Time Release Tablets",
    "fr_drug_brand_name": "NIODAN 500 MG COMPRIMÉS À LIBÉRATION PROLONGÉE",
    "fr_drug_common_name": "Comprimés de niacine à libération prolongée",
    "en_ingredients": "NICOTINIC ACID",
    "fr_ingredients": "Acide nicotinique",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54011,
    "drug": {
      "current_status": "MARKETED",
      "id": 32222,
      "drug_code": 9993,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8251253,
          "ingredient": {
            "id": 738,
            "ingredient_code": 4918,
            "en_name": "VITAMIN K1",
            "fr_name": "Vitamine K1"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00781878",
      "brand_name": "VITAMIN K1",
      "brand_name_fr": "VITAMINE K1",
      "descriptor": "PRESERVATIVE FREE",
      "pediatric_flag": false,
      "accession_number": "69568",
      "number_of_ais": "1",
      "ai_group_no": "0108526002"
    },
    "created_date": "2018-07-03T22:36:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00781878",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "B02BA01",
    "atc_description": "VITAMIN K AND OTHER HEMOSTATICS",
    "estimated_end_date": "2018-12-07T00:00:00-05:00",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2018-11-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-11-27T06:00:06-05:00",
    "status": "resolved",
    "en_comments": "To maintain our inventory levels and to avoid unanticipated bulk orders, the products will be placed on protective allocation at 200% of historical monthly volumes at this time.\r\nBaxter Product.",
    "fr_comments": "Pour maintenir notre niveau des stocks et éviter les commandes en vrac imprévues, les produits font à présent partie d’un processus de distribution restreinte correspondant à 200 % des volumes mensuels historiques.",
    "en_drug_brand_name": "VITAMIN K1 INJ 1MG/0.5ML USP",
    "en_drug_common_name": "VITAMIN K1 2MG/ML",
    "fr_drug_brand_name": "VITAMIN K1 2MG/ML",
    "fr_drug_common_name": "VITAMIN K1 2MG/ML",
    "en_ingredients": "VITAMIN K1",
    "fr_ingredients": "Vitamine K1",
    "drug_strength": "2MG",
    "drug_dosage_form": "EMULSION",
    "drug_dosage_form_fr": "Émulsion",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "10 x 0.5mL amps",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54014,
    "drug": {
      "current_status": "MARKETED",
      "id": 32224,
      "drug_code": 9994,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8251254,
          "ingredient": {
            "id": 738,
            "ingredient_code": 4918,
            "en_name": "VITAMIN K1",
            "fr_name": "Vitamine K1"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00804312",
      "brand_name": "VITAMIN K1",
      "brand_name_fr": "VITAMINE K1",
      "descriptor": "PRESERVATIVE FREE",
      "pediatric_flag": false,
      "accession_number": "69569",
      "number_of_ais": "1",
      "ai_group_no": "0108526001"
    },
    "created_date": "2018-07-03T22:37:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00804312",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "B02BA01",
    "atc_description": "VITAMIN K AND OTHER HEMOSTATICS",
    "estimated_end_date": "2018-12-07T00:00:00-05:00",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2018-11-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-11-27T06:00:06-05:00",
    "status": "resolved",
    "en_comments": "To maintain our inventory levels and to avoid unanticipated bulk orders, the products will be placed on protective allocation at 125% of historical monthly volumes at this time.\r\nBaxter Product.",
    "fr_comments": "Pour maintenir notre niveau des stocks et éviter les commandes en vrac imprévues, les produits font à présent partie d’un processus de distribution restreinte correspondant à 125 % des volumes mensuels historiques.",
    "en_drug_brand_name": "VITAMIN K1 INJ 10MG/ML USP",
    "en_drug_common_name": "VITAMIN K1 10MG/ML",
    "fr_drug_brand_name": "VITAMIN K1 10MG/ML",
    "fr_drug_common_name": "VITAMIN K1 10MG/ML",
    "en_ingredients": "VITAMIN K1",
    "fr_ingredients": "Vitamine K1",
    "drug_strength": "10MG",
    "drug_dosage_form": "EMULSION",
    "drug_dosage_form_fr": "Émulsion",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "10 x 10mL vials",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54162,
    "drug": {
      "current_status": "MARKETED",
      "id": 13416,
      "drug_code": 73098,
      "updated_date": "2025-05-15T02:31:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254867,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02248730",
      "brand_name": "APO-ALENDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150323002"
    },
    "created_date": "2018-07-04T11:01:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248730",
    "company_name": "APOTEX INC",
    "atc_number": "M05BA04",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2018-11-16T00:00:00-05:00",
    "actual_start_date": "2018-07-02T00:00:00-04:00",
    "actual_end_date": "2018-10-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-09T13:12:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ALENDRONATE",
    "en_drug_common_name": "ALENDRONATE",
    "fr_drug_brand_name": "APO-ALENDRONATE",
    "fr_drug_common_name": "ALENDRONATE",
    "en_ingredients": "ALENDRONIC ACID",
    "fr_ingredients": "ALENDRONATE",
    "drug_strength": "70MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54165,
    "drug": {
      "current_status": "MARKETED",
      "id": 376,
      "drug_code": 10904,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251437,
          "ingredient": {
            "id": 268,
            "ingredient_code": 2072,
            "en_name": "ALPRAZOLAM",
            "fr_name": "Alprazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00865397",
      "brand_name": "APO-ALPRAZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71037",
      "number_of_ais": "1",
      "ai_group_no": "0115008001"
    },
    "created_date": "2018-07-04T11:03:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00865397",
    "company_name": "APOTEX INC",
    "atc_number": "N05BA12",
    "atc_description": "ANXIOLYTICS",
    "estimated_end_date": "2018-10-31T00:00:00-04:00",
    "actual_start_date": "2018-07-02T00:00:00-04:00",
    "actual_end_date": "2018-10-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-12T15:50:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ALPRAZ",
    "en_drug_common_name": "ALPRAZOLAM",
    "fr_drug_brand_name": "APO-ALPRAZ",
    "fr_drug_common_name": "ALPRAZOLAM",
    "en_ingredients": "ALPRAZOLAM",
    "fr_ingredients": "Alprazolam",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54168,
    "drug": {
      "current_status": "MARKETED",
      "id": 11198,
      "drug_code": 67531,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254206,
          "ingredient": {
            "id": 268,
            "ingredient_code": 2072,
            "en_name": "ALPRAZOLAM",
            "fr_name": "Alprazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243612",
      "brand_name": "APO-ALPRAZ TS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115008004"
    },
    "created_date": "2018-07-04T11:04:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243612",
    "company_name": "APOTEX INC",
    "atc_number": "N05BA12",
    "atc_description": "ANXIOLYTICS",
    "hc_updated_date": "2020-09-28T16:16:52-04:00",
    "actual_start_date": "2018-07-02T00:00:00-04:00",
    "actual_end_date": "2020-09-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-28T16:16:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ALPRAZ TS",
    "en_drug_common_name": "ALPRAZOLAM",
    "fr_drug_brand_name": "APO-ALPRAZ TS",
    "fr_drug_common_name": "ALPRAZOLAM",
    "en_ingredients": "ALPRAZOLAM",
    "fr_ingredients": "Alprazolam",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54171,
    "drug": {
      "current_status": "DORMANT",
      "id": 382,
      "drug_code": 10907,
      "updated_date": "2025-12-03T02:32:14-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8366607,
          "ingredient": {
            "id": 266,
            "ingredient_code": 1983,
            "en_name": "CAPTOPRIL",
            "fr_name": "Captopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00893609",
      "brand_name": "APO-CAPTO TAB 25MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71040",
      "number_of_ais": "1",
      "ai_group_no": "0114954001"
    },
    "created_date": "2018-07-04T11:08:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00893609",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA01",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2018-09-28T00:00:00-04:00",
    "actual_start_date": "2018-07-02T00:00:00-04:00",
    "actual_end_date": "2018-09-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-05T16:03:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CAPTO TAB 25MG",
    "en_drug_common_name": "CAPTOPRIL",
    "fr_drug_brand_name": "APO-CAPTO TAB 25MG",
    "fr_drug_common_name": "CAPTOPRIL",
    "en_ingredients": "CAPTOPRIL",
    "fr_ingredients": "Captopril",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54174,
    "drug": {
      "current_status": "MARKETED",
      "id": 4826,
      "drug_code": 2657,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250432,
          "ingredient": {
            "id": 810,
            "ingredient_code": 9418,
            "en_name": "DIAZEPAM",
            "fr_name": "Diazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00362158",
      "brand_name": "DIAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "50813",
      "number_of_ais": "1",
      "ai_group_no": "0103614001"
    },
    "created_date": "2018-07-04T11:11:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00362158",
    "company_name": "APOTEX INC",
    "atc_number": "N05BA01",
    "atc_description": "ANXIOLYTICS",
    "actual_start_date": "2018-07-02T00:00:00-04:00",
    "actual_end_date": "2018-09-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-09T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO DIAZEPAM TAB 5MG",
    "en_drug_common_name": "DIAZEPAM",
    "fr_drug_brand_name": "APO DIAZEPAM TAB 5MG",
    "fr_drug_common_name": "DIAZEPAM",
    "en_ingredients": "DIAZEPAM",
    "fr_ingredients": "Diazépam",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54177,
    "drug": {
      "current_status": "MARKETED",
      "id": 15296,
      "drug_code": 75839,
      "updated_date": "2025-05-15T02:31:42-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255465,
          "ingredient": {
            "id": 452,
            "ingredient_code": 4068,
            "en_name": "LEVODOPA",
            "fr_name": "Lévodopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8255464,
          "ingredient": {
            "id": 450,
            "ingredient_code": 2370,
            "en_name": "CARBIDOPA",
            "fr_name": "Carbidopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02272873",
      "brand_name": "AA-LEVOCARB CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0210315003"
    },
    "created_date": "2018-07-04T11:22:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02272873",
    "company_name": "APOTEX INC",
    "atc_number": "N04BA02",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2018-09-10T00:00:00-04:00",
    "actual_start_date": "2018-07-02T00:00:00-04:00",
    "actual_end_date": "2018-08-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-22T14:33:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LEVOCARB CR",
    "en_drug_common_name": "LEVOCARB",
    "fr_drug_brand_name": "APO-LEVOCARB CR",
    "fr_drug_common_name": "LEVOCARB",
    "en_ingredients": "CARBIDOPA\r\nLEVODOPA",
    "fr_ingredients": "Carbidopa\r\nLévodopa",
    "drug_strength": "25MG\r\n100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54184,
    "drug": {
      "current_status": "MARKETED",
      "id": 11640,
      "drug_code": 68715,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254330,
          "ingredient": {
            "id": 806,
            "ingredient_code": 7538,
            "en_name": "MEDROXYPROGESTERONE ACETATE",
            "fr_name": "Acétate de médroxyprogestérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244726",
      "brand_name": "AA-MEDROXY",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106339004"
    },
    "created_date": "2018-07-04T11:42:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244726",
    "company_name": "APOTEX INC",
    "atc_number": "G03DA02",
    "atc_description": "PROGESTOGENS",
    "estimated_end_date": "2018-09-28T00:00:00-04:00",
    "actual_start_date": "2018-07-02T00:00:00-04:00",
    "actual_end_date": "2018-08-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-22T14:36:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MEDROXY TABLETS",
    "en_drug_common_name": "MEDROXYPROGESTERONE",
    "fr_drug_brand_name": "APO-MEDROXY TABLETS",
    "fr_drug_common_name": "MEDROXYPROGESTERONE",
    "en_ingredients": "MEDROXYPROGESTERONE ACETATE",
    "fr_ingredients": "Acétate de médroxyprogestérone",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54187,
    "drug": {
      "current_status": "MARKETED",
      "id": 4146,
      "drug_code": 20002,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252590,
          "ingredient": {
            "id": 1478,
            "ingredient_code": 2048,
            "en_name": "SOTALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de sotalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02210428",
      "brand_name": "APO-SOTALOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82301",
      "number_of_ais": "1",
      "ai_group_no": "0113778002"
    },
    "created_date": "2018-07-04T11:44:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02210428",
    "company_name": "APOTEX INC",
    "atc_number": "C07AA07",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2018-10-01T00:00:00-04:00",
    "actual_start_date": "2018-07-02T00:00:00-04:00",
    "actual_end_date": "2018-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-13T05:00:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SOTALOL 80MG TABLETS",
    "en_drug_common_name": "SOTALOL",
    "fr_drug_brand_name": "APO-SOTALOL 80MG TABLETS",
    "fr_drug_common_name": "SOTALOL",
    "en_ingredients": "SOTALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de sotalol",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54212,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17494,
      "drug_code": 78536,
      "updated_date": "2025-05-15T04:13:00-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8344534,
          "ingredient": {
            "id": 272,
            "ingredient_code": 20170,
            "en_name": "ENALAPRIL SODIUM",
            "fr_name": "Énalapril sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02300036",
      "brand_name": "MYLAN-ENALAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152325001"
    },
    "created_date": "2018-07-04T12:33:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02300036",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09AA02",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2018-07-03T00:00:00-04:00",
    "actual_start_date": "2018-07-03T00:00:00-04:00",
    "actual_end_date": "2020-01-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-02-20T13:02:21-05:00",
    "status": "resolved",
    "en_comments": "Discontinued in ID 106753. Last lot 3074857 exp 2021-10-31",
    "fr_comments": "Discontinued in ID 106753. Last lot 3074857 exp 2021-10-31",
    "en_drug_brand_name": "MYLAN-ENALAPRIL",
    "en_drug_common_name": "ENALAPRIL",
    "fr_drug_brand_name": "MYLAN-ENALAPRIL",
    "fr_drug_common_name": "ENALAPRIL",
    "en_ingredients": "ENALAPRIL SODIUM",
    "fr_ingredients": "Énalapril sodique",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54219,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17496,
      "drug_code": 78537,
      "updated_date": "2025-05-15T04:13:00-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8344535,
          "ingredient": {
            "id": 272,
            "ingredient_code": 20170,
            "en_name": "ENALAPRIL SODIUM",
            "fr_name": "Énalapril sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02300044",
      "brand_name": "MYLAN-ENALAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152325004"
    },
    "created_date": "2018-07-04T12:35:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02300044",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09AA02",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2018-07-03T00:00:00-04:00",
    "actual_start_date": "2018-07-03T00:00:00-04:00",
    "actual_end_date": "2020-01-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-02-20T13:03:07-05:00",
    "status": "resolved",
    "en_comments": "Discontinued in ID 106756. Last lot 3048422-1 exp 2019-11-30",
    "fr_comments": "Discontinued in ID 106756. Last lot 3048422-1 exp 2019-11-30",
    "en_drug_brand_name": "MYLAN-ENALAPRIL",
    "en_drug_common_name": "ENALAPRIL",
    "fr_drug_brand_name": "MYLAN-ENALAPRIL",
    "fr_drug_common_name": "ENALAPRIL",
    "en_ingredients": "ENALAPRIL SODIUM",
    "fr_ingredients": "Énalapril sodique",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT, 500 BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54237,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17498,
      "drug_code": 78538,
      "updated_date": "2025-05-15T04:13:00-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8344536,
          "ingredient": {
            "id": 272,
            "ingredient_code": 20170,
            "en_name": "ENALAPRIL SODIUM",
            "fr_name": "Énalapril sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02300052",
      "brand_name": "MYLAN-ENALAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152325002"
    },
    "created_date": "2018-07-04T12:47:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02300052",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09AA02",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2018-07-03T00:00:00-04:00",
    "actual_start_date": "2018-07-03T00:00:00-04:00",
    "actual_end_date": "2020-01-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-02-20T13:05:50-05:00",
    "status": "resolved",
    "en_comments": "Discontinued in ID 106759. Last lot 3049782-1 exp 2019-12-31",
    "fr_comments": "Discontinued in ID 106759. Last lot 3049782-1 exp 2019-12-31",
    "en_drug_brand_name": "MYLAN-ENALAPRIL",
    "en_drug_common_name": "ENALAPRIL",
    "fr_drug_brand_name": "MYLAN-ENALAPRIL",
    "fr_drug_common_name": "ENALAPRIL",
    "en_ingredients": "ENALAPRIL SODIUM",
    "fr_ingredients": "Énalapril sodique",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT, 500 BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54242,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17500,
      "drug_code": 78539,
      "updated_date": "2025-05-15T04:13:00-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8344537,
          "ingredient": {
            "id": 272,
            "ingredient_code": 20170,
            "en_name": "ENALAPRIL SODIUM",
            "fr_name": "Énalapril sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02300060",
      "brand_name": "MYLAN-ENALAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152325003"
    },
    "created_date": "2018-07-04T12:52:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02300060",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09AA02",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2018-07-03T00:00:00-04:00",
    "actual_start_date": "2018-07-03T00:00:00-04:00",
    "actual_end_date": "2020-01-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-02-20T13:05:35-05:00",
    "status": "resolved",
    "en_comments": "Discontinued in ID 106762. Last lot 8044629-1 exp 2019-12-31",
    "fr_comments": "Discontinued in ID 106762. Last lot 8044629-1 exp 2019-12-31",
    "en_drug_brand_name": "MYLAN-ENALAPRIL",
    "en_drug_common_name": "ENALAPRIL",
    "fr_drug_brand_name": "MYLAN-ENALAPRIL",
    "fr_drug_common_name": "ENALAPRIL",
    "en_ingredients": "ENALAPRIL SODIUM",
    "fr_ingredients": "Énalapril sodique",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT, 500 BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54279,
    "drug": {
      "current_status": "MARKETED",
      "id": 4388,
      "drug_code": 2087,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 272,
        "created_date": "2017-03-09T13:22:39-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12428,
        "mfr_code": "",
        "name": "SANOFI PASTEUR LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "Customer Service/Service à la clientèle: 1-800-268-4171\r\nVaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146"
      },
      "drug_ingredients": [
        {
          "id": 8250356,
          "ingredient": {
            "id": 1684,
            "ingredient_code": 7783,
            "en_name": "PURIFIED PROTEIN DERIVATIVE OF TUBERCULIN",
            "fr_name": "Dérivé protéique purifiée de tuberculine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "TUB",
          "strength_type": "",
          "dosage_value": "0.1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00317268",
      "brand_name": "TUBERSOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "47293",
      "number_of_ais": "1",
      "ai_group_no": "0106264001"
    },
    "created_date": "2018-07-04T13:23:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00317268",
    "company_name": "SANOFI PASTEUR LIMITED",
    "atc_number": "V04CF01",
    "atc_description": "OTHER DIAGNOSTIC AGENTS",
    "anticipated_start_date": "2018-06-29T00:00:00-04:00",
    "actual_start_date": "2018-06-29T00:00:00-04:00",
    "actual_end_date": "2018-07-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-07-12T05:00:21-04:00",
    "status": "resolved",
    "en_comments": "The supply has been restored.",
    "fr_comments": "L'approvisionnement a été restauré.",
    "en_drug_brand_name": "TUBERSOL",
    "en_drug_common_name": "Tuberculin Purified Protein Derivative (Mantoux)",
    "fr_drug_brand_name": "TUBERSOL® (00317268)",
    "fr_drug_common_name": "Tuberculine dérivée de protéines purifiées (Mantoux)",
    "en_ingredients": "PURIFIED PROTEIN DERIVATIVE OF TUBERCULIN",
    "fr_ingredients": "Dérivé protéique purifiée de tuberculine",
    "drug_strength": "5TUB",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRADERMAL",
    "drug_route_fr": "Intradermique",
    "drug_package_quantity": "5 mL multidose vial (5 TU per test)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54285,
    "drug": {
      "current_status": "MARKETED",
      "id": 31598,
      "drug_code": 93915,
      "updated_date": "2025-05-15T02:35:18-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261826,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "27",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452758",
      "brand_name": "APO-METHYLPHENIDATE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548007"
    },
    "created_date": "2018-07-04T13:57:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452758",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA04",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2018-08-27T00:00:00-04:00",
    "actual_start_date": "2018-07-02T00:00:00-04:00",
    "actual_end_date": "2018-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-01T13:03:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "en_drug_common_name": "METHYLPHENIDATE",
    "fr_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "fr_drug_common_name": "METHYLPHENIDATE",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "27MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54288,
    "drug": {
      "current_status": "MARKETED",
      "id": 13602,
      "drug_code": 73417,
      "updated_date": "2025-05-15T02:31:34-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254915,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02249332",
      "brand_name": "APO-METHYLPHENIDATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548002"
    },
    "created_date": "2018-07-04T13:59:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02249332",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA04",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2018-10-26T00:00:00-04:00",
    "actual_start_date": "2018-07-02T00:00:00-04:00",
    "actual_end_date": "2018-10-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-11T20:27:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METHYLPHENIDATE",
    "en_drug_common_name": "METHYLPHENIDATE",
    "fr_drug_brand_name": "APO-METHYLPHENIDATE",
    "fr_drug_common_name": "METHYLPHENIDATE",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54292,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25522,
      "drug_code": 87953,
      "updated_date": "2025-05-15T04:20:34-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8352201,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02394367",
      "brand_name": "LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971001"
    },
    "created_date": "2018-07-04T14:12:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394367",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09CA01",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "hc_updated_date": "2023-07-11T14:51:03-04:00",
    "actual_start_date": "2018-07-04T00:00:00-04:00",
    "actual_end_date": "2023-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-07-11T14:51:09-04:00",
    "status": "resolved",
    "en_comments": "Discontinued as of July 10, 2023 – Discontinué en date du 10 juillet 2023.",
    "fr_comments": "Discontinued as of July 10, 2023 – Discontinué en date du 10 juillet 2023.",
    "en_drug_brand_name": "LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54297,
    "drug": {
      "current_status": "MARKETED",
      "id": 12398,
      "drug_code": 70894,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254565,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246699",
      "brand_name": "APO-NAPROXEN EC TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109634001"
    },
    "created_date": "2018-07-04T14:16:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246699",
    "company_name": "APOTEX INC",
    "atc_number": "M01AE02",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "actual_start_date": "2018-07-02T00:00:00-04:00",
    "actual_end_date": "2018-12-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-12-28T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-NAPROXEN EC TABLETS",
    "en_drug_common_name": "NAPROXEN",
    "fr_drug_brand_name": "APO-NAPROXEN EC TABLETS",
    "fr_drug_common_name": "NAPROXEN",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54300,
    "drug": {
      "current_status": "DORMANT",
      "id": 50646,
      "drug_code": 94018,
      "updated_date": "2025-12-03T02:32:39-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369391,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8369390,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02453622",
      "brand_name": "APO-OLMESARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252502003"
    },
    "created_date": "2018-07-04T14:18:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453622",
    "company_name": "APOTEX INC",
    "atc_number": "C09DA08",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2020-07-24T00:00:00-04:00",
    "actual_start_date": "2018-07-02T00:00:00-04:00",
    "actual_end_date": "2020-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-07-11T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLMESARTAN/HCTZ",
    "en_drug_common_name": "OLMESARTAN-HCTZ",
    "fr_drug_brand_name": "APO-OLMESARTAN/HCTZ",
    "fr_drug_common_name": "OLMESARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nOLMESARTAN MEDOXOMIL",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "25MG\r\n40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54303,
    "drug": {
      "current_status": "DORMANT",
      "id": 51251,
      "drug_code": 94016,
      "updated_date": "2025-12-03T02:32:39-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369387,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8369386,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02453606",
      "brand_name": "APO-OLMESARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252502001"
    },
    "created_date": "2018-07-04T14:19:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453606",
    "company_name": "APOTEX INC",
    "atc_number": "C09DA08",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2018-11-23T00:00:00-05:00",
    "actual_start_date": "2018-07-02T00:00:00-04:00",
    "actual_end_date": "2018-11-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-11-22T22:56:52-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLMESARTAN/HCTZ",
    "en_drug_common_name": "OLMESARTAN-HCTZ",
    "fr_drug_brand_name": "APO-OLMESARTAN/HCTZ",
    "fr_drug_common_name": "OLMESARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nOLMESARTAN MEDOXOMIL",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "12.5MG\r\n20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL and 30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54306,
    "drug": {
      "current_status": "MARKETED",
      "id": 16816,
      "drug_code": 77774,
      "updated_date": "2025-05-15T02:31:54-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255942,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02292394",
      "brand_name": "APO-PRAMIPEXOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169003"
    },
    "created_date": "2018-07-04T14:50:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292394",
    "company_name": "APOTEX INC",
    "atc_number": "N04BC05",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2018-10-26T00:00:00-04:00",
    "actual_start_date": "2018-07-02T00:00:00-04:00",
    "actual_end_date": "2018-10-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-12T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PRAMIPEXOLE",
    "en_drug_common_name": "PRAMIPEXOLE",
    "fr_drug_brand_name": "APO-PRAMIPEXOLE",
    "fr_drug_common_name": "PRAMIPEXOLE",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "1.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54309,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20980,
      "drug_code": 83100,
      "updated_date": "2025-12-03T01:27:36-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8348527,
          "ingredient": {
            "id": 2884,
            "ingredient_code": 12149,
            "en_name": "RABEPRAZOLE SODIUM",
            "fr_name": "Rabéprazole sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02345587",
      "brand_name": "APO-RABEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143681002"
    },
    "created_date": "2018-07-04T14:53:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02345587",
    "company_name": "APOTEX INC",
    "atc_number": "A02BC04",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2018-09-17T00:00:00-04:00",
    "actual_start_date": "2018-07-02T00:00:00-04:00",
    "actual_end_date": "2018-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-17T17:29:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RABEPRAZOLE",
    "en_drug_common_name": "RABEPRAZOLE",
    "fr_drug_brand_name": "APO-RABEPRAZOLE",
    "fr_drug_common_name": "RABEPRAZOLE",
    "en_ingredients": "RABEPRAZOLE SODIUM",
    "fr_ingredients": "Rabéprazole sodique",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54312,
    "drug": {
      "current_status": "MARKETED",
      "id": 27234,
      "drug_code": 89490,
      "updated_date": "2025-05-15T02:34:00-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259838,
          "ingredient": {
            "id": 1068,
            "ingredient_code": 660,
            "en_name": "DESOGESTREL",
            "fr_name": "Désogestrel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "TAB",
          "base": true
        },
        {
          "id": 8259837,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.0300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "TAB",
          "base": true
        }
      ],
      "din": "02410249",
      "brand_name": "MIRVALA 21",
      "brand_name_fr": "",
      "descriptor": "ORAL CONTRACEPTIVE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0224591001"
    },
    "created_date": "2018-07-04T14:58:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02410249",
    "company_name": "APOTEX INC",
    "atc_number": "G03AA09",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "estimated_end_date": "2018-08-13T00:00:00-04:00",
    "actual_start_date": "2018-07-02T00:00:00-04:00",
    "actual_end_date": "2018-07-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-12T13:17:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MIRVALA 21",
    "en_drug_common_name": "DESOGESTREL+ETHINYL ESTRADIOL",
    "fr_drug_brand_name": "MIRVALA 21",
    "fr_drug_common_name": "DESOGESTREL+ETHINYL ESTRADIOL",
    "en_ingredients": "DESOGESTREL\r\nETHINYL ESTRADIOL",
    "fr_ingredients": "Désogestrel\r\nÉthinylestradiol",
    "drug_strength": "0.1500MG\r\n0.0300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "21 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54315,
    "drug": {
      "current_status": "MARKETED",
      "id": 27236,
      "drug_code": 89491,
      "updated_date": "2025-05-15T02:34:00-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259840,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.0300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "TAB",
          "base": true
        },
        {
          "id": 8259839,
          "ingredient": {
            "id": 1068,
            "ingredient_code": 660,
            "en_name": "DESOGESTREL",
            "fr_name": "Désogestrel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "TAB",
          "base": true
        }
      ],
      "din": "02410257",
      "brand_name": "MIRVALA 28",
      "brand_name_fr": "",
      "descriptor": "ORAL CONTRACEPTIVE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0224591001"
    },
    "created_date": "2018-07-04T15:00:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02410257",
    "company_name": "APOTEX INC",
    "atc_number": "G03AA09",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "estimated_end_date": "2018-08-13T00:00:00-04:00",
    "actual_start_date": "2018-07-02T00:00:00-04:00",
    "actual_end_date": "2018-07-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-12T13:18:42-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MIRVALA 28",
    "en_drug_common_name": "DESOGESTREL+ETHINYL ESTRADIOL",
    "fr_drug_brand_name": "MIRVALA 28",
    "fr_drug_common_name": "DESOGESTREL+ETHINYL ESTRADIOL",
    "en_ingredients": "DESOGESTREL\r\nETHINYL ESTRADIOL",
    "fr_ingredients": "Désogestrel\r\nÉthinylestradiol",
    "drug_strength": "0.1500MG\r\n0.0300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54338,
    "drug": {
      "current_status": "MARKETED",
      "id": 11230,
      "drug_code": 67616,
      "updated_date": "2025-05-15T02:31:15-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8254214,
          "ingredient": {
            "id": 2880,
            "ingredient_code": 12110,
            "en_name": "LINEZOLID",
            "fr_name": "Linézolide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02243686",
      "brand_name": "ZYVOXAM",
      "brand_name_fr": "",
      "descriptor": "3G PER BOTTLE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143501006"
    },
    "created_date": "2018-07-04T19:34:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243686",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "J01XX08",
    "atc_description": "OTHER ANTIBACTERIALS",
    "actual_start_date": "2018-08-21T00:00:00-04:00",
    "actual_end_date": "2018-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-24T13:21:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ZYVOXAM",
    "en_drug_common_name": "Zyvoxam",
    "fr_drug_brand_name": "ZYVOX",
    "fr_drug_common_name": "Zyvox",
    "en_ingredients": "LINEZOLID",
    "fr_ingredients": "Linézolide",
    "drug_strength": "3G",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1x240ml Btl",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54349,
    "drug": {
      "current_status": "DORMANT",
      "id": 17774,
      "drug_code": 78842,
      "updated_date": "2025-05-15T06:55:36-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8368114,
          "ingredient": {
            "id": 170,
            "ingredient_code": 9060,
            "en_name": "HEPARIN SODIUM",
            "fr_name": "Héparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02303094",
      "brand_name": "HEPARIN SODIUM INJECTION USP     (SINGLE USE VIAL-PRESERVATIVE FREE)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104596002"
    },
    "created_date": "2018-07-04T22:04:46-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02303094",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "B01AB01",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "discontinuation_date": "2018-07-30T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-30T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-31T05:00:08-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "HEPARIN SODIUM INJECTION USP         (SINGLE USE VIAL-PRESERVATIVE FREE)",
    "en_drug_common_name": "HEPARIN Na Inj 10,000U/mL 10x1mLV",
    "fr_drug_brand_name": "HEPARIN Na Inj 10,000U/mL 10x1mLV",
    "fr_drug_common_name": "HEPARIN Na Inj 10,000U/mL 10x1mLV",
    "en_ingredients": "HEPARIN SODIUM",
    "fr_ingredients": "Héparine sodique",
    "drug_strength": "10000UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "10 X 1mL Vials",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54361,
    "drug": {
      "current_status": "MARKETED",
      "id": 12164,
      "drug_code": 70217,
      "updated_date": "2025-05-15T02:31:20-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254495,
          "ingredient": {
            "id": 2992,
            "ingredient_code": 11229,
            "en_name": "FLUNARIZINE",
            "fr_name": "Flunarizine (Chlorhydrate de flunarizine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246082",
      "brand_name": "FLUNARIZINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133140001"
    },
    "created_date": "2018-07-05T12:42:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246082",
    "company_name": "AA PHARMA INC",
    "atc_number": "N07CA03",
    "atc_description": "ANTIVERTIGO PREPARATIONS",
    "estimated_end_date": "2018-07-11T00:00:00-04:00",
    "actual_start_date": "2018-07-05T00:00:00-04:00",
    "actual_end_date": "2018-07-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-01-10T19:30:32-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FLUNARIZINE",
    "en_drug_common_name": "Flunarizine",
    "fr_drug_brand_name": "Flunarizine",
    "fr_drug_common_name": "Flunarizine",
    "en_ingredients": "FLUNARIZINE",
    "fr_ingredients": "HYDROCHLORURE DE FLUNARIZINE",
    "drug_strength": "5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54440,
    "drug": {
      "current_status": "MARKETED",
      "id": 20278,
      "drug_code": 81730,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8257185,
          "ingredient": {
            "id": 2624,
            "ingredient_code": 11799,
            "en_name": "BRINZOLAMIDE",
            "fr_name": "Brinzolamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        },
        {
          "id": 8257184,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02331624",
      "brand_name": "AZARGA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252645001"
    },
    "created_date": "2018-07-05T13:50:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02331624",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01ED51",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2018-07-25T00:00:00-04:00",
    "actual_start_date": "2018-06-25T00:00:00-04:00",
    "actual_end_date": "2018-07-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-27T18:51:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AZARGA",
    "en_drug_common_name": "AZARGA OPH SUSP 5ML",
    "fr_drug_brand_name": "AZARGA",
    "fr_drug_common_name": "AZARGA OPH SUSP 5ML",
    "en_ingredients": "TIMOLOL\r\nBRINZOLAMIDE",
    "fr_ingredients": "Brinzolamide",
    "drug_strength": "0.5%\r\n1.0%",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54449,
    "drug": {
      "current_status": "MARKETED",
      "id": 18194,
      "drug_code": 79459,
      "updated_date": "2025-05-15T02:32:08-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8256383,
          "ingredient": {
            "id": 3460,
            "ingredient_code": 20215,
            "en_name": "NEPAFENAC",
            "fr_name": "Népafénac"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02308983",
      "brand_name": "NEVANAC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152459001"
    },
    "created_date": "2018-07-05T13:56:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02308983",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01BC10",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "anticipated_start_date": "2018-07-05T00:00:00-04:00",
    "estimated_end_date": "2018-07-11T00:00:00-04:00",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2018-07-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-21T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NEVANAC",
    "en_drug_common_name": "NEVANAC SUSP 5ML",
    "fr_drug_brand_name": "NEVANAC",
    "fr_drug_common_name": "NEVANAC SUSPENSION 5ML",
    "en_ingredients": "NEPAFENAC",
    "fr_ingredients": "Népafénac",
    "drug_strength": "0.1%",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54646,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18536,
      "drug_code": 79820,
      "updated_date": "2025-05-15T04:13:55-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8345683,
          "ingredient": {
            "id": 2160,
            "ingredient_code": 1290,
            "en_name": "LOVASTATIN",
            "fr_name": "Lovastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02312670",
      "brand_name": "PRO-LOVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0120669002"
    },
    "created_date": "2018-07-06T14:03:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02312670",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C10AA02",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2018-07-05T00:00:00-04:00",
    "actual_end_date": "2018-07-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-27T05:00:05-04:00",
    "status": "resolved",
    "en_comments": "Discontinued",
    "fr_comments": "Cessation de vente",
    "en_drug_brand_name": "PRO-LOVASTATIN",
    "en_drug_common_name": "LOVASTATIN",
    "fr_drug_brand_name": "PRO-LOVASTATIN",
    "fr_drug_common_name": "LOVASTATIN",
    "en_ingredients": "LOVASTATIN",
    "fr_ingredients": "Lovastatine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30-100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54712,
    "drug": {
      "current_status": "MARKETED",
      "id": 23790,
      "drug_code": 86441,
      "updated_date": "2025-05-15T02:33:11-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258574,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378620",
      "brand_name": "MAR-METFORMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2018-07-06T16:23:30-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02378620",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "A10BA02",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2018-08-07T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-08-06T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "To be Discontinued",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-08-08T05:00:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-METFORMIN",
    "en_drug_common_name": "MAR-Metformin",
    "fr_drug_brand_name": "MAR-Metformin",
    "fr_drug_common_name": "Metformin",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Tabs",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54715,
    "drug": {
      "current_status": "MARKETED",
      "id": 23790,
      "drug_code": 86441,
      "updated_date": "2025-05-15T02:33:11-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258574,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378620",
      "brand_name": "MAR-METFORMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2018-07-06T16:24:36-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02378620",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "A10BA02",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2018-08-07T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-08-06T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "To be Discontinued",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-08-08T05:00:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-METFORMIN",
    "en_drug_common_name": "MAR-Metformin",
    "fr_drug_brand_name": "MAR-Metformin",
    "fr_drug_common_name": "Metformin",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 Tabs",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54718,
    "drug": {
      "current_status": "MARKETED",
      "id": 23792,
      "drug_code": 86442,
      "updated_date": "2025-05-15T02:33:11-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258575,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "850",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378639",
      "brand_name": "MAR-METFORMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773002"
    },
    "created_date": "2018-07-06T16:25:53-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02378639",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "A10BA02",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2018-08-07T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-08-06T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "To Be Discontinued",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-08-08T05:00:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-METFORMIN",
    "en_drug_common_name": "MAR-Metformin",
    "fr_drug_brand_name": "MAR-Metformin",
    "fr_drug_common_name": "Metformin",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "850MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Tabs",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54721,
    "drug": {
      "current_status": "MARKETED",
      "id": 30350,
      "drug_code": 92401,
      "updated_date": "2025-12-03T00:32:47-05:00",
      "company": {
        "id": 678,
        "created_date": "2017-03-09T13:23:04-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 14108,
        "mfr_code": "",
        "name": "TAKEDA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "3800",
        "street_name": "22 ADELAIDE STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5H 4E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261091,
          "ingredient": {
            "id": 3532,
            "ingredient_code": 20437,
            "en_name": "LISDEXAMFETAMINE DIMESYLATE",
            "fr_name": "Dimésylate de lisdexamfétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439603",
      "brand_name": "VYVANSE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152536006"
    },
    "created_date": "2018-07-06T16:27:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439603",
    "company_name": "SHIRE PHARMA CANADA ULC",
    "atc_number": "N06BA12",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2018-07-16T00:00:00-04:00",
    "actual_start_date": "2018-07-06T00:00:00-04:00",
    "actual_end_date": "2018-07-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-07-14T05:00:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VYVANSE",
    "en_drug_common_name": "Lisdexamfetamine Dimesylate capsules",
    "fr_drug_brand_name": "Vyvanse 10mg capsules",
    "fr_drug_common_name": "Capsules de Dimésylate de lisdexamfétamine",
    "en_ingredients": "LISDEXAMFETAMINE DIMESYLATE",
    "fr_ingredients": "Dimésylate de lisdexamfétamine",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54725,
    "drug": {
      "current_status": "MARKETED",
      "id": 23132,
      "drug_code": 85710,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258356,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02371979",
      "brand_name": "MAR-ATENOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113847004"
    },
    "created_date": "2018-07-06T16:49:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02371979",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "C07AB03",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2018-12-03T00:00:00-05:00",
    "estimated_end_date": "2018-08-15T00:00:00-04:00",
    "actual_end_date": "2018-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-08-15T14:08:09-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "MAR-ATENOLOL",
    "en_drug_common_name": "MAR-Atenolol",
    "fr_drug_brand_name": "MAR-Atenolol",
    "fr_drug_common_name": "MAR-Atenolol",
    "en_ingredients": "ATENOLOL",
    "fr_ingredients": "Aténolol",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Tabs",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54731,
    "drug": {
      "current_status": "DORMANT",
      "id": 31094,
      "drug_code": 93263,
      "updated_date": "2025-05-15T06:55:56-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369327,
          "ingredient": {
            "id": 2840,
            "ingredient_code": 12034,
            "en_name": "MOXIFLOXACIN",
            "fr_name": "Moxifloxacine (Chlorhydrate de moxifloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02447053",
      "brand_name": "MAR-MOXIFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142242001"
    },
    "created_date": "2018-07-06T16:56:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02447053",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "J01MA14",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "anticipated_start_date": "2018-11-03T00:00:00-04:00",
    "estimated_end_date": "2019-01-14T00:00:00-05:00",
    "actual_start_date": "2018-08-15T00:00:00-04:00",
    "actual_end_date": "2019-01-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-01-15T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-MOXIFLOXACIN",
    "en_drug_common_name": "MAR-Moxifloxacin",
    "fr_drug_brand_name": "MAR-Moxifloxacin",
    "fr_drug_common_name": "MAR-Moxifloxacin",
    "en_ingredients": "MOXIFLOXACIN",
    "fr_ingredients": "Moxifloxacin",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54737,
    "drug": {
      "current_status": "DORMANT",
      "id": 28378,
      "drug_code": 90504,
      "updated_date": "2025-05-15T06:55:51-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369071,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420457",
      "brand_name": "MAR-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858001"
    },
    "created_date": "2018-07-06T17:03:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420457",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "C09AA05",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2018-08-17T00:00:00-04:00",
    "actual_start_date": "2018-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-08-16T05:00:04-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MAR-RAMIPRIL",
    "en_drug_common_name": "Ramipril",
    "fr_drug_brand_name": "MAR-Ramipril",
    "fr_drug_common_name": "MAR-Ramipril",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "1.25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 Caps",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54742,
    "drug": {
      "current_status": "DORMANT",
      "id": 27682,
      "drug_code": 899,
      "updated_date": "2025-05-15T06:55:19-04:00",
      "company": {
        "id": 17157,
        "created_date": "2022-01-07T05:00:11-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 16672,
        "mfr_code": "",
        "name": "LIEBEL-FLARSHEIM COMPANY LLC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "8800 DURANT RD.",
        "province": "NORTH CAROLINA",
        "country": "UNITED STATES",
        "city": "RALEIGH",
        "postal_code": "27616",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8365802,
          "ingredient": {
            "id": 544,
            "ingredient_code": 12859,
            "en_name": "IOTHALAMATE MEGLUMINE",
            "fr_name": "Iothalamate de méglumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00131237",
      "brand_name": "CONRAY 60",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "32052",
      "number_of_ais": "1",
      "ai_group_no": "0102763001"
    },
    "created_date": "2018-07-06T19:05:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00131237",
    "company_name": "LIEBEL-FLARSHEIM CANADA INC",
    "atc_number": "V08AA04",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "estimated_end_date": "2018-11-06T00:00:00-05:00",
    "actual_start_date": "2018-07-06T00:00:00-04:00",
    "actual_end_date": "2018-10-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-10-23T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Reason for Shortage: Change of Manufacturing site",
    "fr_comments": "Raison de la pénurie: changement de site de fabrication",
    "en_drug_brand_name": "CONRAY 60",
    "en_drug_common_name": "Iothalamate Meglumine Injection 60 %",
    "fr_drug_brand_name": "CONRAY 60",
    "fr_drug_common_name": "Solution injectable d'iothalamate de méglumine 60 %",
    "en_ingredients": "IOTHALAMATE MEGLUMINE",
    "fr_ingredients": "Iothalamate de méglumine",
    "drug_strength": "600MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVASCULAR",
    "drug_route_fr": "Intravasculaire",
    "drug_package_quantity": "50 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54750,
    "drug": {
      "current_status": "MARKETED",
      "id": 9032,
      "drug_code": 61609,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8253560,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02238216",
      "brand_name": "SINGULAIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823001"
    },
    "created_date": "2018-07-07T21:44:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238216",
    "company_name": "MERCK CANADA INC",
    "atc_number": "R03DC03",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "anticipated_start_date": "2018-07-27T00:00:00-04:00",
    "estimated_end_date": "2018-08-10T00:00:00-04:00",
    "actual_start_date": "2018-07-19T00:00:00-04:00",
    "actual_end_date": "2018-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-08-01T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SINGULAIR",
    "en_drug_common_name": "montelukast tablets",
    "fr_drug_brand_name": "SINGULAIR",
    "fr_drug_common_name": "comprimés de montélukast",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "montelukast",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (CHEWABLE)",
    "drug_dosage_form_fr": "Comprimé (à mâcher)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30TAB BLIS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54756,
    "drug": {
      "current_status": "MARKETED",
      "id": 5272,
      "drug_code": 3396,
      "updated_date": "2025-05-15T02:30:29-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8250509,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00402249",
      "brand_name": "SODIUM CHLORIDE BACTERIOSTATIC INJ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54173",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2018-07-09T13:09:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00402249",
    "company_name": "OMEGA LABORATORIES LTD",
    "atc_number": "B05XA03",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "estimated_end_date": "2018-07-31T00:00:00-04:00",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2018-07-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-25T15:29:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SODIUM CHLORIDE BACTERIOSTATIC INJ",
    "en_drug_common_name": "Sodium Chloride Bacteriostatic for Injection USP",
    "fr_drug_brand_name": "Sodium Chloride Bacteriostatic for Injection USP",
    "fr_drug_common_name": "Chlorure de sodium bactériostatique pour injection",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "9MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "10 x 30 mL vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54767,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1044,
      "drug_code": 12422,
      "updated_date": "2025-05-15T03:38:46-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8289751,
          "ingredient": {
            "id": 598,
            "ingredient_code": 11162,
            "en_name": "ACEBUTOLOL",
            "fr_name": "Acébutolol (Chlorhydrate d'acébutolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "01926551",
      "brand_name": "SECTRAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73518",
      "number_of_ais": "1",
      "ai_group_no": "0131282003"
    },
    "created_date": "2018-07-09T14:35:25-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "01926551",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "C07AB04",
    "atc_description": "BETA BLOCKING AGENTS",
    "discontinuation_date": "2018-08-09T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Discontinuation of API",
    "en_discontinuation_comments": "Discontinuation date could be earlier than anticipated depending on the demand of stock, recently released.  At depletion of this stock the product will be discontinued.",
    "fr_discontinuation_comments": "La date de cessation de vente prévue pourrait être devancée dépendamment de l'écoulement du stock récemment relâché. À l'épuisement de ce stock, le produit sera discontinué.",
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-09-07T19:49:19-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "SECTRAL",
    "en_drug_common_name": "Sectral 200mg",
    "fr_drug_brand_name": "Sectral",
    "fr_drug_common_name": "Sectral 200mg",
    "en_ingredients": "ACEBUTOLOL",
    "fr_ingredients": "Acebutolol Hydrochloride",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54770,
    "drug": {
      "current_status": "MARKETED",
      "id": 6782,
      "drug_code": 44263,
      "updated_date": "2025-12-03T00:30:37-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253180,
          "ingredient": {
            "id": 1592,
            "ingredient_code": 5900,
            "en_name": "METHOTREXATE",
            "fr_name": "Méthotrexate (Méthotrexate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02182963",
      "brand_name": "APO-METHOTREXATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9987",
      "number_of_ais": "1",
      "ai_group_no": "0107545001"
    },
    "created_date": "2018-07-09T14:50:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02182963",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "L01BA01",
    "atc_description": "ANTIMETABOLITES",
    "hc_updated_date": "2021-07-23T14:41:20-04:00",
    "anticipated_start_date": "2018-12-30T00:00:00-05:00",
    "estimated_end_date": "2021-07-30T00:00:00-04:00",
    "actual_start_date": "2018-12-30T00:00:00-05:00",
    "actual_end_date": "2021-07-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-07-23T14:41:21-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METHOTREXATE",
    "en_drug_common_name": "METHOTREXATE",
    "fr_drug_brand_name": "APO-METHOTREXATE",
    "fr_drug_common_name": "METHOTREXATE",
    "en_ingredients": "METHOTREXATE",
    "fr_ingredients": "Méthotrexate",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54773,
    "drug": {
      "current_status": "MARKETED",
      "id": 23866,
      "drug_code": 86529,
      "updated_date": "2025-05-15T02:33:11-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8258590,
          "ingredient": {
            "id": 2406,
            "ingredient_code": 11431,
            "en_name": "TOPOTECAN",
            "fr_name": "Topotécane (Chlorhydrate de topotécan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02379422",
      "brand_name": "TOPOTECAN HYDROCHLORIDE FOR INJECTION",
      "brand_name_fr": "CHLORHYDRATE DE TOPOTÉCAN POUR INJECTION",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132984002"
    },
    "created_date": "2018-07-09T14:53:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379422",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "L01XX17",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "actual_start_date": "2018-08-07T00:00:00-04:00",
    "actual_end_date": "2018-09-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-09-05T05:00:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TOPOTECAN HYDROCHLORIDE FOR INJECTION",
    "en_drug_common_name": "TOPOTECAN",
    "fr_drug_brand_name": "TOPOTECAN HYDROCHLORIDE",
    "fr_drug_common_name": "TOPOTECAN",
    "en_ingredients": "TOPOTECAN",
    "fr_ingredients": "TOPOTECAN",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "5 x 4mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54783,
    "drug": {
      "current_status": "MARKETED",
      "id": 16248,
      "drug_code": 77030,
      "updated_date": "2025-05-15T02:31:47-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255799,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02284758",
      "brand_name": "SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415003"
    },
    "created_date": "2018-07-09T16:38:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02284758",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C10AA01",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2018-08-31T00:00:00-04:00",
    "actual_start_date": "2018-09-04T00:00:00-04:00",
    "actual_end_date": "2021-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-05-06T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SIMVASTATIN",
    "en_drug_common_name": "SIMVASTATIN TAB",
    "fr_drug_brand_name": "SIMVASTATIN",
    "fr_drug_common_name": "SIMVASTATIN COMPRIME",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54790,
    "drug": {
      "current_status": "MARKETED",
      "id": 16244,
      "drug_code": 77028,
      "updated_date": "2025-05-15T02:31:47-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255797,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02284723",
      "brand_name": "SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415001"
    },
    "created_date": "2018-07-09T16:39:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02284723",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C10AA01",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2018-08-31T00:00:00-04:00",
    "actual_start_date": "2018-09-04T00:00:00-04:00",
    "actual_end_date": "2021-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-05-06T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SIMVASTATIN",
    "en_drug_common_name": "SIMVASTATIN TAB",
    "fr_drug_brand_name": "SIMVASTATIN",
    "fr_drug_common_name": "SIMVASTATIN COMPRIME",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54794,
    "drug": {
      "current_status": "MARKETED",
      "id": 16250,
      "drug_code": 77031,
      "updated_date": "2025-05-15T02:31:47-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255800,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02284766",
      "brand_name": "SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415002"
    },
    "created_date": "2018-07-09T16:44:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02284766",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C10AA01",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2018-10-31T00:00:00-04:00",
    "actual_start_date": "2018-11-21T00:00:00-05:00",
    "actual_end_date": "2021-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-05-06T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SIMVASTATIN",
    "en_drug_common_name": "SIMVASTATIN TAB",
    "fr_drug_brand_name": "SIMVASTATIN",
    "fr_drug_common_name": "SIMVASTATIN COMPRIME",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54798,
    "drug": {
      "current_status": "MARKETED",
      "id": 16252,
      "drug_code": 77032,
      "updated_date": "2025-05-15T02:31:47-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255801,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02284774",
      "brand_name": "SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415005"
    },
    "created_date": "2018-07-09T16:45:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02284774",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C10AA01",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2018-10-31T00:00:00-04:00",
    "actual_start_date": "2018-11-21T00:00:00-05:00",
    "actual_end_date": "2021-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-05-06T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SIMVASTATIN",
    "en_drug_common_name": "SIMVASTATIN TAB",
    "fr_drug_brand_name": "SIMVASTATIN",
    "fr_drug_common_name": "SIMVASTATIN COMPRIME",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54802,
    "drug": {
      "current_status": "MARKETED",
      "id": 16246,
      "drug_code": 77029,
      "updated_date": "2025-05-15T02:31:47-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255798,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02284731",
      "brand_name": "SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415004"
    },
    "created_date": "2018-07-09T16:46:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02284731",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C10AA01",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2019-01-01T00:00:00-05:00",
    "actual_end_date": "2021-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-05-06T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SIMVASTATIN",
    "en_drug_common_name": "SIMVASTATIN TAB",
    "fr_drug_brand_name": "SIMVASTATIN",
    "fr_drug_common_name": "SIMVASTATIN COMPRIME",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54816,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10796,
      "drug_code": 66609,
      "updated_date": "2025-05-15T04:02:21-04:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8333125,
          "ingredient": {
            "id": 2560,
            "ingredient_code": 11764,
            "en_name": "MELOXICAM",
            "fr_name": "Méloxicam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242786",
      "brand_name": "MOBICOX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131676004"
    },
    "created_date": "2018-07-09T17:36:12-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02242786",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "M01AC06",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "discontinuation_date": "2018-08-20T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-08-21T05:00:07-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MOBICOX",
    "en_drug_common_name": "Mobicox",
    "fr_drug_brand_name": "Mobicox",
    "fr_drug_common_name": "Mobicox 15MG",
    "en_ingredients": "MELOXICAM",
    "fr_ingredients": "Méloxicam",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100s",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54819,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10794,
      "drug_code": 66608,
      "updated_date": "2025-05-15T04:02:21-04:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8333124,
          "ingredient": {
            "id": 2560,
            "ingredient_code": 11764,
            "en_name": "MELOXICAM",
            "fr_name": "Méloxicam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242785",
      "brand_name": "MOBICOX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131676003"
    },
    "created_date": "2018-07-09T17:40:11-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02242785",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "M01AC06",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "discontinuation_date": "2018-10-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2019-01-01T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Duplicated record",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-06-10T17:20:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MOBICOX",
    "en_drug_common_name": "Mobicox 7.5MG",
    "fr_drug_brand_name": "Mobicox",
    "fr_drug_common_name": "Mobicox 7.5MG",
    "en_ingredients": "MELOXICAM",
    "fr_ingredients": "Méloxicam",
    "drug_strength": "7.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100s",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54822,
    "drug": {
      "current_status": "MARKETED",
      "id": 2058,
      "drug_code": 14355,
      "updated_date": "2025-12-03T00:30:31-05:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8251952,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.03",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251951,
          "ingredient": {
            "id": 1068,
            "ingredient_code": 660,
            "en_name": "DESOGESTREL",
            "fr_name": "Désogestrel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02042479",
      "brand_name": "MARVELON 28",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75956",
      "number_of_ais": "2",
      "ai_group_no": "0224591001"
    },
    "created_date": "2018-07-09T18:00:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02042479",
    "company_name": "MERCK CANADA INC",
    "atc_number": "G03AA09",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "anticipated_start_date": "2018-08-20T00:00:00-04:00",
    "estimated_end_date": "2018-08-24T00:00:00-04:00",
    "actual_start_date": "2018-08-16T00:00:00-04:00",
    "actual_end_date": "2018-08-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-08-26T12:24:37-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MARVELON 28",
    "en_drug_common_name": "desogestrel and ethinyl estradiol tablets,",
    "fr_drug_brand_name": "MARVELON",
    "fr_drug_common_name": "comprimés de désogestrel et d’éthinyl estradiol",
    "en_ingredients": "DESOGESTREL\r\nETHINYL ESTRADIOL",
    "fr_ingredients": "Désogestrel\r\nÉthinylestradiol",
    "drug_strength": "0.15MG\r\n0.03MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54850,
    "drug": {
      "current_status": "MARKETED",
      "id": 16320,
      "drug_code": 77112,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 16988,
        "created_date": "2020-11-09T00:00:05-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 18078,
        "mfr_code": "",
        "name": "COVIS PHARMA GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "GRAFENAUWEG 12",
        "province": "ZUG",
        "country": "SWITZERLAND",
        "city": "ZUG",
        "postal_code": "6300",
        "post_office_box": "",
        "contact_information": "Covis Pharma GmbH\r\nGrafenauweg 12\r\nZug, 6300 \r\nSwitzerland"
      },
      "drug_ingredients": [
        {
          "id": 8255822,
          "ingredient": {
            "id": 3346,
            "ingredient_code": 19961,
            "en_name": "CICLESONIDE",
            "fr_name": "Ciclésonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02285614",
      "brand_name": "ALVESCO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151669002"
    },
    "created_date": "2018-07-09T19:15:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02285614",
    "company_name": "ASTRAZENECA CANADA INC",
    "atc_number": "R03BA08",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "anticipated_start_date": "2018-07-16T00:00:00-04:00",
    "estimated_end_date": "2018-10-12T00:00:00-04:00",
    "actual_start_date": "2018-07-13T00:00:00-04:00",
    "actual_end_date": "2018-10-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2018-10-12T19:11:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ALVESCO",
    "en_drug_common_name": "ciclesonide",
    "fr_drug_brand_name": "Alvesco",
    "fr_drug_common_name": "ciclésonide",
    "en_ingredients": "CICLESONIDE",
    "fr_ingredients": "Ciclésonide",
    "drug_strength": "200MCG",
    "drug_dosage_form": "AEROSOL, METERED DOSE",
    "drug_dosage_form_fr": "Aérosol, dose mesurée",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "120 doses",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54854,
    "drug": {
      "current_status": "MARKETED",
      "id": 7398,
      "drug_code": 49943,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253298,
          "ingredient": {
            "id": 1122,
            "ingredient_code": 2097,
            "en_name": "PINAVERIUM BROMIDE",
            "fr_name": "Bromure de pinavérium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02230684",
      "brand_name": "DICETEL",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED TABLET",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113429002"
    },
    "created_date": "2018-07-09T19:18:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230684",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "A03AX04",
    "atc_description": "DRUGS FOR FUNCTIONAL BOWEL DISORDERS",
    "anticipated_start_date": "2018-07-26T00:00:00-04:00",
    "estimated_end_date": "2018-08-10T00:00:00-04:00",
    "actual_end_date": "2018-08-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-08-09T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DICETEL",
    "en_drug_common_name": "PINAVERIUM BROMIDE",
    "fr_drug_brand_name": "DICETEL",
    "fr_drug_common_name": "Bromure de pinavérium",
    "en_ingredients": "PINAVERIUM BROMIDE",
    "fr_ingredients": "Bromure de pinavérium",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "5 x 20",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54875,
    "drug": {
      "current_status": "MARKETED",
      "id": 6774,
      "drug_code": 44257,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8253176,
          "ingredient": {
            "id": 202,
            "ingredient_code": 7358,
            "en_name": "CHORIONIC GONADOTROPIN",
            "fr_name": "Ganodotrophine chorionique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02182904",
      "brand_name": "PREGNYL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9981",
      "number_of_ais": "1",
      "ai_group_no": "0106481003"
    },
    "created_date": "2018-07-09T19:44:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02182904",
    "company_name": "MERCK CANADA INC",
    "atc_number": "G03GA01",
    "atc_description": "GONADOTROPHINS AND OTHER OVULATION STIMULANTS",
    "anticipated_start_date": "2018-07-17T00:00:00-04:00",
    "estimated_end_date": "2018-11-30T00:00:00-05:00",
    "actual_start_date": "2018-07-17T00:00:00-04:00",
    "actual_end_date": "2018-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-12-01T06:00:07-05:00",
    "status": "resolved",
    "en_comments": "Limited quantity available",
    "fr_comments": "Quantité limitée disponible",
    "en_drug_brand_name": "PREGNYL",
    "en_drug_common_name": "chorionic gonadotropin for injection",
    "fr_drug_brand_name": "PREGNYL",
    "fr_drug_common_name": "gonadotrophine chorionique pour injection",
    "en_ingredients": "CHORIONIC GONADOTROPIN\r\nWATER",
    "fr_ingredients": "Ganodotrophine chorionique\r\nEau",
    "drug_strength": "10000UNIT\r\n10ML",
    "drug_dosage_form": "KIT\r\nLIQUID\r\nPOWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Trousse\r\nLiquide\r\nPoudre pour solution",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "10000U VIAL & 10ML SOLVENT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54882,
    "drug": {
      "current_status": "MARKETED",
      "id": 3532,
      "drug_code": 18862,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252393,
          "ingredient": {
            "id": 558,
            "ingredient_code": 8970,
            "en_name": "ATROPINE SULFATE",
            "fr_name": "Sulfate d'atropine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02148358",
      "brand_name": "MINIMS ATROPINE SULPHATE",
      "brand_name_fr": "MINIMS SULPHATE D'ATROPINE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81142",
      "number_of_ais": "1",
      "ai_group_no": "0104748001"
    },
    "created_date": "2018-07-09T20:16:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02148358",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "S01FA01",
    "atc_description": "MYDRIATICSAND CYCLOPLEGICS",
    "actual_start_date": "2018-07-06T00:00:00-04:00",
    "actual_end_date": "2018-09-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-09-10T18:31:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINIMS ATROPINE SULPHATE 1%",
    "en_drug_common_name": "MINIMS ATROPINE SULPHATE 1%",
    "fr_drug_brand_name": "MINIMS ATROPINE SULPHATE 1%",
    "fr_drug_common_name": "MINIMS ATROPINE SULPHATE 1%",
    "en_ingredients": "ATROPINE SULFATE",
    "fr_ingredients": "Sulfate d'atropine",
    "drug_strength": "1%",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "n/a",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54891,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 31344,
      "drug_code": 93635,
      "updated_date": "2025-05-15T04:24:24-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8356478,
          "ingredient": {
            "id": 3624,
            "ingredient_code": 13238,
            "en_name": "EVEROLIMUS",
            "fr_name": "Évérolimus"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02450267",
      "brand_name": "AFINITOR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152682009"
    },
    "created_date": "2018-07-09T21:29:34-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02450267",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "L01XE10",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "discontinuation_date": "2018-07-09T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "No remaining supply - inventory depleted",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-10T05:00:10-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "AFINITOR",
    "en_drug_common_name": "AFINITOR 7.5MG TAB (4X7)",
    "fr_drug_brand_name": "AFINITOR",
    "fr_drug_common_name": "AFINITOR 7.5MG TAB (4X7)",
    "en_ingredients": "EVEROLIMUS",
    "fr_ingredients": "Évérolimus",
    "drug_strength": "7.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4 X 7",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54894,
    "drug": {
      "current_status": "MARKETED",
      "id": 22720,
      "drug_code": 85256,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8258187,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02367726",
      "brand_name": "VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885003"
    },
    "created_date": "2018-07-10T00:13:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02367726",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2020-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-02-01T06:00:05-05:00",
    "status": "resolved",
    "en_comments": "Recall",
    "fr_comments": "Retrait",
    "en_drug_brand_name": "VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30-100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54897,
    "drug": {
      "current_status": "MARKETED",
      "id": 22722,
      "drug_code": 85257,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8258188,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02367734",
      "brand_name": "VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885001"
    },
    "created_date": "2018-07-10T00:15:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02367734",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2020-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-02-01T06:00:05-05:00",
    "status": "resolved",
    "en_comments": "Recall",
    "fr_comments": "Retrait",
    "en_drug_brand_name": "VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30-100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54900,
    "drug": {
      "current_status": "MARKETED",
      "id": 22724,
      "drug_code": 85258,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8258189,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02367742",
      "brand_name": "VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885002"
    },
    "created_date": "2018-07-10T00:16:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02367742",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2020-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-02-01T06:00:06-05:00",
    "status": "resolved",
    "en_comments": "Recall",
    "fr_comments": "Retrait",
    "en_drug_brand_name": "VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30-100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54903,
    "drug": {
      "current_status": "MARKETED",
      "id": 22726,
      "drug_code": 85259,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8258190,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "320",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02367750",
      "brand_name": "VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885004"
    },
    "created_date": "2018-07-10T00:18:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02367750",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2020-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-02-01T06:00:06-05:00",
    "status": "resolved",
    "en_comments": "Recall",
    "fr_comments": "Retrait",
    "en_drug_brand_name": "VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "320MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30-100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54922,
    "drug": {
      "current_status": "MARKETED",
      "id": 23094,
      "drug_code": 85684,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258339,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02371707",
      "brand_name": "MAR-AMLODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131437003"
    },
    "created_date": "2018-07-10T12:50:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02371707",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "C08CA01",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "anticipated_start_date": "2018-07-10T00:00:00-04:00",
    "estimated_end_date": "2019-09-12T00:00:00-04:00",
    "actual_start_date": "2018-07-10T00:00:00-04:00",
    "actual_end_date": "2019-09-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-10-07T13:15:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-AMLODIPINE TABLETS",
    "en_drug_common_name": "MAR-Amlodipine",
    "fr_drug_brand_name": "MAR-Amlodipine",
    "fr_drug_common_name": "MAR-Amlodipine",
    "en_ingredients": "AMLODIPINE",
    "fr_ingredients": "Amlodipine",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54938,
    "drug": {
      "current_status": "DORMANT",
      "id": 29614,
      "drug_code": 91655,
      "updated_date": "2025-05-15T06:55:54-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369203,
          "ingredient": {
            "id": 2382,
            "ingredient_code": 11384,
            "en_name": "TOPIRAMATE",
            "fr_name": "Topiramate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02432102",
      "brand_name": "MAR-TOPIRAMATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132938002"
    },
    "created_date": "2018-07-10T13:33:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02432102",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N03AX11",
    "atc_description": "ANTIEPILEPTICS",
    "actual_start_date": "2018-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-11T05:00:13-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MAR-TOPIRAMATE",
    "en_drug_common_name": "MAR-TOPIRAMATE",
    "fr_drug_brand_name": "MAR-TOPIRAMATE",
    "fr_drug_common_name": "MAR-TOPIRAMATE",
    "en_ingredients": "TOPIRAMATE",
    "fr_ingredients": "Topiramate",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54941,
    "drug": {
      "current_status": "MARKETED",
      "id": 31522,
      "drug_code": 93848,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261781,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452278",
      "brand_name": "MAR-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485004"
    },
    "created_date": "2018-07-10T13:35:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452278",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "G04BE08",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2018-07-10T00:00:00-04:00",
    "actual_start_date": "2018-07-10T00:00:00-04:00",
    "actual_end_date": "2018-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-13T14:48:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-TADALAFIL",
    "en_drug_common_name": "MAR-TADALAFIL",
    "fr_drug_brand_name": "MAR-TADALAFIL",
    "fr_drug_common_name": "MAR-TADALAFIL",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54945,
    "drug": {
      "current_status": "MARKETED",
      "id": 31526,
      "drug_code": 93850,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261783,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452243",
      "brand_name": "MAR-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485002"
    },
    "created_date": "2018-07-10T13:37:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452243",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "G04BE08",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2018-07-10T00:00:00-04:00",
    "actual_start_date": "2018-07-10T00:00:00-04:00",
    "actual_end_date": "2018-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-13T14:48:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-TADALAFIL",
    "en_drug_common_name": "MAR-TADALAFIL",
    "fr_drug_brand_name": "MAR-TADALAFIL",
    "fr_drug_common_name": "MAR-TADALAFIL",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54951,
    "drug": {
      "current_status": "MARKETED",
      "id": 31524,
      "drug_code": 93849,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261782,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452251",
      "brand_name": "MAR-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485001"
    },
    "created_date": "2018-07-10T13:40:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452251",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "G04BE08",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2018-07-10T00:00:00-04:00",
    "estimated_end_date": "2018-07-12T00:00:00-04:00",
    "actual_start_date": "2018-07-10T00:00:00-04:00",
    "actual_end_date": "2018-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-13T05:00:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-TADALAFIL",
    "en_drug_common_name": "MAR-TADALAFIL",
    "fr_drug_brand_name": "MAR-TADALAFIL",
    "fr_drug_common_name": "MAR-TADALAFIL",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 54972,
    "drug": {
      "current_status": "MARKETED",
      "id": 27528,
      "drug_code": 89772,
      "updated_date": "2025-12-03T00:32:22-05:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259948,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02413051",
      "brand_name": "MAR-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963004"
    },
    "created_date": "2018-07-10T13:54:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02413051",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "C10AA07",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2018-07-10T00:00:00-04:00",
    "actual_start_date": "2018-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-11T05:00:07-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MAR-ROSUVASTATIN",
    "en_drug_common_name": "MAR-ROSUVASTATIN",
    "fr_drug_brand_name": "MAR-ROSUVASTATIN",
    "fr_drug_common_name": "MAR-ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55003,
    "drug": {
      "current_status": "MARKETED",
      "id": 21796,
      "drug_code": 84187,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257784,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356740",
      "brand_name": "SANDOZ VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885003"
    },
    "created_date": "2018-07-10T14:32:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356740",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2020-08-21T00:00:00-04:00",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2020-08-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-08-26T17:32:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "SANDOZ VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55029,
    "drug": {
      "current_status": "MARKETED",
      "id": 21802,
      "drug_code": 84190,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257787,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "320",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356775",
      "brand_name": "SANDOZ VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885004"
    },
    "created_date": "2018-07-10T15:10:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356775",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2020-06-12T00:00:00-04:00",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2020-06-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-06-22T14:06:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ VALSARTAN",
    "en_drug_common_name": "SANDOZ VALSARTAN",
    "fr_drug_brand_name": "SANDOZ VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "320MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55032,
    "drug": {
      "current_status": "MARKETED",
      "id": 21800,
      "drug_code": 84189,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257786,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356767",
      "brand_name": "SANDOZ VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885002"
    },
    "created_date": "2018-07-10T15:11:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356767",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2020-08-07T00:00:00-04:00",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2020-08-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-08-17T12:33:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "SANDOZ VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55035,
    "drug": {
      "current_status": "MARKETED",
      "id": 21800,
      "drug_code": 84189,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257786,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356767",
      "brand_name": "SANDOZ VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885002"
    },
    "created_date": "2018-07-10T15:13:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356767",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2020-08-07T00:00:00-04:00",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2020-08-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-08-17T12:32:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "SANDOZ VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55038,
    "drug": {
      "current_status": "MARKETED",
      "id": 21798,
      "drug_code": 84188,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257785,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356759",
      "brand_name": "SANDOZ VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885001"
    },
    "created_date": "2018-07-10T15:14:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356759",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2020-09-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-09-08T12:29:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "SANDOZ VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55045,
    "drug": {
      "current_status": "MARKETED",
      "id": 21800,
      "drug_code": 84189,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257786,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356767",
      "brand_name": "SANDOZ VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885002"
    },
    "created_date": "2018-07-10T15:23:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356767",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2020-06-19T00:00:00-04:00",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2020-06-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-06-22T14:05:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "SANDOZ VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55050,
    "drug": {
      "current_status": "MARKETED",
      "id": 21802,
      "drug_code": 84190,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257787,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "320",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356775",
      "brand_name": "SANDOZ VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885004"
    },
    "created_date": "2018-07-10T15:32:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356775",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2018-07-09T00:00:00-04:00",
    "estimated_end_date": "2020-07-10T00:00:00-04:00",
    "actual_start_date": "2018-07-11T00:00:00-04:00",
    "actual_end_date": "2020-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-07-20T13:16:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "SANDOZ VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "320MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55057,
    "drug": {
      "current_status": "MARKETED",
      "id": 21796,
      "drug_code": 84187,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257784,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356740",
      "brand_name": "SANDOZ VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885003"
    },
    "created_date": "2018-07-10T15:49:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356740",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2020-08-21T00:00:00-04:00",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2020-08-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-08-26T17:31:32-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "SANDOZ VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55060,
    "drug": {
      "current_status": "MARKETED",
      "id": 21798,
      "drug_code": 84188,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257785,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356759",
      "brand_name": "SANDOZ VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885001"
    },
    "created_date": "2018-07-10T15:50:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356759",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2020-08-14T00:00:00-04:00",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2020-08-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-08-17T14:03:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "SANDOZ VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55063,
    "drug": {
      "current_status": "MARKETED",
      "id": 21798,
      "drug_code": 84188,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257785,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356759",
      "brand_name": "SANDOZ VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885001"
    },
    "created_date": "2018-07-10T15:52:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356759",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2020-08-07T00:00:00-04:00",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2020-08-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-08-17T14:02:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "SANDOZ VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55083,
    "drug": {
      "current_status": "MARKETED",
      "id": 22652,
      "drug_code": 85176,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258160,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02366940",
      "brand_name": "VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885003"
    },
    "created_date": "2018-07-10T17:13:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02366940",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2020-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-02-29T06:00:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VALSARTAN",
    "en_drug_common_name": "VALSARTAN TAB",
    "fr_drug_brand_name": "VALSARTAN",
    "fr_drug_common_name": "VALSARTAN COMPRIME",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55088,
    "drug": {
      "current_status": "MARKETED",
      "id": 22654,
      "drug_code": 85177,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258161,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02366959",
      "brand_name": "VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885001"
    },
    "created_date": "2018-07-10T17:14:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02366959",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2020-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-02-29T06:00:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VALSARTAN",
    "en_drug_common_name": "VALSARTAN TAB",
    "fr_drug_brand_name": "VALSARTAN",
    "fr_drug_common_name": "VALSARTAN COMPRIME",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55093,
    "drug": {
      "current_status": "MARKETED",
      "id": 22656,
      "drug_code": 85178,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258162,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02366967",
      "brand_name": "VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885002"
    },
    "created_date": "2018-07-10T17:15:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02366967",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2020-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-02-29T06:00:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VALSARTAN",
    "en_drug_common_name": "VALSARTAN TAB",
    "fr_drug_brand_name": "VALSARTAN",
    "fr_drug_common_name": "VALSARTAN COMPRIME",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55098,
    "drug": {
      "current_status": "MARKETED",
      "id": 22658,
      "drug_code": 85179,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258163,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "320",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02366975",
      "brand_name": "VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885004"
    },
    "created_date": "2018-07-10T17:16:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02366975",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2020-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-02-29T06:00:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VALSARTAN",
    "en_drug_common_name": "VALSARTAN TAB",
    "fr_drug_brand_name": "VALSARTAN",
    "fr_drug_common_name": "VALSARTAN COMPRIME",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "320MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55105,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 29428,
      "drug_code": 91438,
      "updated_date": "2025-05-15T04:22:50-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8355043,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8355042,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02429969",
      "brand_name": "TRAMADOL / ACETAMINOPHEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0250601001"
    },
    "created_date": "2018-07-10T17:23:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429969",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N02AJ13",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2018-08-01T00:00:00-04:00",
    "estimated_end_date": "2018-09-17T00:00:00-04:00",
    "actual_start_date": "2018-07-30T00:00:00-04:00",
    "actual_end_date": "2018-09-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-09-20T19:29:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TRAMADOL / ACETAMINOPHEN",
    "en_drug_common_name": "TRAMADOL HCL/ACETAMINOPHEN",
    "fr_drug_brand_name": "TRAMADOL HCL/ACETAMINOPHEN",
    "fr_drug_common_name": "TRAMADOL HCL/ACETAMINOPHEN",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE\r\nACETAMINOPHEN",
    "fr_ingredients": "Chlorhydrate de tramadol\r\nAcétaminophène",
    "drug_strength": "37.5MG\r\n325MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55110,
    "drug": {
      "current_status": "MARKETED",
      "id": 24206,
      "drug_code": 86830,
      "updated_date": "2025-05-15T02:33:19-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258711,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02382466",
      "brand_name": "MONTELUKAST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823001"
    },
    "created_date": "2018-07-10T17:27:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382466",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "R03DC03",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "anticipated_start_date": "2018-07-05T00:00:00-04:00",
    "actual_start_date": "2018-07-05T00:00:00-04:00",
    "actual_end_date": "2018-08-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-09-11T20:46:27-04:00",
    "status": "resolved",
    "fr_comments": "temporairement indisponible",
    "en_drug_brand_name": "MONTELUKAST",
    "en_drug_common_name": "MONTELUKAST",
    "fr_drug_brand_name": "MONTELUKAST",
    "fr_drug_common_name": "MONTELUKAST",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "100",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (CHEWABLE)",
    "drug_dosage_form_fr": "Comprimé (à mâcher)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55113,
    "drug": {
      "current_status": "MARKETED",
      "id": 30698,
      "drug_code": 92751,
      "updated_date": "2025-05-15T02:34:54-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261283,
          "ingredient": {
            "id": 272,
            "ingredient_code": 20170,
            "en_name": "ENALAPRIL SODIUM",
            "fr_name": "Énalapril sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442981",
      "brand_name": "ENALAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152325003"
    },
    "created_date": "2018-07-10T17:29:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02442981",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09AA02",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2018-08-20T00:00:00-04:00",
    "estimated_end_date": "2018-10-19T00:00:00-04:00",
    "actual_start_date": "2018-08-17T00:00:00-04:00",
    "actual_end_date": "2018-10-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-10-22T14:47:48-04:00",
    "status": "resolved",
    "en_comments": "TEMPORARILY UNAVAILABLE",
    "fr_comments": "TEMPORAIREMENT INDISPONIBLE",
    "en_drug_brand_name": "ENALAPRIL",
    "en_drug_common_name": "ENALAPRIL",
    "fr_drug_brand_name": "ENALAPRIL",
    "fr_drug_common_name": "ENALAPRIL",
    "en_ingredients": "ENALAPRIL SODIUM",
    "fr_ingredients": "Énalapril sodique",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55116,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30688,
      "drug_code": 92746,
      "updated_date": "2025-05-15T04:23:59-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8355975,
          "ingredient": {
            "id": 1522,
            "ingredient_code": 1966,
            "en_name": "NIFEDIPINE",
            "fr_name": "Nifédipine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442930",
      "brand_name": "NIFEDIPINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115253004"
    },
    "created_date": "2018-07-10T17:32:35-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02442930",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C08CA05",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "discontinuation_date": "2018-08-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-09-04T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-09-10T13:11:41-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "NIFEDIPINE ER",
    "en_drug_common_name": "NIFEDIPINE ER",
    "fr_drug_brand_name": "NIFEDIPINE ER",
    "fr_drug_common_name": "NIFEDIPINE ER",
    "en_ingredients": "NIFEDIPINE",
    "fr_ingredients": "Nifédipine",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55119,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30690,
      "drug_code": 92747,
      "updated_date": "2025-05-15T04:23:59-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8355976,
          "ingredient": {
            "id": 1522,
            "ingredient_code": 1966,
            "en_name": "NIFEDIPINE",
            "fr_name": "Nifédipine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442949",
      "brand_name": "NIFEDIPINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115253005"
    },
    "created_date": "2018-07-10T17:34:43-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02442949",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C08CA05",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "discontinuation_date": "2018-08-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-08-16T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-08-22T19:25:22-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "NIFEDIPINE ER",
    "en_drug_common_name": "NIFEDIPINE ER",
    "fr_drug_brand_name": "NIFEDIPINE ER",
    "fr_drug_common_name": "NIFEDIPINE ER",
    "en_ingredients": "NIFEDIPINE",
    "fr_ingredients": "Nifédipine",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55130,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11118,
      "drug_code": 67341,
      "updated_date": "2025-05-15T04:02:58-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8333749,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "375",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243432",
      "brand_name": "MYLAN-NAPROXEN EC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109634004"
    },
    "created_date": "2018-07-10T17:51:52-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02243432",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "M01AE02",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "discontinuation_date": "2018-07-10T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 5916. Last lot 8054933 Expires 31-May-19",
    "fr_discontinuation_comments": "Discontinued in shortage ID 5916. Last lot 8054933 Expires 31-May-19",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-11T05:00:21-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-NAPROXEN EC",
    "en_drug_common_name": "NAPROXEN",
    "fr_drug_brand_name": "MYLAN-NAPROXEN EC",
    "fr_drug_common_name": "NAPROXEN",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "375MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55139,
    "drug": {
      "current_status": "MARKETED",
      "id": 24384,
      "drug_code": 87024,
      "updated_date": "2025-05-15T02:33:21-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258797,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02384523",
      "brand_name": "VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885003"
    },
    "created_date": "2018-07-10T17:55:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02384523",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "hc_updated_date": "2021-08-16T21:22:12-04:00",
    "anticipated_start_date": "2018-07-10T00:00:00-04:00",
    "actual_start_date": "2018-07-10T00:00:00-04:00",
    "actual_end_date": "2021-08-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2021-08-17T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "TEMPORARILY UNAVAILABLE",
    "fr_comments": "TEMPORAIREMENT INDISPONIBLE",
    "en_drug_brand_name": "VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55141,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10058,
      "drug_code": 64618,
      "updated_date": "2025-05-15T04:00:17-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8330568,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02241024",
      "brand_name": "MYLAN-NAPROXEN EC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109634003"
    },
    "created_date": "2018-07-10T17:55:46-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02241024",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "M01AE02",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "discontinuation_date": "2018-07-10T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in ID 34097. Last lot 8045142 Expires 31-May-19",
    "fr_discontinuation_comments": "Discontinued in ID 34097. Last lot 8045142 Expires 31-May-19",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-11T05:00:22-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-NAPROXEN EC",
    "en_drug_common_name": "NAPROXEN",
    "fr_drug_brand_name": "MYLAN-NAPROXEN EC",
    "fr_drug_common_name": "NAPROXEN",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55149,
    "drug": {
      "current_status": "MARKETED",
      "id": 24386,
      "drug_code": 87025,
      "updated_date": "2025-05-15T02:33:21-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258798,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02384531",
      "brand_name": "VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885001"
    },
    "created_date": "2018-07-10T17:57:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02384531",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "hc_updated_date": "2021-08-16T21:22:56-04:00",
    "anticipated_start_date": "2018-07-10T00:00:00-04:00",
    "actual_start_date": "2018-07-10T00:00:00-04:00",
    "actual_end_date": "2021-08-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2021-08-17T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "TEMPORARILY UNAVAILABLE",
    "fr_comments": "TEMPORAIREMENT INDISPONIBLE",
    "en_drug_brand_name": "VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55152,
    "drug": {
      "current_status": "MARKETED",
      "id": 24386,
      "drug_code": 87025,
      "updated_date": "2025-05-15T02:33:21-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258798,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02384531",
      "brand_name": "VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885001"
    },
    "created_date": "2018-07-10T18:01:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02384531",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "hc_updated_date": "2021-08-16T21:23:28-04:00",
    "actual_start_date": "2018-07-10T00:00:00-04:00",
    "actual_end_date": "2021-08-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2021-08-17T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Temporarily unavalaible",
    "en_drug_brand_name": "VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55155,
    "drug": {
      "current_status": "MARKETED",
      "id": 24388,
      "drug_code": 87026,
      "updated_date": "2025-05-15T02:33:21-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258799,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02384558",
      "brand_name": "VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885002"
    },
    "created_date": "2018-07-10T18:03:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02384558",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "hc_updated_date": "2021-08-16T21:24:05-04:00",
    "actual_start_date": "2018-07-10T00:00:00-04:00",
    "actual_end_date": "2021-08-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2021-08-17T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "temporarily unavailable",
    "fr_comments": "Temporairement indisponible",
    "en_drug_brand_name": "VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55158,
    "drug": {
      "current_status": "MARKETED",
      "id": 24388,
      "drug_code": 87026,
      "updated_date": "2025-05-15T02:33:21-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258799,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02384558",
      "brand_name": "VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885002"
    },
    "created_date": "2018-07-10T18:04:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02384558",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "hc_updated_date": "2021-08-16T21:25:19-04:00",
    "actual_start_date": "2018-07-10T00:00:00-04:00",
    "actual_end_date": "2021-08-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2021-08-17T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Temporarily unavailable",
    "fr_comments": "Temporairement indisponible",
    "en_drug_brand_name": "VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55161,
    "drug": {
      "current_status": "MARKETED",
      "id": 24390,
      "drug_code": 87027,
      "updated_date": "2025-05-15T02:33:21-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258800,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "320",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02384566",
      "brand_name": "VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885004"
    },
    "created_date": "2018-07-10T18:06:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02384566",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2018-07-10T00:00:00-04:00",
    "actual_end_date": "2018-12-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2018-12-29T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Temporarily unavailable - This pack size will be discontinued",
    "fr_comments": "Temporairement indisponible",
    "en_drug_brand_name": "VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "320MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55164,
    "drug": {
      "current_status": "MARKETED",
      "id": 24390,
      "drug_code": 87027,
      "updated_date": "2025-05-15T02:33:21-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258800,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "320",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02384566",
      "brand_name": "VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885004"
    },
    "created_date": "2018-07-10T18:07:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02384566",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "hc_updated_date": "2021-08-16T21:26:26-04:00",
    "actual_start_date": "2018-07-10T00:00:00-04:00",
    "actual_end_date": "2021-08-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2021-08-17T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Temporarily unavailable",
    "fr_comments": "Temporairement indisponible",
    "en_drug_brand_name": "VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "320MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55171,
    "drug": {
      "current_status": "MARKETED",
      "id": 23096,
      "drug_code": 85685,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258340,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02371715",
      "brand_name": "MAR-AMLODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131437002"
    },
    "created_date": "2018-07-10T19:33:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02371715",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "C08CA01",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "anticipated_start_date": "2018-07-16T00:00:00-04:00",
    "estimated_end_date": "2018-09-27T00:00:00-04:00",
    "actual_start_date": "2018-07-16T00:00:00-04:00",
    "actual_end_date": "2018-09-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-09-28T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-AMLODIPINE TABLETS",
    "en_drug_common_name": "MAR-Amlodipine",
    "fr_drug_brand_name": "MAR-Amlodipine",
    "fr_drug_common_name": "MAR-Amlodipine",
    "en_ingredients": "AMLODIPINE",
    "fr_ingredients": "Amlodipine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55174,
    "drug": {
      "current_status": "MARKETED",
      "id": 23106,
      "drug_code": 85690,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258345,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02371774",
      "brand_name": "MAR-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332007"
    },
    "created_date": "2018-07-10T19:41:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02371774",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N05AX08",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2018-07-10T00:00:00-04:00",
    "estimated_end_date": "2018-10-11T00:00:00-04:00",
    "actual_start_date": "2018-07-10T00:00:00-04:00",
    "actual_end_date": "2018-10-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-10-12T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-RISPERIDONE",
    "en_drug_common_name": "MAR-Risperidone",
    "fr_drug_brand_name": "MAR-Risperidone",
    "fr_drug_common_name": "MAR-Risperidone",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "0.50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55180,
    "drug": {
      "current_status": "DORMANT",
      "id": 28378,
      "drug_code": 90504,
      "updated_date": "2025-05-15T06:55:51-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369071,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420457",
      "brand_name": "MAR-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858001"
    },
    "created_date": "2018-07-10T19:43:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420457",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "C09AA05",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2018-09-10T00:00:00-04:00",
    "actual_start_date": "2018-09-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-09-11T05:00:08-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MAR-RAMIPRIL",
    "en_drug_common_name": "MAR-Ramipril",
    "fr_drug_brand_name": "MAR-Ramipril",
    "fr_drug_common_name": "MAR-Ramipril",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "1.25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLST",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55204,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 55471,
      "drug_code": 96047,
      "updated_date": "2025-05-15T04:25:29-04:00",
      "company": {
        "id": 12,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5034,
        "mfr_code": "RIV07",
        "name": "LABORATOIRE RIVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOUL. INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8357666,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02471353",
      "brand_name": "RIVA-OLMESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152496002"
    },
    "created_date": "2018-07-10T20:52:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02471353",
    "company_name": "LABORATOIRE RIVA INC",
    "atc_number": "C09CA08",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2018-07-10T00:00:00-04:00",
    "actual_start_date": "2018-07-10T00:00:00-04:00",
    "actual_end_date": "2019-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2019-04-18T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Discontinued",
    "fr_comments": "Discontinued",
    "en_drug_brand_name": "RIVA-OLMESARTAN",
    "en_drug_common_name": "Riva-Olmesartan 20mg",
    "fr_drug_brand_name": "Riva-Olmesartan",
    "fr_drug_common_name": "Riva-Olmesartan",
    "en_ingredients": "OLMESARTAN MEDOXOMIL",
    "fr_ingredients": "Olmesartan medoxomil",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 / 100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55210,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 55473,
      "drug_code": 96048,
      "updated_date": "2025-05-15T04:25:29-04:00",
      "company": {
        "id": 12,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5034,
        "mfr_code": "RIV07",
        "name": "LABORATOIRE RIVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOUL. INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8357667,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02471361",
      "brand_name": "RIVA-OLMESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152496003"
    },
    "created_date": "2018-07-10T20:56:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02471361",
    "company_name": "LABORATOIRE RIVA INC",
    "atc_number": "C09CA08",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2018-07-10T00:00:00-04:00",
    "actual_start_date": "2018-07-10T00:00:00-04:00",
    "actual_end_date": "2019-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2019-04-18T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Discontinued",
    "fr_comments": "Discontined",
    "en_drug_brand_name": "RIVA-OLMESARTAN",
    "en_drug_common_name": "Riva-Olmesartan 40mg",
    "fr_drug_brand_name": "Riva-Olmesartan",
    "fr_drug_common_name": "riva-Olmesartan 40mg",
    "en_ingredients": "OLMESARTAN MEDOXOMIL",
    "fr_ingredients": "Olmesartan medoxomil",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 / 100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55264,
    "drug": {
      "current_status": "MARKETED",
      "id": 2662,
      "drug_code": 16471,
      "updated_date": "2025-05-15T02:30:56-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252124,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "SRT",
          "base": false
        }
      ],
      "din": "02091194",
      "brand_name": "APO-DICLO SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78362",
      "number_of_ais": "1",
      "ai_group_no": "0114417001"
    },
    "created_date": "2018-07-11T11:58:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02091194",
    "company_name": "APOTEX INC",
    "atc_number": "M01AB05",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2020-01-10T00:00:00-05:00",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2020-01-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-01-07T14:38:19-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DICLO SR",
    "en_drug_common_name": "DICLOFENAC",
    "fr_drug_brand_name": "APO-DICLO SR",
    "fr_drug_common_name": "DICLOFENAC",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55267,
    "drug": {
      "current_status": "MARKETED",
      "id": 3690,
      "drug_code": 19125,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252438,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02162814",
      "brand_name": "APO-DICLO SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81416",
      "number_of_ais": "1",
      "ai_group_no": "0114417005"
    },
    "created_date": "2018-07-11T12:00:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02162814",
    "company_name": "APOTEX INC",
    "atc_number": "M01AB05",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2020-01-10T00:00:00-05:00",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2020-01-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-01-07T14:39:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DICLO SR",
    "en_drug_common_name": "DICLOFENAC",
    "fr_drug_brand_name": "APO-DICLO SR",
    "fr_drug_common_name": "DICLOFENAC",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55270,
    "drug": {
      "current_status": "MARKETED",
      "id": 30436,
      "drug_code": 92479,
      "updated_date": "2025-05-15T02:34:45-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261116,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02440423",
      "brand_name": "APO-DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350001"
    },
    "created_date": "2018-07-11T12:05:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02440423",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX21",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-09-17T00:00:00-04:00",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2018-08-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-30T12:06:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DULOXETINE",
    "en_drug_common_name": "DULOXETINE",
    "fr_drug_brand_name": "APO-DULOXETINE",
    "fr_drug_common_name": "DULOXETINE",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "DULOXETINE",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL & 30 BLS & 100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55273,
    "drug": {
      "current_status": "MARKETED",
      "id": 30438,
      "drug_code": 92480,
      "updated_date": "2025-05-15T02:34:45-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261117,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02440431",
      "brand_name": "APO-DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350002"
    },
    "created_date": "2018-07-11T12:08:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02440431",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX21",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-08-31T00:00:00-04:00",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2018-08-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-22T14:32:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DULOXETINE",
    "en_drug_common_name": "DULOXETINE",
    "fr_drug_brand_name": "APO-DULOXETINE",
    "fr_drug_common_name": "DULOXETINE",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "DULOXETINE",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55276,
    "drug": {
      "current_status": "MARKETED",
      "id": 16784,
      "drug_code": 77741,
      "updated_date": "2025-05-15T02:31:53-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255931,
          "ingredient": {
            "id": 1474,
            "ingredient_code": 156,
            "en_name": "FAMCICLOVIR",
            "fr_name": "Famciclovir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02292041",
      "brand_name": "APO-FAMCICLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127885001"
    },
    "created_date": "2018-07-11T12:10:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292041",
    "company_name": "APOTEX INC",
    "atc_number": "J05AB09",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2018-09-10T00:00:00-04:00",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2018-08-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-09T13:35:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FAMCICLOVIR",
    "en_drug_common_name": "FAMCICLOVIR",
    "fr_drug_brand_name": "APO-FAMCICLOVIR",
    "fr_drug_common_name": "FAMCICLOVIR",
    "en_ingredients": "FAMCICLOVIR",
    "fr_ingredients": "Famciclovir",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55281,
    "drug": {
      "current_status": "DORMANT",
      "id": 17044,
      "drug_code": 78069,
      "updated_date": "2025-05-15T06:55:36-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368076,
          "ingredient": {
            "id": 2948,
            "ingredient_code": 12597,
            "en_name": "GLIMEPIRIDE",
            "fr_name": "Glimépiride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02295385",
      "brand_name": "APO-GLIMEPIRIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0146247002"
    },
    "created_date": "2018-07-11T12:22:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02295385",
    "company_name": "APOTEX INC",
    "atc_number": "A10BB12",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2019-09-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-09-21T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "All strengths of APO-GLIMEPIRIDE have been discontinued",
    "fr_comments": "All strengths of APO-GLIMEPIRIDE have been discontinued",
    "en_drug_brand_name": "APO-GLIMEPIRIDE",
    "en_drug_common_name": "GLIMEPIRIDE",
    "fr_drug_brand_name": "APO-GLIMEPIRIDE",
    "fr_drug_common_name": "GLIMEPIRIDE",
    "en_ingredients": "GLIMEPIRIDE",
    "fr_ingredients": "Glimépiride",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55284,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23820,
      "drug_code": 86490,
      "updated_date": "2025-12-03T01:29:46-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8351187,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379058",
      "brand_name": "APO-LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971001"
    },
    "created_date": "2018-07-11T12:25:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379058",
    "company_name": "APOTEX INC",
    "atc_number": "C09CA01",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-03-15T22:10:59-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "APO-LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55287,
    "drug": {
      "current_status": "MARKETED",
      "id": 51245,
      "drug_code": 94001,
      "updated_date": "2025-12-03T00:33:04-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261862,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02453460",
      "brand_name": "APO-OLMESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152496003"
    },
    "created_date": "2018-07-11T12:28:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453460",
    "company_name": "APOTEX INC",
    "atc_number": "C09CA08",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2020-09-11T00:00:00-04:00",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2020-08-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-01T19:07:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLMESARTAN",
    "en_drug_common_name": "OLMESARTAN MEDOXOMIL",
    "fr_drug_brand_name": "APO-OLMESARTAN",
    "fr_drug_common_name": "OLMESARTAN MEDOXOMIL",
    "en_ingredients": "OLMESARTAN MEDOXOMIL",
    "fr_ingredients": "OLMESARTAN MEDOXOMIL",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55290,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28320,
      "drug_code": 90469,
      "updated_date": "2025-12-03T01:32:09-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8354331,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420082",
      "brand_name": "APO-TELMISARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138223001"
    },
    "created_date": "2018-07-11T12:33:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420082",
    "company_name": "APOTEX INC",
    "atc_number": "C09CA07",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2018-07-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-11T15:01:48-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TELMISARTAN",
    "en_drug_common_name": "TELMISARTAN",
    "fr_drug_brand_name": "APO-TELMISARTAN",
    "fr_drug_common_name": "TELMISARTAN",
    "en_ingredients": "TELMISARTAN",
    "fr_ingredients": "Telmisartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55293,
    "drug": {
      "current_status": "DORMANT",
      "id": 27198,
      "drug_code": 89436,
      "updated_date": "2025-05-15T06:55:50-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368996,
          "ingredient": {
            "id": 3158,
            "ingredient_code": 13348,
            "en_name": "VORICONAZOLE",
            "fr_name": "Voriconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02409682",
      "brand_name": "APO-VORICONAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150242002"
    },
    "created_date": "2018-07-11T12:36:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02409682",
    "company_name": "APOTEX INC",
    "atc_number": "J02AC03",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2018-09-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-12T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-VORICONAZOLE",
    "en_drug_common_name": "VORICONAZOLE",
    "fr_drug_brand_name": "APO-VORICONAZOLE",
    "fr_drug_common_name": "VORICONAZOLE",
    "en_ingredients": "VORICONAZOLE",
    "fr_ingredients": "Voriconazole",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55296,
    "drug": {
      "current_status": "DORMANT",
      "id": 27196,
      "drug_code": 89435,
      "updated_date": "2025-05-15T06:55:50-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368995,
          "ingredient": {
            "id": 3158,
            "ingredient_code": 13348,
            "en_name": "VORICONAZOLE",
            "fr_name": "Voriconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02409674",
      "brand_name": "APO-VORICONAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150242001"
    },
    "created_date": "2018-07-11T12:37:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02409674",
    "company_name": "APOTEX INC",
    "atc_number": "J02AC03",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2018-09-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-12T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-VORICONAZOLE",
    "en_drug_common_name": "VORICONAZOLE",
    "fr_drug_brand_name": "APO-VORICONAZOLE",
    "fr_drug_common_name": "VORICONAZOLE",
    "en_ingredients": "VORICONAZOLE",
    "fr_ingredients": "Voriconazole",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55299,
    "drug": {
      "current_status": "MARKETED",
      "id": 31560,
      "drug_code": 93876,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261801,
          "ingredient": {
            "id": 610,
            "ingredient_code": 1249,
            "en_name": "FELODIPINE",
            "fr_name": "Félodipine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452375",
      "brand_name": "APO-FELODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121733002"
    },
    "created_date": "2018-07-11T12:38:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452375",
    "company_name": "APOTEX INC",
    "atc_number": "C08CA02",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "estimated_end_date": "2018-09-07T00:00:00-04:00",
    "actual_start_date": "2018-07-09T00:00:00-04:00",
    "actual_end_date": "2018-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-01T13:01:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FELODIPINE",
    "en_drug_common_name": "FELODIPINE",
    "fr_drug_brand_name": "APO-FELODIPINE",
    "fr_drug_common_name": "FELODIPINE",
    "en_ingredients": "FELODIPINE",
    "fr_ingredients": "Félodipine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55320,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24962,
      "drug_code": 87462,
      "updated_date": "2025-05-15T04:20:21-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8351807,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389118",
      "brand_name": "MAR-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783005"
    },
    "created_date": "2018-07-11T14:17:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389118",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2018-07-11T00:00:00-04:00",
    "estimated_end_date": "2018-07-16T00:00:00-04:00",
    "actual_start_date": "2018-07-11T00:00:00-04:00",
    "actual_end_date": "2018-07-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-17T05:00:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-OLANZAPINE ODT",
    "en_drug_common_name": "MAR-OLANZAPINE ODT",
    "fr_drug_brand_name": "MAR-OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE ODT",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLST",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55349,
    "drug": {
      "current_status": "MARKETED",
      "id": 29678,
      "drug_code": 91701,
      "updated_date": "2025-05-15T02:34:33-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260753,
          "ingredient": {
            "id": 2666,
            "ingredient_code": 11852,
            "en_name": "MODAFINIL",
            "fr_name": "Modafinil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02432560",
      "brand_name": "MAR-MODAFINIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136083001"
    },
    "created_date": "2018-07-11T14:35:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02432560",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06BA07",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2018-07-11T00:00:00-04:00",
    "estimated_end_date": "2018-10-18T00:00:00-04:00",
    "actual_start_date": "2018-07-11T00:00:00-04:00",
    "actual_end_date": "2018-10-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-10-19T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-MODAFINIL",
    "en_drug_common_name": "MAR-Modafinil",
    "fr_drug_brand_name": "MAR-Modafinil",
    "fr_drug_common_name": "MAR-Modafinil",
    "en_ingredients": "MODAFINIL",
    "fr_ingredients": "Modafinil",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55363,
    "drug": {
      "current_status": "MARKETED",
      "id": 28616,
      "drug_code": 90733,
      "updated_date": "2025-05-15T02:34:16-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260380,
          "ingredient": {
            "id": 3046,
            "ingredient_code": 12754,
            "en_name": "EZETIMIBE",
            "fr_name": "Ézétimibe"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02422662",
      "brand_name": "MAR-EZETIMIBE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149164001"
    },
    "created_date": "2018-07-11T14:43:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02422662",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "C10AX09",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2018-07-11T00:00:00-04:00",
    "actual_start_date": "2018-07-11T00:00:00-04:00",
    "actual_end_date": "2019-01-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-01-07T20:08:01-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-EZETIMIBE",
    "en_drug_common_name": "MAR-Ezetimibe",
    "fr_drug_brand_name": "MAR-Ezetimibe",
    "fr_drug_common_name": "Ezetimibe",
    "en_ingredients": "EZETIMIBE",
    "fr_ingredients": "Ézétimibe",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55366,
    "drug": {
      "current_status": "MARKETED",
      "id": 28616,
      "drug_code": 90733,
      "updated_date": "2025-05-15T02:34:16-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260380,
          "ingredient": {
            "id": 3046,
            "ingredient_code": 12754,
            "en_name": "EZETIMIBE",
            "fr_name": "Ézétimibe"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02422662",
      "brand_name": "MAR-EZETIMIBE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149164001"
    },
    "created_date": "2018-07-11T14:44:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02422662",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "C10AX09",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2018-07-11T00:00:00-04:00",
    "estimated_end_date": "2019-02-05T00:00:00-05:00",
    "actual_start_date": "2018-07-11T00:00:00-04:00",
    "actual_end_date": "2019-02-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-08-15T14:44:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-EZETIMIBE",
    "en_drug_common_name": "MAR-Ezetimibe",
    "fr_drug_brand_name": "MAR-Ezetimibe",
    "fr_drug_common_name": "Ezetimibe",
    "en_ingredients": "EZETIMIBE",
    "fr_ingredients": "Ézétimibe",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55369,
    "drug": {
      "current_status": "MARKETED",
      "id": 26344,
      "drug_code": 88697,
      "updated_date": "2025-05-15T02:33:49-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259506,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02402106",
      "brand_name": "MAR-DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548002"
    },
    "created_date": "2018-07-11T14:45:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402106",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06DA02",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "anticipated_start_date": "2018-07-11T00:00:00-04:00",
    "estimated_end_date": "2018-08-27T00:00:00-04:00",
    "actual_start_date": "2018-07-11T00:00:00-04:00",
    "actual_end_date": "2018-08-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-08-28T20:26:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-DONEPEZIL",
    "en_drug_common_name": "MAR-Donepezil",
    "fr_drug_brand_name": "MAR-Donepezil",
    "fr_drug_common_name": "Donepezil",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55372,
    "drug": {
      "current_status": "MARKETED",
      "id": 26344,
      "drug_code": 88697,
      "updated_date": "2025-05-15T02:33:49-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259506,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02402106",
      "brand_name": "MAR-DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548002"
    },
    "created_date": "2018-07-11T14:46:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402106",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06DA02",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "anticipated_start_date": "2018-07-11T00:00:00-04:00",
    "actual_start_date": "2018-07-11T00:00:00-04:00",
    "actual_end_date": "2019-08-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-08-26T15:30:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-DONEPEZIL",
    "en_drug_common_name": "MAR-Donepezil",
    "fr_drug_brand_name": "MAR-Donepezil",
    "fr_drug_common_name": "Donepezil",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55375,
    "drug": {
      "current_status": "MARKETED",
      "id": 26342,
      "drug_code": 88696,
      "updated_date": "2025-05-15T02:33:49-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259505,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02402092",
      "brand_name": "MAR-DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548001"
    },
    "created_date": "2018-07-11T14:47:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402092",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06DA02",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "anticipated_start_date": "2018-07-11T00:00:00-04:00",
    "actual_start_date": "2018-07-11T00:00:00-04:00",
    "actual_end_date": "2019-08-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-08-26T15:29:37-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-DONEPEZIL",
    "en_drug_common_name": "MAR-Donepezil",
    "fr_drug_brand_name": "MAR-Donepezil",
    "fr_drug_common_name": "MAR-Donepezil",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 Caps",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55378,
    "drug": {
      "current_status": "MARKETED",
      "id": 26558,
      "drug_code": 88864,
      "updated_date": "2025-12-03T00:32:15-05:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259588,
          "ingredient": {
            "id": 824,
            "ingredient_code": 1840,
            "en_name": "DOMPERIDONE",
            "fr_name": "Dompéridone (Maléate de dompéridone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02403870",
      "brand_name": "MAR-DOMPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116957001"
    },
    "created_date": "2018-07-11T14:50:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403870",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "A03FA03",
    "atc_description": "PROPULSIVES",
    "anticipated_start_date": "2018-07-11T00:00:00-04:00",
    "actual_start_date": "2018-07-11T00:00:00-04:00",
    "actual_end_date": "2018-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-14T14:06:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-DOMPERIDONE",
    "en_drug_common_name": "MAR-Domperidone",
    "fr_drug_brand_name": "MAR-Domperidone",
    "fr_drug_common_name": "Domperidone",
    "en_ingredients": "DOMPERIDONE",
    "fr_ingredients": "Domperidone",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55381,
    "drug": {
      "current_status": "MARKETED",
      "id": 23128,
      "drug_code": 85702,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258355,
          "ingredient": {
            "id": 2658,
            "ingredient_code": 11847,
            "en_name": "CITALOPRAM",
            "fr_name": "Citalopram (Bromhydrate de citalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02371901",
      "brand_name": "MAR-CITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136243002"
    },
    "created_date": "2018-07-11T14:51:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02371901",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06AB04",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2018-07-11T00:00:00-04:00",
    "estimated_end_date": "2018-09-27T00:00:00-04:00",
    "actual_start_date": "2018-07-11T00:00:00-04:00",
    "actual_end_date": "2018-09-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-09-28T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-CITALOPRAM",
    "en_drug_common_name": "MAR-Citalopram",
    "fr_drug_brand_name": "MAR-Citalopram",
    "fr_drug_common_name": "Citalopram",
    "en_ingredients": "CITALOPRAM",
    "fr_ingredients": "Citalopram",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55388,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18538,
      "drug_code": 79821,
      "updated_date": "2025-05-15T04:13:55-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8345684,
          "ingredient": {
            "id": 2160,
            "ingredient_code": 1290,
            "en_name": "LOVASTATIN",
            "fr_name": "Lovastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02312689",
      "brand_name": "PRO-LOVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0120669001"
    },
    "created_date": "2018-07-11T14:53:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02312689",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C10AA02",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2018-07-11T00:00:00-04:00",
    "actual_end_date": "2018-07-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-27T05:00:05-04:00",
    "status": "resolved",
    "en_comments": "Discontinued",
    "fr_comments": "Cessation de vente",
    "en_drug_brand_name": "PRO-LOVASTATIN",
    "en_drug_common_name": "LOVASTATIN",
    "fr_drug_brand_name": "PRO-LOVASTATIN",
    "fr_drug_common_name": "LOVASTATIN",
    "en_ingredients": "LOVASTATIN",
    "fr_ingredients": "Lovastatine",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30-100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55394,
    "drug": {
      "current_status": "MARKETED",
      "id": 28316,
      "drug_code": 90466,
      "updated_date": "2025-05-15T02:34:12-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260269,
          "ingredient": {
            "id": 2680,
            "ingredient_code": 11865,
            "en_name": "CELECOXIB",
            "fr_name": "Célécoxib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420058",
      "brand_name": "MAR-CELECOXIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137043001"
    },
    "created_date": "2018-07-11T14:55:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420058",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "M01AH01",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "anticipated_start_date": "2018-07-11T00:00:00-04:00",
    "estimated_end_date": "2018-09-13T00:00:00-04:00",
    "actual_start_date": "2018-07-11T00:00:00-04:00",
    "actual_end_date": "2018-09-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-09-14T18:25:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-CELECOXIB",
    "en_drug_common_name": "MAR-Celecoxib",
    "fr_drug_brand_name": "MAR-Celecoxib",
    "fr_drug_common_name": "Celecoxib",
    "en_ingredients": "CELECOXIB",
    "fr_ingredients": "Célécoxib",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 Caps",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55397,
    "drug": {
      "current_status": "MARKETED",
      "id": 27862,
      "drug_code": 90056,
      "updated_date": "2025-05-15T02:34:07-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8260123,
          "ingredient": {
            "id": 2678,
            "ingredient_code": 11860,
            "en_name": "REPAGLINIDE",
            "fr_name": "Répaglinide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02415968",
      "brand_name": "REPAGLINIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137035001"
    },
    "created_date": "2018-07-11T14:56:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02415968",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "A10BX02",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "actual_start_date": "2018-11-15T00:00:00-05:00",
    "actual_end_date": "2019-01-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-01-12T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "REPAGLINIDE",
    "en_drug_common_name": "REPAGLINIDE",
    "fr_drug_brand_name": "REPAGLINIDE",
    "fr_drug_common_name": "REPAGLINIDE",
    "en_ingredients": "REPAGLINIDE",
    "fr_ingredients": "Répaglinide",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55419,
    "drug": {
      "current_status": "MARKETED",
      "id": 11184,
      "drug_code": 67513,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8254202,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02243595",
      "brand_name": "ASMANEX TWISTHALER",
      "brand_name_fr": "",
      "descriptor": "FOR ORAL INHALATION ONLY",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121732003"
    },
    "created_date": "2018-07-11T16:08:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243595",
    "company_name": "MERCK CANADA INC",
    "atc_number": "R03BA07",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "anticipated_start_date": "2018-07-11T00:00:00-04:00",
    "estimated_end_date": "2018-11-09T00:00:00-05:00",
    "actual_start_date": "2018-07-11T00:00:00-04:00",
    "actual_end_date": "2018-10-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-13T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ASMANEX TWISTHALER",
    "en_drug_common_name": "mometasone furoate dry powder inhaler",
    "fr_drug_brand_name": "ASMANEX TWISTHALER",
    "fr_drug_common_name": "furoate de mométasone inhalateur de poudre sèche",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "200MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "60 dose",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55437,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9536,
      "drug_code": 6311,
      "updated_date": "2025-05-15T03:29:43-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8280180,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00658855",
      "brand_name": "LOPRESOR SR 100MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62779",
      "number_of_ais": "1",
      "ai_group_no": "0111923003"
    },
    "created_date": "2018-07-11T21:17:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00658855",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "C07AB02",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2018-08-20T00:00:00-04:00",
    "estimated_end_date": "2018-10-16T00:00:00-04:00",
    "actual_start_date": "2018-07-18T00:00:00-04:00",
    "actual_end_date": "2018-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-10-24T19:40:19-04:00",
    "status": "resolved",
    "en_comments": "Lopresor SR 100mg Tabs 100's pack is available",
    "fr_comments": "Lopresor SR 100mg Tabs 100's format est disponible",
    "en_drug_brand_name": "LOPRESOR SR 100MG",
    "en_drug_common_name": "LOPRESOR SR 100MG 250'S",
    "fr_drug_brand_name": "LOPRESOR",
    "fr_drug_common_name": "LOPRESOR SR 100MG TABS 200'S",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "250'S",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55440,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11598,
      "drug_code": 68582,
      "updated_date": "2025-05-15T04:04:03-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8335137,
          "ingredient": {
            "id": 2930,
            "ingredient_code": 916,
            "en_name": "DIDANOSINE",
            "fr_name": "Didanosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244596",
      "brand_name": "VIDEX EC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123132011"
    },
    "created_date": "2018-07-11T21:30:03-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02244596",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "J05AF02",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2020-03-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "All strengths are being deleted",
    "fr_supply_disruption_mitigation": "Tous les teneurs seront discontinués.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-01T13:33:18-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "VIDEX EC",
    "en_drug_common_name": "Didanosine",
    "fr_drug_brand_name": "VIDEX EC",
    "fr_drug_common_name": "Didanosine",
    "en_ingredients": "DIDANOSINE",
    "fr_ingredients": "Didanosine",
    "drug_strength": "125MG",
    "drug_dosage_form": "CAPSULE (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Capsule (entérosoluble)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 BTL x 30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55443,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11600,
      "drug_code": 68583,
      "updated_date": "2025-05-15T04:04:03-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8335138,
          "ingredient": {
            "id": 2930,
            "ingredient_code": 916,
            "en_name": "DIDANOSINE",
            "fr_name": "Didanosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244597",
      "brand_name": "VIDEX EC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123132012"
    },
    "created_date": "2018-07-11T21:34:23-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02244597",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "J05AF02",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2020-03-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "All strengths are being deleted.",
    "fr_supply_disruption_mitigation": "Tous les teneurs seront discontinués.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-01T13:32:11-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "VIDEX EC",
    "en_drug_common_name": "DIDANOSINE",
    "fr_drug_brand_name": "VIDEX EC",
    "fr_drug_common_name": "Didanosine",
    "en_ingredients": "DIDANOSINE",
    "fr_ingredients": "Didanosine",
    "drug_strength": "200MG",
    "drug_dosage_form": "CAPSULE (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Capsule (entérosoluble)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 BTL x 30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55446,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11602,
      "drug_code": 68584,
      "updated_date": "2025-05-15T04:04:03-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8335139,
          "ingredient": {
            "id": 2930,
            "ingredient_code": 916,
            "en_name": "DIDANOSINE",
            "fr_name": "Didanosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244598",
      "brand_name": "VIDEX EC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123132013"
    },
    "created_date": "2018-07-11T21:37:39-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02244598",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "J05AF02",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2020-03-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "All strengths are being deleted.",
    "fr_supply_disruption_mitigation": "Tous les teneurs seront discontinués.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-01T13:28:44-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "VIDEX EC",
    "en_drug_common_name": "DIDANOSINE",
    "fr_drug_brand_name": "VIDEX EC",
    "fr_drug_common_name": "Didanosine",
    "en_ingredients": "DIDANOSINE",
    "fr_ingredients": "Didanosine",
    "drug_strength": "250MG",
    "drug_dosage_form": "CAPSULE (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Capsule (entérosoluble)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 BTL x 30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55449,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11604,
      "drug_code": 68585,
      "updated_date": "2025-05-15T04:04:03-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8335140,
          "ingredient": {
            "id": 2930,
            "ingredient_code": 916,
            "en_name": "DIDANOSINE",
            "fr_name": "Didanosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244599",
      "brand_name": "VIDEX EC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123132014"
    },
    "created_date": "2018-07-11T21:40:15-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02244599",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "J05AF02",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2020-03-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "All strengths are being deleted.",
    "fr_supply_disruption_mitigation": "Tous les teneurs seront discontinués.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-01T13:26:21-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "VIDEX EC",
    "en_drug_common_name": "DIDANOSINE",
    "fr_drug_brand_name": "VIDEX EC",
    "fr_drug_common_name": "Didanosine",
    "en_ingredients": "DIDANOSINE",
    "fr_ingredients": "Didanosine",
    "drug_strength": "400MG",
    "drug_dosage_form": "CAPSULE (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Capsule (entérosoluble)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 BTL x 30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55453,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 4342,
      "drug_code": 20322,
      "updated_date": "2025-05-15T03:46:18-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8305625,
          "ingredient": {
            "id": 1656,
            "ingredient_code": 66,
            "en_name": "STAVUDINE",
            "fr_name": "Stavudine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02216086",
      "brand_name": "ZERIT - CAP 15MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82630",
      "number_of_ais": "1",
      "ai_group_no": "0128554005"
    },
    "created_date": "2018-07-11T21:43:17-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02216086",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "J05AF04",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2020-03-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "All strengths are being deleted.",
    "fr_supply_disruption_mitigation": "Tous les teneurs seront discontinués.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-01T13:37:12-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ZERIT - CAP 15MG",
    "en_drug_common_name": "STAVUDINE",
    "fr_drug_brand_name": "ZERIT CAP 15MG",
    "fr_drug_common_name": "Stavudine",
    "en_ingredients": "STAVUDINE",
    "fr_ingredients": "Stavudine",
    "drug_strength": "15MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 BTL x 60",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55456,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 4348,
      "drug_code": 20325,
      "updated_date": "2025-05-15T03:46:18-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8305628,
          "ingredient": {
            "id": 1656,
            "ingredient_code": 66,
            "en_name": "STAVUDINE",
            "fr_name": "Stavudine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02216094",
      "brand_name": "ZERIT - CAP 20MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82633",
      "number_of_ais": "1",
      "ai_group_no": "0128554003"
    },
    "created_date": "2018-07-11T21:46:19-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02216094",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "J05AF04",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2020-03-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "All strengths are being deleted.",
    "fr_supply_disruption_mitigation": "Tous les teneurs seront discontinués.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-01T13:36:13-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ZERIT - CAP 20MG",
    "en_drug_common_name": "STAVUDINE",
    "fr_drug_brand_name": "ZERIT CAP 20MG",
    "fr_drug_common_name": "Stavudine",
    "en_ingredients": "STAVUDINE",
    "fr_ingredients": "Stavudine",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 BTL x 60",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55459,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 4346,
      "drug_code": 20324,
      "updated_date": "2025-05-15T03:46:18-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8305627,
          "ingredient": {
            "id": 1656,
            "ingredient_code": 66,
            "en_name": "STAVUDINE",
            "fr_name": "Stavudine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02216108",
      "brand_name": "ZERIT - CAP 30MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82632",
      "number_of_ais": "1",
      "ai_group_no": "0128554002"
    },
    "created_date": "2018-07-11T21:48:45-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02216108",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "J05AF04",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2020-03-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "All strengths are being deleted.",
    "fr_supply_disruption_mitigation": "Tous les teneurs seront discontinués.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-01T13:35:16-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ZERIT - CAP 30MG",
    "en_drug_common_name": "STAVUDINE",
    "fr_drug_brand_name": "ZERIT CAP 30MG",
    "fr_drug_common_name": "Stavudine",
    "en_ingredients": "STAVUDINE",
    "fr_ingredients": "Stavudine",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 BTL x 60",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55462,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 4344,
      "drug_code": 20323,
      "updated_date": "2025-05-15T03:46:18-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8305626,
          "ingredient": {
            "id": 1656,
            "ingredient_code": 66,
            "en_name": "STAVUDINE",
            "fr_name": "Stavudine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02216116",
      "brand_name": "ZERIT - CAP 40MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82631",
      "number_of_ais": "1",
      "ai_group_no": "0128554001"
    },
    "created_date": "2018-07-11T21:51:09-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02216116",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "J05AF04",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2020-03-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "All strengths are being deleted.",
    "fr_supply_disruption_mitigation": "Tous les teneurs seront discontinués.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-01T13:34:21-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ZERIT - CAP 40MG",
    "en_drug_common_name": "STAVUDINE",
    "fr_drug_brand_name": "ZERIT CAP 40MG",
    "fr_drug_common_name": "Stavudine",
    "en_ingredients": "STAVUDINE",
    "fr_ingredients": "Stavudine",
    "drug_strength": "40MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 BTL x 60",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55518,
    "drug": {
      "current_status": "MARKETED",
      "id": 55369,
      "drug_code": 94721,
      "updated_date": "2025-05-15T02:35:43-04:00",
      "company": {
        "id": 16976,
        "created_date": "2020-10-02T23:51:29-04:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 17602,
        "mfr_code": "",
        "name": "HIKMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "55 STANDISH COURT, SUITE 1050",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 0G3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262243,
          "ingredient": {
            "id": 1642,
            "ingredient_code": 10303,
            "en_name": "ACETYLCYSTEINE",
            "fr_name": "Acétylcystéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02459906",
      "brand_name": "ACETYLCYSTEINE SOLUTION USP",
      "brand_name_fr": "SOLUTION D'ACÉTYLCYSTÉINE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0100024001"
    },
    "created_date": "2018-07-12T14:24:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02459906",
    "company_name": "TELIGENT OU",
    "atc_number": "R05CB01",
    "atc_description": "EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.",
    "estimated_end_date": "2018-08-29T00:00:00-04:00",
    "actual_start_date": "2018-02-12T00:00:00-05:00",
    "actual_end_date": "2018-08-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-04T13:22:58-04:00",
    "status": "resolved",
    "en_comments": "Alveda DIN 02300435 Acetylcysteine Injection 200 mg/mL is discontinued. Product will be available as Teligent DIN 02459906 Acetylcysteine Solution USP will be in stock July 22 2018.",
    "fr_comments": "Alveda DIN 02300435 Acétylcystéine Injection 200 mg/ml est discontinué. Le produit sera disponible comme Teligent DIN 02459906 Solution d'acétylcystéine USP, qui sera en stock juillet 22 2018.",
    "en_drug_brand_name": "ACETYLCYSTEINE SOLUTION USP",
    "en_drug_common_name": "Acetylcysteine Solution USP",
    "fr_drug_brand_name": "Solution d'acétylcystéine USP",
    "fr_drug_common_name": "Solution d'acétylcystéine USP",
    "en_ingredients": "ACETYLCYSTEINE",
    "fr_ingredients": "Acétylcystéine",
    "drug_strength": "200MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION\r\nINTRAVENOUS\r\nORAL",
    "drug_route_fr": "Inhalation\r\nIntraveineuse\r\nOrale",
    "drug_package_quantity": "10 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55523,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20436,
      "drug_code": 82047,
      "updated_date": "2025-05-15T04:15:30-04:00",
      "company": {
        "id": 176,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T03:21:45-04:00",
        "company_code": 11642,
        "mfr_code": "",
        "name": "HOSPIRA HEALTHCARE ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / Service à la clientele 1-866-488-6088 option 3"
      },
      "drug_ingredients": [
        {
          "id": 8347744,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02334844",
      "brand_name": "AZITHROMYCIN FOR INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "10 ML FLIP TOP VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072006"
    },
    "created_date": "2018-07-12T14:35:50-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02334844",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "J01FA10",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "discontinuation_date": "2018-12-15T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Zithromax IV remains available.",
    "fr_discontinuation_comments": "Zithromax IV est encore disponible.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-03-28T14:37:33-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "AZITHROMYCIN FOR INJECTION, USP",
    "en_drug_common_name": "AZITHROMYCIN",
    "fr_drug_brand_name": "AZITHROMYCIN POUR INJECTION USP",
    "fr_drug_common_name": "AZITHROMYCIN",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "500MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 x 500mg GVL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55552,
    "drug": {
      "current_status": "MARKETED",
      "id": 50278,
      "drug_code": 94579,
      "updated_date": "2025-05-15T02:35:40-04:00",
      "company": {
        "id": 110,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 5096,
        "mfr_code": "SEV07",
        "name": "SERVIER CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "270",
        "street_name": "3224 AVENUE JEAN-BÉRAUD",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7T 2S4",
        "post_office_box": "",
        "contact_information": "Address: 3224, rue Jean-Béraud, bur. 270, Laval, Quebec, H7T 2S4\r\nPhone : (450) 978-9700"
      },
      "drug_ingredients": [
        {
          "id": 8262182,
          "ingredient": {
            "id": 6505,
            "ingredient_code": 22816,
            "en_name": "EDOXABAN",
            "fr_name": "Édoxaban (Tosylate d'édoxaban monohydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02458640",
      "brand_name": "LIXIANA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0158530001"
    },
    "created_date": "2018-07-12T20:09:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02458640",
    "company_name": "SERVIER CANADA INC",
    "atc_number": "B01AF03",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2018-07-30T00:00:00-04:00",
    "actual_start_date": "2018-06-26T00:00:00-04:00",
    "actual_end_date": "2018-07-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-31T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LIXIANA",
    "en_drug_common_name": "LIXIANA",
    "fr_drug_brand_name": "LIXIANA",
    "fr_drug_common_name": "LIXIANA",
    "en_ingredients": "EDOXABAN",
    "fr_ingredients": "EDOXABAN",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55561,
    "drug": {
      "current_status": "MARKETED",
      "id": 28406,
      "drug_code": 90531,
      "updated_date": "2025-05-15T02:34:12-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8260298,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "32",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8260297,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420740",
      "brand_name": "SANDOZ CANDESARTAN PLUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0244181003"
    },
    "created_date": "2018-07-12T21:42:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420740",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA06",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2018-08-24T00:00:00-04:00",
    "actual_start_date": "2018-07-06T00:00:00-04:00",
    "actual_end_date": "2018-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-08-23T15:01:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ CANDESARTAN PLUS",
    "en_drug_common_name": "CANDESARTAN PLUS",
    "fr_drug_brand_name": "CANDESARTAN PLUS",
    "fr_drug_common_name": "CANDESARTAN PLUS",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nCANDESARTAN CILEXETIL",
    "fr_ingredients": "Hydrochlorothiazide\r\nCandésartan cilexétil",
    "drug_strength": "25MG\r\n32MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55564,
    "drug": {
      "current_status": "MARKETED",
      "id": 11332,
      "drug_code": 67777,
      "updated_date": "2025-12-03T00:30:48-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254238,
          "ingredient": {
            "id": 2674,
            "ingredient_code": 1400,
            "en_name": "AMIODARONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amiodarone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243836",
      "brand_name": "SANDOZ AMIODARONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118593001"
    },
    "created_date": "2018-07-12T21:48:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243836",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C01BD01",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "estimated_end_date": "2018-07-27T00:00:00-04:00",
    "actual_start_date": "2018-07-06T00:00:00-04:00",
    "actual_end_date": "2018-07-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2018-08-13T14:26:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ AMIODARONE",
    "en_drug_common_name": "ESTRADIOL",
    "fr_drug_brand_name": "AMIODARONE",
    "fr_drug_common_name": "AMIODARONE",
    "en_ingredients": "AMIODARONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amiodarone",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55625,
    "drug": {
      "current_status": "MARKETED",
      "id": 30340,
      "drug_code": 92397,
      "updated_date": "2025-05-15T02:34:45-04:00",
      "company": {
        "id": 1770,
        "created_date": "2017-03-09T13:25:40-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 15633,
        "mfr_code": "",
        "name": "NATCO PHARMA (CANADA) INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2000 ARGENTIA ROAD, PLAZA 1, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 1P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261089,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439557",
      "brand_name": "NAT-DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548001"
    },
    "created_date": "2018-07-13T15:48:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439557",
    "company_name": "NATCO PHARMA (CANADA) INC",
    "atc_number": "N06DA02",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "estimated_end_date": "2020-10-01T00:00:00-04:00",
    "actual_start_date": "2018-07-13T00:00:00-04:00",
    "actual_end_date": "2020-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-26T18:37:40-04:00",
    "status": "resolved",
    "en_comments": "Resolved",
    "fr_comments": "Resolved",
    "en_drug_brand_name": "NAT-DONEPEZIL",
    "en_drug_common_name": "DONEPEZIL HYDROCHLORIDE TABLETS",
    "fr_drug_brand_name": "NAT-DONEPEZIL",
    "fr_drug_common_name": "COMPRIMÉS DE CHLORHYDRATE DE DONÉPÉZIL",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "Bottle of 100s",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55630,
    "drug": {
      "current_status": "MARKETED",
      "id": 30342,
      "drug_code": 92398,
      "updated_date": "2025-05-15T02:34:45-04:00",
      "company": {
        "id": 1770,
        "created_date": "2017-03-09T13:25:40-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 15633,
        "mfr_code": "",
        "name": "NATCO PHARMA (CANADA) INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2000 ARGENTIA ROAD, PLAZA 1, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 1P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261090,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439565",
      "brand_name": "NAT-DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548002"
    },
    "created_date": "2018-07-13T15:52:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439565",
    "company_name": "NATCO PHARMA (CANADA) INC",
    "atc_number": "N06DA02",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "estimated_end_date": "2020-01-13T00:00:00-05:00",
    "actual_start_date": "2018-07-13T00:00:00-04:00",
    "actual_end_date": "2020-10-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-26T18:40:42-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NAT-DONEPEZIL",
    "en_drug_common_name": "DONEPEZIL HYDROCHLORIDE TABLETS",
    "fr_drug_brand_name": "NAT-DONEPEZIL",
    "fr_drug_common_name": "COMPRIMÉS DE CHLORHYDRATE DE DONÉPÉZIL",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "Bottle of 100s",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55646,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13684,
      "drug_code": 73528,
      "updated_date": "2025-05-15T04:08:23-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8339759,
          "ingredient": {
            "id": 3124,
            "ingredient_code": 13311,
            "en_name": "VARDENAFIL",
            "fr_name": "Vardénafil (Chlorhydrate de vardénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02250489",
      "brand_name": "LEVITRA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150003003"
    },
    "created_date": "2018-07-13T17:01:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02250489",
    "company_name": "BAYER INC",
    "atc_number": "G04BE09",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2018-07-31T00:00:00-04:00",
    "estimated_end_date": "2018-11-19T00:00:00-05:00",
    "actual_end_date": "2018-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-11-14T16:48:49-05:00",
    "status": "resolved",
    "en_comments": "Product is available to market.",
    "en_drug_brand_name": "LEVITRA",
    "en_drug_common_name": "Vardenafil tablets",
    "fr_drug_brand_name": "LEVITRA",
    "fr_drug_common_name": "Comprimés de vardénafil",
    "en_ingredients": "VARDENAFIL",
    "fr_ingredients": "VARDENAFIL",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55662,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 4348,
      "drug_code": 20325,
      "updated_date": "2025-05-15T03:46:18-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8305628,
          "ingredient": {
            "id": 1656,
            "ingredient_code": 66,
            "en_name": "STAVUDINE",
            "fr_name": "Stavudine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02216094",
      "brand_name": "ZERIT - CAP 20MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82633",
      "number_of_ais": "1",
      "ai_group_no": "0128554003"
    },
    "created_date": "2018-07-13T17:59:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02216094",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "J05AF04",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2019-03-25T00:00:00-04:00",
    "estimated_end_date": "2019-03-25T00:00:00-04:00",
    "actual_end_date": "2019-03-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-03-29T14:35:08-04:00",
    "status": "resolved",
    "en_comments": "Product on allocation",
    "fr_comments": "en allocation",
    "en_drug_brand_name": "ZERIT - CAP 20MG",
    "en_drug_common_name": "STAVUDINE",
    "fr_drug_brand_name": "Zerit cap 20mg",
    "fr_drug_common_name": "Stavudine",
    "en_ingredients": "STAVUDINE",
    "fr_ingredients": "Stavudine",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 BTL x 60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55679,
    "drug": {
      "current_status": "MARKETED",
      "id": 17268,
      "drug_code": 78322,
      "updated_date": "2025-05-15T02:31:58-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8256095,
          "ingredient": {
            "id": 35968,
            "ingredient_code": 23453,
            "en_name": "VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED",
            "fr_name": "Vaccin contre le virus de la varicelle et zona vivant, atténué (souche Oka)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1995.2623",
          "strength_unit": "CCID50",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8256094,
          "ingredient": {
            "id": 1968,
            "ingredient_code": 11271,
            "en_name": "MUMPS VIRUS VACCINE LIVE ATTENUATED",
            "fr_name": "Vaccin contre les oreillons vivant atténué (souche jeryl lynn)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25118.9",
          "strength_unit": "CCID50",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8256093,
          "ingredient": {
            "id": 1970,
            "ingredient_code": 7897,
            "en_name": "RUBELLA VIRUS VACCINE LIVE ATTENUATED",
            "fr_name": "Vaccin antirubéoleux vivant atténué (souche wistar ra27/3)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "CCID50",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8256092,
          "ingredient": {
            "id": 1972,
            "ingredient_code": 7908,
            "en_name": "MEASLES VIRUS VACCINE LIVE ATTENUATED",
            "fr_name": "Vaccin antirougeoleux, vivant, atténué"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "CCID50",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02297884",
      "brand_name": "PRIORIX-TETRA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "4",
      "ai_group_no": "0464901001"
    },
    "created_date": "2018-07-13T18:16:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02297884",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07BD54",
    "atc_description": "VIRAL VACCINES",
    "estimated_end_date": "2018-09-07T00:00:00-04:00",
    "actual_start_date": "2018-07-10T00:00:00-04:00",
    "actual_end_date": "2018-08-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-08-22T15:17:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PRIORIX-TETRA",
    "en_drug_common_name": "Combined measles, mumps, rubella and varicella vaccine, live, attenuated",
    "fr_drug_brand_name": "PRIORIX-TETRA",
    "fr_drug_common_name": "Vaccin associé rougeole-oreillons-rubéole-varicelle à virus vivants, atténués",
    "en_ingredients": "MUMPS VIRUS VACCINE LIVE ATTENUATED\r\nVARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED\r\nRUBELLA VIRUS VACCINE LIVE ATTENUATED\r\nMEASLES VIRUS VACCINE LIVE ATTENUATED",
    "fr_ingredients": "Vaccin antirougeoleux, vivant, atténué",
    "drug_strength": "25118.9UNIT\r\n1995.2623UNIT\r\n1000UNIT\r\n1000UNIT",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAMUSCULAR\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nSous-cutanée",
    "drug_package_quantity": "10's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55681,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9752,
      "drug_code": 63732,
      "updated_date": "2025-05-15T03:59:23-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8329157,
          "ingredient": {
            "id": 704,
            "ingredient_code": 9054,
            "en_name": "WARFARIN SODIUM",
            "fr_name": "Warfarine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240206",
      "brand_name": "COUMADIN TAB 6 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104597008"
    },
    "created_date": "2018-07-13T18:16:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240206",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "B01AA03",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2018-09-24T00:00:00-04:00",
    "estimated_end_date": "2018-09-17T00:00:00-04:00",
    "actual_end_date": "2018-09-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-09-17T13:00:44-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "COUMADIN TAB 6 MG",
    "en_drug_common_name": "Warfarin",
    "fr_drug_brand_name": "Coumadin 6mg",
    "fr_drug_common_name": "Warfarine",
    "en_ingredients": "WARFARIN SODIUM",
    "fr_ingredients": "Warfarine sodique",
    "drug_strength": "6MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 BTL x 100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55690,
    "drug": {
      "current_status": "MARKETED",
      "id": 19376,
      "drug_code": 80652,
      "updated_date": "2025-12-03T00:31:24-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256770,
          "ingredient": {
            "id": 3518,
            "ingredient_code": 20429,
            "en_name": "LOTEPREDNOL ETABONATE",
            "fr_name": "Étabonate de lotéprednol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02321114",
      "brand_name": "LOTEMAX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152508002"
    },
    "created_date": "2018-07-13T18:18:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02321114",
    "company_name": "BAUSCH & LOMB INC",
    "atc_number": "S01BA14",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "anticipated_start_date": "2018-08-09T00:00:00-04:00",
    "estimated_end_date": "2018-08-31T00:00:00-04:00",
    "actual_end_date": "2018-08-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-08-24T17:25:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LOTEMAX",
    "en_drug_common_name": "LOTEMAX",
    "fr_drug_brand_name": "LOTEMAX",
    "fr_drug_common_name": "LOTEMAX",
    "en_ingredients": "LOTEPREDNOL ETABONATE",
    "fr_ingredients": "Étabonate de lotéprednol",
    "drug_strength": "0.5%",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "10ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55694,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1560,
      "drug_code": 13375,
      "updated_date": "2025-05-15T03:39:36-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8291375,
          "ingredient": {
            "id": 704,
            "ingredient_code": 9054,
            "en_name": "WARFARIN SODIUM",
            "fr_name": "Warfarine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02007959",
      "brand_name": "COUMADIN TAB 4MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74739",
      "number_of_ais": "1",
      "ai_group_no": "0104597003"
    },
    "created_date": "2018-07-13T18:19:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02007959",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "B01AA03",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2018-12-03T00:00:00-05:00",
    "estimated_end_date": "2018-12-05T00:00:00-05:00",
    "actual_end_date": "2018-11-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-11-22T14:57:48-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "COUMADIN TAB 4MG",
    "en_drug_common_name": "Warfarin",
    "fr_drug_brand_name": "Coumadin 4mg",
    "fr_drug_common_name": "Warfarine",
    "en_ingredients": "WARFARIN SODIUM",
    "fr_ingredients": "Warfarine sodique",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 BTL x 100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55698,
    "drug": {
      "current_status": "MARKETED",
      "id": 14914,
      "drug_code": 75308,
      "updated_date": "2025-12-03T00:31:03-05:00",
      "company": {
        "id": 1806,
        "created_date": "2017-03-09T13:25:49-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 14884,
        "mfr_code": "",
        "name": "BAVARIAN NORDIC AS",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "PHILIP HEYMANS ALLE 3",
        "province": "--",
        "country": "DENMARK",
        "city": "HELLERUP",
        "postal_code": "2900",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255341,
          "ingredient": {
            "id": 36178,
            "ingredient_code": 23916,
            "en_name": "INACTIVATED RABIES VIRUS",
            "fr_name": "VIRUS DE LA RAGE INACTIVÉ (FLURY LEP)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02267667",
      "brand_name": "RABAVERT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0165642001"
    },
    "created_date": "2018-07-13T18:19:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02267667",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07BG01",
    "atc_description": "VIRAL VACCINES",
    "actual_start_date": "2018-07-10T00:00:00-04:00",
    "actual_end_date": "2019-02-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-02-08T21:28:10-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RABAVERT",
    "en_drug_common_name": "Rabies Vaccine",
    "fr_drug_brand_name": "RABAVERT",
    "fr_drug_common_name": "Vaccin antirabique",
    "en_ingredients": "RABIES VACCINE INACTIVATED",
    "fr_ingredients": "Vaccin antirabique inactivé",
    "drug_strength": "2.5UNIT",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "1's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55706,
    "drug": {
      "current_status": "MARKETED",
      "id": 27972,
      "drug_code": 90167,
      "updated_date": "2025-05-15T02:34:09-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8260167,
          "ingredient": {
            "id": 3924,
            "ingredient_code": 22177,
            "en_name": "RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN",
            "fr_name": "Protéine NadA recombinante de Neisseria meningitidis du sérogroupe B"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8260166,
          "ingredient": {
            "id": 3926,
            "ingredient_code": 22178,
            "en_name": "RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN",
            "fr_name": "Protéine fHBP hybride recombinante de Neisseria meningitidis du sérogroupe B"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8260165,
          "ingredient": {
            "id": 3922,
            "ingredient_code": 22176,
            "en_name": "RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN",
            "fr_name": "Protéine NHBA hybride recombinante de Neisseria meningitidis du sérogroupe B"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8260164,
          "ingredient": {
            "id": 3928,
            "ingredient_code": 22179,
            "en_name": "OUTER MEMBRANE VESICLES",
            "fr_name": "Vésicules de membrane externe (Neisseria meningitidis group B souche NZ98/254)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02417030",
      "brand_name": "BEXSERO",
      "brand_name_fr": "",
      "descriptor": "MULTICOMPONENT MENINGOC. B VACCINE (R-DNA ADSORBED). 0.5ML PFS.",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "4",
      "ai_group_no": "0455051001"
    },
    "created_date": "2018-07-13T18:23:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02417030",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07AH09",
    "atc_description": "BACTERIAL VACCINES",
    "estimated_end_date": "2018-08-24T00:00:00-04:00",
    "actual_start_date": "2018-07-10T00:00:00-04:00",
    "actual_end_date": "2018-08-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-08-08T14:46:39-04:00",
    "status": "resolved",
    "en_comments": "Supply in pack size of 1’s is unavailable in the private market. BEXSERO is available in packages of 10.",
    "fr_comments": "Les boîtes de 1 unité ne sont pas offertes au marché privé. BEXSERO est offert en boîtes de 10.",
    "en_drug_brand_name": "BEXSERO",
    "en_drug_common_name": "Multicomponent Meningococcal B Vaccine (recombinant, adsorbed)",
    "fr_drug_brand_name": "BEXSERO",
    "fr_drug_common_name": "Vaccin à constituants multiples contre le méningocoque B (recombinant, adsorbé)",
    "en_ingredients": "Recombinant Neisseria meningitidis group B NHBA fusion protein\r\nRecombinant Neisseria meningitidis group B NadA protein\r\nRecombinant Neisseria meningitidis group B fHBP fusion protein\r\nOuter membrane vesicles",
    "fr_ingredients": "Protéine NHBA hybride recombinante de Neisseria meningitidis du sérogroupe B\r\nProtéine NadA recombinante de Neisseria meningitidis du sérogroupe B\r\nProtéine fHBP hybride recombinante de Neisseria meningitidis du sérogroupe B",
    "drug_strength": "50MCG\r\n50MCG\r\n50MCG\r\n25MCG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "1's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55709,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19326,
      "drug_code": 80596,
      "updated_date": "2025-12-03T01:26:24-05:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8346584,
          "ingredient": {
            "id": 3496,
            "ingredient_code": 20412,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D CARRIER PROTEIN",
            "fr_name": "Polysaccharide du pneumocoque de sérot. 1 conjugué à la prot. D comme porteur"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8346583,
          "ingredient": {
            "id": 3510,
            "ingredient_code": 20419,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D CARRIER PROTEIN",
            "fr_name": "Polysaccharide du pneumocoque de sérot. 23F conjugué à la prot. D comme porteur"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8346582,
          "ingredient": {
            "id": 3512,
            "ingredient_code": 20420,
            "en_name": "PNEUMOCOCCAL POLYSACC. SEROT. 18C CONJUG. TO TETANUS TOXOID CARRIER PROT.",
            "fr_name": "Polysacch. pneumococ. serot. 18C conjugué à l'anatoxine tétaniquE comme porteur"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8346581,
          "ingredient": {
            "id": 3508,
            "ingredient_code": 20418,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D CARRIER PROTEIN",
            "fr_name": "Polysaccharide du pneumocoque de sérot. 14 conjugué à la prot. D comme porteur"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8346580,
          "ingredient": {
            "id": 3506,
            "ingredient_code": 20417,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D CARRIER PROTEIN",
            "fr_name": "Polysaccharide du pneumocoque de sérot. 9V conjugué à la prot. D comme porteur"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8346579,
          "ingredient": {
            "id": 3504,
            "ingredient_code": 20416,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D CARRIER PROTEIN",
            "fr_name": "Polysaccharide du pneumocoque de sérot. 7F conjugué à la prot. D comme porteur"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8346578,
          "ingredient": {
            "id": 3500,
            "ingredient_code": 20414,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D CARRIER PROTEIN",
            "fr_name": "Polysaccharide du pneumocoque de sérot. 5 conjugué à la prot. D comme porteur"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8346577,
          "ingredient": {
            "id": 3502,
            "ingredient_code": 20415,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D CARRIER PROTEIN",
            "fr_name": "Polysaccharide du pneumocoque de sérot. 6B conjugué à la prot. D comme porteur"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8346576,
          "ingredient": {
            "id": 3498,
            "ingredient_code": 20413,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D CARRIER PROTEIN",
            "fr_name": "Polysaccharide du pneumocoque de sérot. 4 conjugué à la prot. D comme porteur"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8346575,
          "ingredient": {
            "id": 3514,
            "ingredient_code": 20421,
            "en_name": "PNEUMOCOCCAL POLYSACCHARID SEROT. 19F CONJUG. TO DIPHTHERIA TOXOID CARRIER PROT.",
            "fr_name": "Polysacc. du pneumoc. de sérot. 19F conj. à l'anatoxine diphtér. comme porteur"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02320541",
      "brand_name": "SYNFLORIX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "10",
      "ai_group_no": "1052505001"
    },
    "created_date": "2018-07-13T18:33:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02320541",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07AL02",
    "atc_description": "BACTERIAL VACCINES",
    "estimated_end_date": "2018-08-17T00:00:00-04:00",
    "actual_start_date": "2018-07-10T00:00:00-04:00",
    "actual_end_date": "2018-08-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-08-02T19:47:17-04:00",
    "status": "resolved",
    "en_comments": "Most recent supply released July 24, 2018 with limited quantity.",
    "fr_comments": "Libération des stocks les plus récents le 24 juillet 2018 en quantités limitées.",
    "en_drug_brand_name": "SYNFLORIX",
    "en_drug_common_name": "Pneumococcal conjugate vaccine (Non-Typeable Haemophilus influenzae (NTHi) protein D, diphtheria or tetanus toxoid conjugates) adsorbed",
    "fr_drug_brand_name": "SYNFLORIX",
    "fr_drug_common_name": "Vaccin antipneumococcique conjugué (polysaccharides conjugués à une protéine D dérivée d’une souche non typable de Haemophilus influenzae, à l’anatoxine diphtérique ou à l’anatoxine tétanique) adsorbé",
    "en_ingredients": "PNEUMOCOCCAL POLYSACC. SEROT. 18C CONJUG. TO TETANUS TOXOID CARRIER PROT.\r\nPNEUMOCOCCAL POLYSACCHARID SEROT. 19F CONJUG. TO DIPHTHERIA TOXOID CARRIER PROT.\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D CARRIER PROTEIN\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D CARRIER PROTEIN\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D CARRIER PROTEIN\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D CARRIER PROTEIN\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D CARRIER PROTEIN\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D CARRIER PROTEIN\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D CARRIER PROTEIN\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D CARRIER PROTEIN",
    "fr_ingredients": "Polysacch. pneumococ. serot. 18C conjugué à l'anatoxine tétaniquE comme porteur\r\nPolysacc. du pneumoc. de sérot. 19F conj. à l'anatoxine diphtér. comme porteur\r\nPolysaccharide du pneumocoque de sérot. 1 conjugué à la prot. D comme porteur\r\nPolysaccharide du pneumocoque de sérot. 4 conjugué à la prot. D comme porteur\r\nPolysaccharide du pneumocoque de sérot. 5 conjugué à la prot. D comme porteur\r\nPolysaccharide du pneumocoque de sérot. 6B conjugué à la prot. D comme porteur\r\nPolysaccharide du pneumocoque de sérot. 7F conjugué à la prot. D comme porteur\r\nPolysaccharide du pneumocoque de sérot. 9V conjugué à la prot. D comme porteur\r\nPolysaccharide du pneumocoque de sérot. 14 conjugué à la prot. D comme porteur\r\nPolysaccharide du pneumocoque de sérot. 23F conjugué à la prot. D comme porteur",
    "drug_strength": "3MCG\r\n3MCG\r\n3MCG\r\n1MCG\r\n3MCG\r\n1MCG\r\n1MCG\r\n1MCG\r\n1MCG\r\n1MCG\r\n1MCG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "10's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55723,
    "drug": {
      "current_status": "MARKETED",
      "id": 282,
      "drug_code": 10770,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8251383,
          "ingredient": {
            "id": 14,
            "ingredient_code": 51,
            "en_name": "CALCIUM CHLORIDE",
            "fr_name": "Chlorure de calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00821780",
      "brand_name": "CALCIJECT INJ 100MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70811",
      "number_of_ais": "1",
      "ai_group_no": "0108565001"
    },
    "created_date": "2018-07-13T19:52:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00821780",
    "company_name": "OMEGA LABORATORIES LTD",
    "atc_number": "B05XA07",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "estimated_end_date": "2018-07-31T00:00:00-04:00",
    "actual_start_date": "2018-07-13T00:00:00-04:00",
    "actual_end_date": "2018-07-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-24T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CALCIJECT INJ 100MG/ML",
    "en_drug_common_name": "Calcium Chloride for Injection USP",
    "fr_drug_brand_name": "Calciject",
    "fr_drug_common_name": "Chlorure de calcium pour injection USP",
    "en_ingredients": "CALCIUM CHLORIDE",
    "fr_ingredients": "Chlorure de calcium",
    "drug_strength": "100MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 x 50 mL vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55726,
    "drug": {
      "current_status": "MARKETED",
      "id": 16166,
      "drug_code": 76957,
      "updated_date": "2025-12-03T00:31:09-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255767,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02284006",
      "brand_name": "PMS-ALENDRONATE-FC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150323002"
    },
    "created_date": "2018-07-13T20:00:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02284006",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "M05BA04",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "anticipated_start_date": "2018-08-01T00:00:00-04:00",
    "estimated_end_date": "2018-12-12T00:00:00-05:00",
    "actual_start_date": "2018-08-23T00:00:00-04:00",
    "actual_end_date": "2018-12-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-12-12T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ALENDRONATE-FC",
    "en_drug_common_name": "ALENDRONATE",
    "fr_drug_brand_name": "PMS-ALENDRONATE-FC",
    "fr_drug_common_name": "ALENDRONATE",
    "en_ingredients": "ALENDRONIC ACID",
    "fr_ingredients": "ALENDRONATE",
    "drug_strength": "70MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55729,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7216,
      "drug_code": 48977,
      "updated_date": "2025-12-03T01:13:46-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8314905,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02230245",
      "brand_name": "PMS-AMOXICILLIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131314002"
    },
    "created_date": "2018-07-13T20:02:48-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02230245",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "J01CA04",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "discontinuation_date": "2018-09-19T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-30T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "DISCONTINUED",
    "fr_discontinuation_comments": "DISCONTINUER",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-09-20T05:00:09-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-AMOXICILLIN",
    "en_drug_common_name": "AMOXICILLIN",
    "fr_drug_brand_name": "AMOXICILLIN",
    "fr_drug_common_name": "AMOXICILLIN",
    "en_ingredients": "AMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "125MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55732,
    "drug": {
      "current_status": "MARKETED",
      "id": 21078,
      "drug_code": 83336,
      "updated_date": "2025-05-15T02:32:39-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257482,
          "ingredient": {
            "id": 2616,
            "ingredient_code": 11795,
            "en_name": "CLOPIDOGREL",
            "fr_name": "Clopidogrel (Bisulfate de clopidogrel)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02348004",
      "brand_name": "PMS-CLOPIDOGREL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134440001"
    },
    "created_date": "2018-07-13T20:04:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02348004",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "B01AC04",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2018-07-19T00:00:00-04:00",
    "actual_end_date": "2018-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-18T19:20:01-04:00",
    "status": "resolved",
    "fr_comments": "Pénurie évitée",
    "en_drug_brand_name": "PMS-CLOPIDOGREL",
    "en_drug_common_name": "CLOPIDOGREL",
    "fr_drug_brand_name": "PMS-CLOPIDOGREL",
    "fr_drug_common_name": "CLOPIDOGREL",
    "en_ingredients": "CLOPIDOGREL",
    "fr_ingredients": "CLOPIDOGREL",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55735,
    "drug": {
      "current_status": "MARKETED",
      "id": 13774,
      "drug_code": 7365,
      "updated_date": "2025-05-15T02:30:39-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251012,
          "ingredient": {
            "id": 186,
            "ingredient_code": 9152,
            "en_name": "DOCUSATE SODIUM",
            "fr_name": "Docusate sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00703494",
      "brand_name": "PMS-DOCUSATE SODIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "65264",
      "number_of_ais": "1",
      "ai_group_no": "0104351002"
    },
    "created_date": "2018-07-13T20:05:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00703494",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A06AA02",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "anticipated_start_date": "2018-08-09T00:00:00-04:00",
    "estimated_end_date": "2018-10-15T00:00:00-04:00",
    "actual_start_date": "2018-08-23T00:00:00-04:00",
    "actual_end_date": "2018-10-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-18T19:20:31-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-DOCUSATE SODIUM",
    "en_drug_common_name": "DOCUSATE SODIUM",
    "fr_drug_brand_name": "PMS-DOCUSATE SODIUM",
    "fr_drug_common_name": "DOCUSATE SODIUM",
    "en_ingredients": "DOCUSATE SODIUM",
    "fr_ingredients": "Docusate sodique",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55738,
    "drug": {
      "current_status": "MARKETED",
      "id": 31276,
      "drug_code": 9349,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251147,
          "ingredient": {
            "id": 1210,
            "ingredient_code": 2300,
            "en_name": "LORAZEPAM",
            "fr_name": "Lorazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00728187",
      "brand_name": "PMS-LORAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68358",
      "number_of_ais": "1",
      "ai_group_no": "0110731003"
    },
    "created_date": "2018-07-13T20:06:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00728187",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N05BA06",
    "atc_description": "ANXIOLYTICS",
    "anticipated_start_date": "2018-08-18T00:00:00-04:00",
    "actual_start_date": "2018-08-23T00:00:00-04:00",
    "actual_end_date": "2018-09-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-19T19:07:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-LORAZEPAM TAB 0.5MG",
    "en_drug_common_name": "LORAZEPAM",
    "fr_drug_brand_name": "PMS-LORAZEPAM TAB 0.5MG",
    "fr_drug_common_name": "LORAZEPAM",
    "en_ingredients": "LORAZEPAM",
    "fr_ingredients": "Lorazépam",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55741,
    "drug": {
      "current_status": "MARKETED",
      "id": 14124,
      "drug_code": 74163,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255100,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02256428",
      "brand_name": "PMS-SUMATRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123238007"
    },
    "created_date": "2018-07-13T20:08:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02256428",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02CC01",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "anticipated_start_date": "2018-08-31T00:00:00-04:00",
    "estimated_end_date": "2018-09-30T00:00:00-04:00",
    "actual_start_date": "2018-08-23T00:00:00-04:00",
    "actual_end_date": "2018-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-03T20:28:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-SUMATRIPTAN",
    "en_drug_common_name": "SUMATRIPTAN",
    "fr_drug_brand_name": "PMS-SUMATRIPTAN",
    "fr_drug_common_name": "PMS-SUMATRIPTAN",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "SUMATRIPTAN",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55744,
    "drug": {
      "current_status": "MARKETED",
      "id": 11158,
      "drug_code": 67438,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254191,
          "ingredient": {
            "id": 2374,
            "ingredient_code": 11368,
            "en_name": "TERAZOSIN",
            "fr_name": "Térazosine (Chlorhydrate de térazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243519",
      "brand_name": "PMS-TERAZOSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136978002"
    },
    "created_date": "2018-07-13T20:11:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243519",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "G04CA03",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "anticipated_start_date": "2018-07-30T00:00:00-04:00",
    "estimated_end_date": "2018-11-07T00:00:00-05:00",
    "actual_start_date": "2018-08-23T00:00:00-04:00",
    "actual_end_date": "2018-11-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-11-29T14:47:51-05:00",
    "status": "resolved",
    "en_comments": "RESOLVED",
    "fr_comments": "RESOLU",
    "en_drug_brand_name": "PMS-TERAZOSIN",
    "en_drug_common_name": "TERAZOSIN",
    "fr_drug_brand_name": "PMS-TERAZOSIN",
    "fr_drug_common_name": "TERAZOSIN",
    "en_ingredients": "TERAZOSIN",
    "fr_ingredients": "TERAZOSIN",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55747,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19602,
      "drug_code": 80970,
      "updated_date": "2025-12-03T01:26:33-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8346892,
          "ingredient": {
            "id": 2614,
            "ingredient_code": 11793,
            "en_name": "ZOLMITRIPTAN",
            "fr_name": "Zolmitriptan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02324229",
      "brand_name": "PMS-ZOLMITRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134381001"
    },
    "created_date": "2018-07-13T20:13:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02324229",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02CC03",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "actual_start_date": "2019-07-30T00:00:00-04:00",
    "actual_end_date": "2020-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-10T13:00:54-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued.",
    "fr_comments": "Product to be discontinued.",
    "en_drug_brand_name": "PMS-ZOLMITRIPTAN",
    "en_drug_common_name": "ZOLMITRIPTAN",
    "fr_drug_brand_name": "PMS-ZOLMITRIPTAN",
    "fr_drug_common_name": "ZOLMITRIPTAN",
    "en_ingredients": "ZOLMITRIPTAN",
    "fr_ingredients": "Zolmitriptan",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55768,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11854,
      "drug_code": 69516,
      "updated_date": "2025-05-15T04:04:35-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8336134,
          "ingredient": {
            "id": 712,
            "ingredient_code": 6469,
            "en_name": "GOLD SODIUM THIOMALATE",
            "fr_name": "Aurothiomalate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02245458",
      "brand_name": "SODIUM AUROTHIOMALATE INJECTION BP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107427001"
    },
    "created_date": "2018-07-13T21:37:41-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02245458",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "M01CB01",
    "atc_description": "SPECIFIC ANTIRHEUMATIC AGENTS",
    "discontinuation_date": "2016-09-10T00:00:00-04:00",
    "anticipated_discontinuation_date": "2016-08-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 2,
      "en_reason": "Raw material availability",
      "fr_reason": "Disponibilité des matières premières",
      "active": true
    },
    "updated_date": "2018-07-13T21:38:29-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "SODIUM AUROTHIOMALATE INJECTION BP",
    "en_drug_common_name": "AUROTHIOMALATE",
    "fr_drug_brand_name": "AUROTHIOMALATE",
    "fr_drug_common_name": "AUROTHIOMALATE",
    "en_ingredients": "GOLD SODIUM THIOMALATE",
    "fr_ingredients": "Aurothiomalate de sodium",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "10 VIALS",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55771,
    "drug": {
      "current_status": "MARKETED",
      "id": 10990,
      "drug_code": 66965,
      "updated_date": "2025-05-15T02:31:13-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254132,
          "ingredient": {
            "id": 1642,
            "ingredient_code": 10303,
            "en_name": "ACETYLCYSTEINE",
            "fr_name": "Acétylcystéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02243098",
      "brand_name": "ACETYLCYSTEINE SOLUTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0100024001"
    },
    "created_date": "2018-07-13T21:50:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243098",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "R05CB01",
    "atc_description": "EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.",
    "estimated_end_date": "2018-08-20T00:00:00-04:00",
    "actual_start_date": "2018-06-23T00:00:00-04:00",
    "actual_end_date": "2018-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2018-08-23T14:38:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACETYLCYSTEINE SOLUTION",
    "en_drug_common_name": "ACETYLCYSTEINE",
    "fr_drug_brand_name": "ACETYLCYSTEINE",
    "fr_drug_common_name": "ACETYLCYSTEINE",
    "en_ingredients": "ACETYLCYSTEINE",
    "fr_ingredients": "Acétylcystéine",
    "drug_strength": "200MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION\r\nINTRAVENOUS\r\nORAL",
    "drug_route_fr": "Inhalation\r\nIntraveineuse\r\nOrale",
    "drug_package_quantity": "10ML VIAL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55774,
    "drug": {
      "current_status": "MARKETED",
      "id": 10990,
      "drug_code": 66965,
      "updated_date": "2025-05-15T02:31:13-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254132,
          "ingredient": {
            "id": 1642,
            "ingredient_code": 10303,
            "en_name": "ACETYLCYSTEINE",
            "fr_name": "Acétylcystéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02243098",
      "brand_name": "ACETYLCYSTEINE SOLUTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0100024001"
    },
    "created_date": "2018-07-13T21:51:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243098",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "R05CB01",
    "atc_description": "EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.",
    "estimated_end_date": "2018-08-20T00:00:00-04:00",
    "actual_start_date": "2018-06-23T00:00:00-04:00",
    "actual_end_date": "2018-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2018-08-23T14:39:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACETYLCYSTEINE SOLUTION",
    "en_drug_common_name": "ACETYLCYSTEINE",
    "fr_drug_brand_name": "ACETYLCYSTEINE",
    "fr_drug_common_name": "ACETYLCYSTEINE",
    "en_ingredients": "ACETYLCYSTEINE",
    "fr_ingredients": "Acétylcystéine",
    "drug_strength": "200MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION\r\nINTRAVENOUS\r\nORAL",
    "drug_route_fr": "Inhalation\r\nIntraveineuse\r\nOrale",
    "drug_package_quantity": "30ML VIAL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55788,
    "drug": {
      "current_status": "DORMANT",
      "id": 24674,
      "drug_code": 87254,
      "updated_date": "2025-05-15T06:55:46-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368799,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02386976",
      "brand_name": "APO-IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700002"
    },
    "created_date": "2018-07-15T10:51:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02386976",
    "company_name": "APOTEX INC",
    "atc_number": "C09CA04",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2019-05-31T00:00:00-04:00",
    "estimated_end_date": "2018-08-20T00:00:00-04:00",
    "actual_end_date": "2018-08-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-21T13:27:52-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "APO-IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "APO-IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55791,
    "drug": {
      "current_status": "DORMANT",
      "id": 24672,
      "drug_code": 87253,
      "updated_date": "2025-05-15T06:55:46-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368798,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02386968",
      "brand_name": "APO-IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700001"
    },
    "created_date": "2018-07-15T10:53:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02386968",
    "company_name": "APOTEX INC",
    "atc_number": "C09CA04",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2019-05-31T00:00:00-04:00",
    "actual_end_date": "2018-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-21T13:28:41-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "APO-IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "APO-IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55794,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28320,
      "drug_code": 90469,
      "updated_date": "2025-12-03T01:32:09-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8354331,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420082",
      "brand_name": "APO-TELMISARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138223001"
    },
    "created_date": "2018-07-15T10:55:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420082",
    "company_name": "APOTEX INC",
    "atc_number": "C09CA07",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2018-08-03T00:00:00-04:00",
    "actual_start_date": "2018-07-30T00:00:00-04:00",
    "actual_end_date": "2018-09-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-12T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TELMISARTAN",
    "en_drug_common_name": "TELMISARTAN",
    "fr_drug_brand_name": "APO-TELMISARTAN",
    "fr_drug_common_name": "TELMISARTAN",
    "en_ingredients": "TELMISARTAN",
    "fr_ingredients": "Telmisartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55798,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28322,
      "drug_code": 90470,
      "updated_date": "2025-12-03T01:32:09-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8354332,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420090",
      "brand_name": "APO-TELMISARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138223002"
    },
    "created_date": "2018-07-15T10:57:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420090",
    "company_name": "APOTEX INC",
    "atc_number": "C09CA07",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2018-11-01T00:00:00-04:00",
    "actual_start_date": "2018-08-13T00:00:00-04:00",
    "actual_end_date": "2018-09-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-12T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TELMISARTAN",
    "en_drug_common_name": "TELMISARTAN",
    "fr_drug_brand_name": "APO-TELMISARTAN",
    "fr_drug_common_name": "TELMISARTAN",
    "en_ingredients": "TELMISARTAN",
    "fr_ingredients": "Telmisartan",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55801,
    "drug": {
      "current_status": "DORMANT",
      "id": 51243,
      "drug_code": 94000,
      "updated_date": "2025-12-03T02:32:39-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369379,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02453452",
      "brand_name": "APO-OLMESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152496002"
    },
    "created_date": "2018-07-15T10:59:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453452",
    "company_name": "APOTEX INC",
    "atc_number": "C09CA08",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2018-09-03T00:00:00-04:00",
    "actual_end_date": "2018-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-21T13:30:09-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "APO-OLMESARTAN",
    "en_drug_common_name": "OLMESARTAN MEDOXOMIL",
    "fr_drug_brand_name": "APO-OLMESARTAN",
    "fr_drug_common_name": "OLMESARTAN MEDOXOMIL",
    "en_ingredients": "OLMESARTAN MEDOXOMIL",
    "fr_ingredients": "OLMESARTAN MEDOXOMIL",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55807,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23056,
      "drug_code": 85641,
      "updated_date": "2025-12-03T01:29:15-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8350517,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8350516,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02371235",
      "brand_name": "APO-LOSARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168001"
    },
    "created_date": "2018-07-15T11:04:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02371235",
    "company_name": "APOTEX INC",
    "atc_number": "C09DA01",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "anticipated_start_date": "2018-07-23T00:00:00-04:00",
    "estimated_end_date": "2018-09-14T00:00:00-04:00",
    "actual_start_date": "2018-07-20T00:00:00-04:00",
    "actual_end_date": "2018-09-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-15T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LOSARTAN/HCTZ",
    "en_drug_common_name": "LOSARTAN/HCTZ",
    "fr_drug_brand_name": "APO-LOSARTAN/HCTZ",
    "fr_drug_common_name": "LOSARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "12.5MG\r\n50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55810,
    "drug": {
      "current_status": "DORMANT",
      "id": 24676,
      "drug_code": 87255,
      "updated_date": "2025-05-15T06:55:46-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368800,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02386984",
      "brand_name": "APO-IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700003"
    },
    "created_date": "2018-07-15T11:07:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02386984",
    "company_name": "APOTEX INC",
    "atc_number": "C09CA04",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2019-10-31T00:00:00-04:00",
    "actual_end_date": "2018-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-21T13:31:50-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "APO-IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "APO-IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55836,
    "drug": {
      "current_status": "MARKETED",
      "id": 53515,
      "drug_code": 95539,
      "updated_date": "2025-05-15T02:35:58-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262664,
          "ingredient": {
            "id": 3520,
            "ingredient_code": 20430,
            "en_name": "DESVENLAFAXINE",
            "fr_name": "Desvenlafaxine (Succinate de desvenlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02466988",
      "brand_name": "APO-DESVENLAFAXINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152509001"
    },
    "created_date": "2018-07-16T14:11:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02466988",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX23",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-11-30T00:00:00-05:00",
    "actual_start_date": "2018-07-16T00:00:00-04:00",
    "actual_end_date": "2018-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-02T17:24:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DESVENLAFAXINE",
    "en_drug_common_name": "DESVENLAFAXINE",
    "fr_drug_brand_name": "APO-DESVENLAFAXINE",
    "fr_drug_common_name": "DESVENLAFAXINE",
    "en_ingredients": "DESVENLAFAXINE",
    "fr_ingredients": "DESVENLAFAXINE",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55839,
    "drug": {
      "current_status": "MARKETED",
      "id": 4708,
      "drug_code": 2472,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250418,
          "ingredient": {
            "id": 564,
            "ingredient_code": 10091,
            "en_name": "FUROSEMIDE",
            "fr_name": "Furosémide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00362166",
      "brand_name": "APO-FUROSEMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "49764",
      "number_of_ais": "1",
      "ai_group_no": "0101944001"
    },
    "created_date": "2018-07-16T14:13:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00362166",
    "company_name": "APOTEX INC",
    "atc_number": "C03CA01",
    "atc_description": "HIGH-CEILING DIURETICS",
    "estimated_end_date": "2018-10-31T00:00:00-04:00",
    "actual_start_date": "2018-07-16T00:00:00-04:00",
    "actual_end_date": "2018-09-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-11T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO FUROSEMIDE TAB 40MG",
    "en_drug_common_name": "FUROSEMIDE",
    "fr_drug_brand_name": "APO FUROSEMIDE TAB 40MG",
    "fr_drug_common_name": "FUROSEMIDE",
    "en_ingredients": "FUROSEMIDE",
    "fr_ingredients": "Furosémide",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55842,
    "drug": {
      "current_status": "MARKETED",
      "id": 15970,
      "drug_code": 76749,
      "updated_date": "2025-12-03T00:31:07-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255704,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02281848",
      "brand_name": "APO-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783005"
    },
    "created_date": "2018-07-16T14:15:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02281848",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-10-12T00:00:00-04:00",
    "actual_start_date": "2018-07-16T00:00:00-04:00",
    "actual_end_date": "2018-10-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-12T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "15.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55847,
    "drug": {
      "current_status": "MARKETED",
      "id": 9048,
      "drug_code": 61676,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253562,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02238280",
      "brand_name": "APO-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417003"
    },
    "created_date": "2018-07-16T14:18:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238280",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB06",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-09-10T00:00:00-04:00",
    "actual_start_date": "2018-07-16T00:00:00-04:00",
    "actual_end_date": "2018-08-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-31T13:14:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "APO-SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55854,
    "drug": {
      "current_status": "MARKETED",
      "id": 552,
      "drug_code": 11196,
      "updated_date": "2025-12-03T00:30:30-05:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8251477,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00851744",
      "brand_name": "ELOCOM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71699",
      "number_of_ais": "1",
      "ai_group_no": "0121732001"
    },
    "created_date": "2018-07-16T16:00:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00851744",
    "company_name": "MERCK CANADA INC",
    "atc_number": "D07AC13",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "anticipated_start_date": "2018-07-16T00:00:00-04:00",
    "estimated_end_date": "2018-09-12T00:00:00-04:00",
    "actual_start_date": "2018-07-16T00:00:00-04:00",
    "actual_end_date": "2018-09-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-09-11T05:00:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ELOCOM CREAM",
    "en_drug_common_name": "mometasone furoate cream",
    "fr_drug_brand_name": "ELOCOM CRÈME",
    "fr_drug_common_name": "crème de furoate de mométasone",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "0.1%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "15gr",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55920,
    "drug": {
      "current_status": "DORMANT",
      "id": 26124,
      "drug_code": 88469,
      "updated_date": "2025-05-15T06:55:48-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368901,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02399849",
      "brand_name": "MAR-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858003"
    },
    "created_date": "2018-07-16T19:09:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02399849",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N05AH04",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2018-12-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-01-01T06:00:02-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MAR-QUETIAPINE",
    "en_drug_common_name": "MAR-Quetiapine",
    "fr_drug_brand_name": "MAR-Quetiapine",
    "fr_drug_common_name": "MAR-Quetiapine",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quetiapine",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 Tabs",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55943,
    "drug": {
      "current_status": "MARKETED",
      "id": 11450,
      "drug_code": 68084,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 80,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4489,
        "mfr_code": "LEO08",
        "name": "LEO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6 ADELAIDE STREET EAST, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5C 1H6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254266,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8254265,
          "ingredient": {
            "id": 856,
            "ingredient_code": 894,
            "en_name": "CALCIPOTRIOL",
            "fr_name": "Calcipotriol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "02244126",
      "brand_name": "DOVOBET OINTMENT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252270001"
    },
    "created_date": "2018-07-16T19:21:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244126",
    "company_name": "LEO PHARMA INC",
    "atc_number": "D05AX52",
    "atc_description": "ANTIPSORIATICS FOR TOPICAL USE",
    "anticipated_start_date": "2018-07-26T00:00:00-04:00",
    "estimated_end_date": "2018-10-01T00:00:00-04:00",
    "actual_start_date": "2018-07-26T00:00:00-04:00",
    "actual_end_date": "2018-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-02T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DOVOBET OINTMENT",
    "en_drug_common_name": "calcipotriol and betamethasone dipropionate",
    "fr_drug_brand_name": "l'onguent Dovobet",
    "fr_drug_common_name": "calcipotriol et dipropionate de bêtaméthasone",
    "en_ingredients": "BETAMETHASONE\r\nCALCIPOTRIOL",
    "fr_ingredients": "Bétaméthasone\r\nCalcipotriol",
    "drug_strength": "0.5MG\r\n50MCG",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "120g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55964,
    "drug": {
      "current_status": "MARKETED",
      "id": 30568,
      "drug_code": 92624,
      "updated_date": "2025-05-15T02:34:48-04:00",
      "company": {
        "id": 2303,
        "created_date": "2017-04-06T17:15:09-04:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 17200,
        "mfr_code": "",
        "name": "ALTIUS HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "360 RUE DES ENTREPRENEURS",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTMAGNY",
        "postal_code": "G5V 4T1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261217,
          "ingredient": {
            "id": 2294,
            "ingredient_code": 11086,
            "en_name": "PANTOPRAZOLE",
            "fr_name": "Pantoprazole (Pantoprazole sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02441853",
      "brand_name": "PANTOPRAZOLE MAGNESIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133229001"
    },
    "created_date": "2018-07-16T20:19:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02441853",
    "company_name": "ALTIUS HEALTHCARE INC",
    "atc_number": "A02BC02",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "anticipated_start_date": "2018-07-17T00:00:00-04:00",
    "estimated_end_date": "2018-10-31T00:00:00-04:00",
    "actual_start_date": "2018-08-15T00:00:00-04:00",
    "actual_end_date": "2018-09-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-09-25T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Replenishment will begin week of September 24th but will extend into early October until all wholesalers carry product",
    "fr_comments": "Distribution reprend la semaine du 24 septembre mais peut s'étendre jusqu'au début du mois d'octobre avant que tous les grossistes recoivent leur inventaire.",
    "en_drug_brand_name": "PANTOPRAZOLE MAGNESIUM",
    "en_drug_common_name": "Pantoprazole Magnesium",
    "fr_drug_brand_name": "Pantoprazole Magnesium",
    "fr_drug_common_name": "Pantoprazole Magnesium",
    "en_ingredients": "PANTOPRAZOLE",
    "fr_ingredients": "pantoprazole magnesium",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 55999,
    "drug": {
      "current_status": "MARKETED",
      "id": 12020,
      "drug_code": 69937,
      "updated_date": "2025-05-15T02:31:18-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254458,
          "ingredient": {
            "id": 814,
            "ingredient_code": 1241,
            "en_name": "KETOROLAC TROMETHAMINE",
            "fr_name": "Kétorolac trométhamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245821",
      "brand_name": "KETOROLAC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121995003"
    },
    "created_date": "2018-07-17T14:57:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245821",
    "company_name": "AA PHARMA INC",
    "atc_number": "S01BC05",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "estimated_end_date": "2018-10-11T00:00:00-04:00",
    "actual_start_date": "2018-07-17T00:00:00-04:00",
    "actual_end_date": "2018-10-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-01-08T23:46:45-05:00",
    "status": "resolved",
    "en_drug_brand_name": "KETOROLAC",
    "en_drug_common_name": "Ketorolac",
    "fr_drug_brand_name": "KETOROLAC",
    "fr_drug_common_name": "KETOROLAC",
    "en_ingredients": "KETOROLAC TROMETHAMINE",
    "fr_ingredients": "Kétorolac trométhamine",
    "drug_strength": "0.5%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "5ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56002,
    "drug": {
      "current_status": "MARKETED",
      "id": 21424,
      "drug_code": 83817,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257656,
          "ingredient": {
            "id": 1070,
            "ingredient_code": 1810,
            "en_name": "ENALAPRIL MALEATE",
            "fr_name": "Maléate d'énalapril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257655,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02352931",
      "brand_name": "ENALAPRIL MALEATE/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0217290001"
    },
    "created_date": "2018-07-17T15:16:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02352931",
    "company_name": "AA PHARMA INC",
    "atc_number": "C09BA02",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "estimated_end_date": "2019-01-16T00:00:00-05:00",
    "actual_start_date": "2018-07-17T00:00:00-04:00",
    "actual_end_date": "2019-01-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-01-16T12:13:23-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ENALAPRIL MALEATE/HCTZ",
    "en_drug_common_name": "ENALAPRIL MALEATE/HCTZ",
    "fr_drug_brand_name": "ENALAPRIL MALEATE/HCTZ",
    "fr_drug_common_name": "ENALAPRIL MALEATE/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nENALAPRIL MALEATE",
    "fr_ingredients": "Hydrochlorothiazide\r\nMaléate d'énalapril",
    "drug_strength": "25.0MG\r\n10.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56007,
    "drug": {
      "current_status": "MARKETED",
      "id": 57152,
      "drug_code": 94413,
      "updated_date": "2025-05-15T02:35:34-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8262085,
          "ingredient": {
            "id": 1838,
            "ingredient_code": 1896,
            "en_name": "LABETALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de labétalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02457040",
      "brand_name": "LABETALOL HYDROCHLORIDE INJECTION",
      "brand_name_fr": "CHLORHYDRATE DE LABÉTALOL INJECTION",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116170002"
    },
    "created_date": "2018-07-17T16:36:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457040",
    "company_name": "OMEGA LABORATORIES LTD",
    "atc_number": "C07AG01",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2018-11-01T00:00:00-04:00",
    "actual_end_date": "2018-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-12-12T19:16:49-05:00",
    "status": "resolved",
    "en_comments": "On allocation at 100%.",
    "fr_comments": "En allocation à 100%.",
    "en_drug_brand_name": "LABETALOL HYDROCHLORIDE INJECTION",
    "en_drug_common_name": "Labetalol Hydrochloride Injection",
    "fr_drug_brand_name": "Labetalol Hydrochloride Injection",
    "fr_drug_common_name": "Chlorhydrate de labetalol injection",
    "en_ingredients": "LABETALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de labétalol",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1 x 20mL vials",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56072,
    "drug": {
      "current_status": "MARKETED",
      "id": 3276,
      "drug_code": 18314,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 17394,
        "created_date": "2025-12-03T00:30:14-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 22013,
        "mfr_code": "",
        "name": "IOVANCE BIOTHERAPEUTICS MANUFACTURING LLC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "300 ROUSE BLVD.",
        "province": "PENNSYLVANIA",
        "country": "UNITED STATES",
        "city": "PHILADELPHIA",
        "postal_code": "19112",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252296,
          "ingredient": {
            "id": 1390,
            "ingredient_code": 278,
            "en_name": "ALDESLEUKIN",
            "fr_name": "Aldesleukine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "22000000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02130181",
      "brand_name": "PROLEUKIN",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "80542",
      "number_of_ais": "1",
      "ai_group_no": "0126785001"
    },
    "created_date": "2018-07-18T20:21:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02130181",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "L03AC01",
    "atc_description": "IMMUNOSTIMULANTS",
    "anticipated_start_date": "2018-12-20T00:00:00-05:00",
    "estimated_end_date": "2018-12-21T00:00:00-05:00",
    "actual_end_date": "2018-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-01-03T16:07:17-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PROLEUKIN",
    "en_drug_common_name": "PROLEUKIN 1.3MG VIALS 1X1",
    "fr_drug_brand_name": "PROLEUKIN",
    "fr_drug_common_name": "PROLEUKIN 1.3MG VIALS 1X1",
    "en_ingredients": "ALDESLEUKIN",
    "fr_ingredients": "Aldesleukine",
    "drug_strength": "22000000UNIT",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1.3MG 1X1",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56080,
    "drug": {
      "current_status": "DORMANT",
      "id": 29718,
      "drug_code": 91731,
      "updated_date": "2025-05-15T06:55:54-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369214,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02432900",
      "brand_name": "TELMISARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138223002"
    },
    "created_date": "2018-07-19T12:44:57-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02432900",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09CA07",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "discontinuation_date": "2018-07-19T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-08-30T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "IN DEACTIVATION PROCESS",
    "fr_discontinuation_comments": "EN PROCESSUS DE DÉSACTIVATION",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-27T17:04:47-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TELMISARTAN",
    "en_drug_common_name": "TELMISARTAN",
    "fr_drug_brand_name": "pms-TELMISARTAN",
    "fr_drug_common_name": "TELMISARTAN",
    "en_ingredients": "TELMISARTAN",
    "fr_ingredients": "Telmisartan",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56088,
    "drug": {
      "current_status": "MARKETED",
      "id": 19942,
      "drug_code": 81253,
      "updated_date": "2025-05-15T02:32:25-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8256972,
          "ingredient": {
            "id": 1592,
            "ingredient_code": 5900,
            "en_name": "METHOTREXATE",
            "fr_name": "Méthotrexate (Méthotrexate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02327236",
      "brand_name": "METHOTREXATE INJECTION BP",
      "brand_name_fr": "METHOTREXATE INJECTABLE BP",
      "descriptor": "WITHOUT PRESERVATIVE (2 ML SINGLE-USE VIALS)",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107545002"
    },
    "created_date": "2018-07-19T15:22:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327236",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "L01BA01",
    "atc_description": "ANTIMETABOLITES",
    "anticipated_start_date": "2018-07-19T00:00:00-04:00",
    "estimated_end_date": "2018-08-10T00:00:00-04:00",
    "actual_start_date": "2018-07-19T00:00:00-04:00",
    "actual_end_date": "2018-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-02T13:37:32-04:00",
    "status": "resolved",
    "en_drug_brand_name": "METHOTREXATE INJECTION BP",
    "en_drug_common_name": "METHOTREXATE",
    "fr_drug_brand_name": "METHOTREXATE",
    "fr_drug_common_name": "METHOTREXATE",
    "en_ingredients": "METHOTREXATE",
    "fr_ingredients": "Méthotrexate",
    "drug_strength": "25MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRA-ARTERIAL\r\nINTRAMUSCULAR\r\nINTRATHECAL\r\nINTRAVENOUS\r\nINTRAVENTRICULAR",
    "drug_route_fr": "Intra-artérielle\r\nIntramusculaire\r\nIntrathécale\r\nIntraveineuse\r\nIntraventriculaire",
    "drug_package_quantity": "40 ML PER VIAL  | 40 ML PAR FLACON",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56097,
    "drug": {
      "current_status": "MARKETED",
      "id": 5548,
      "drug_code": 36947,
      "updated_date": "2025-12-03T00:30:35-05:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252870,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02213214",
      "brand_name": "ELTROXIN",
      "brand_name_fr": "ELTROXIN",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H4373",
      "number_of_ais": "1",
      "ai_group_no": "0107794004"
    },
    "created_date": "2018-07-19T16:53:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02213214",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "H03AA01",
    "atc_description": "THYROID PREPARATIONS",
    "estimated_end_date": "2018-09-21T00:00:00-04:00",
    "actual_start_date": "2018-07-20T00:00:00-04:00",
    "actual_end_date": "2018-09-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-09-18T14:11:48-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ELTROXIN",
    "en_drug_common_name": "Eltroxin 150 mcg",
    "fr_drug_brand_name": "Eltroxin",
    "fr_drug_common_name": "Eltroxin 150 mcg",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "150MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 tablets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56102,
    "drug": {
      "current_status": "MARKETED",
      "id": 12020,
      "drug_code": 69937,
      "updated_date": "2025-05-15T02:31:18-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254458,
          "ingredient": {
            "id": 814,
            "ingredient_code": 1241,
            "en_name": "KETOROLAC TROMETHAMINE",
            "fr_name": "Kétorolac trométhamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245821",
      "brand_name": "KETOROLAC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121995003"
    },
    "created_date": "2018-07-19T20:05:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245821",
    "company_name": "AA PHARMA INC",
    "atc_number": "S01BC05",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "anticipated_start_date": "2019-01-09T00:00:00-05:00",
    "estimated_end_date": "2019-02-07T00:00:00-05:00",
    "actual_start_date": "2019-01-14T00:00:00-05:00",
    "actual_end_date": "2019-02-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-08T18:12:29-05:00",
    "status": "resolved",
    "en_drug_brand_name": "KETOROLAC",
    "en_drug_common_name": "Ketorolac",
    "fr_drug_brand_name": "Ketorolac",
    "fr_drug_common_name": "Ketorolac",
    "en_ingredients": "KETOROLAC TROMETHAMINE",
    "fr_ingredients": "Kétorolac trométhamine",
    "drug_strength": "0.5%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "10 ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56105,
    "drug": {
      "current_status": "MARKETED",
      "id": 3832,
      "drug_code": 19348,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252483,
          "ingredient": {
            "id": 814,
            "ingredient_code": 1241,
            "en_name": "KETOROLAC TROMETHAMINE",
            "fr_name": "Kétorolac trométhamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02162660",
      "brand_name": "TORADOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81640",
      "number_of_ais": "1",
      "ai_group_no": "0121995001"
    },
    "created_date": "2018-07-19T20:06:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02162660",
    "company_name": "AA PHARMA INC",
    "atc_number": "M01AB15",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2018-08-07T00:00:00-04:00",
    "actual_start_date": "2018-07-19T00:00:00-04:00",
    "actual_end_date": "2018-07-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-01-14T21:14:23-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TORADOL",
    "en_drug_common_name": "Toradol",
    "fr_drug_brand_name": "TORADOL",
    "fr_drug_common_name": "TORADOL",
    "en_ingredients": "KETOROLAC TROMETHAMINE",
    "fr_ingredients": "Kétorolac trométhamine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56121,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22260,
      "drug_code": 84673,
      "updated_date": "2025-05-15T04:17:52-04:00",
      "company": {
        "id": 30,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 3574,
        "mfr_code": "ALL07",
        "name": "ALLERGAN INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "300",
        "street_name": "1380 RODICK ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MARKHAM",
        "postal_code": "L3R 4G5",
        "post_office_box": "",
        "contact_information": "Company contact information;\r\nTelephone number: 800-668-6424\r\nEmail address: MR-GENERAL_INQUIRY@allergan.com\r\nWebsite address: allergan.ca\r\nPostal address:  500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5"
      },
      "drug_ingredients": [
        {
          "id": 8349770,
          "ingredient": {
            "id": 3698,
            "ingredient_code": 20659,
            "en_name": "SILODOSIN",
            "fr_name": "Silodosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02361663",
      "brand_name": "RAPAFLO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152869001"
    },
    "created_date": "2018-07-20T13:11:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02361663",
    "company_name": "ALLERGAN INC",
    "atc_number": "G04CA04",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2018-08-10T00:00:00-04:00",
    "actual_start_date": "2018-07-06T00:00:00-04:00",
    "actual_end_date": "2018-09-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-09-25T17:39:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAPAFLO",
    "en_drug_common_name": "Rapaflo",
    "fr_drug_brand_name": "Rapaflo",
    "fr_drug_common_name": "Rapfalo",
    "en_ingredients": "SILODOSIN",
    "fr_ingredients": "Silodosine",
    "drug_strength": "4MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 cap bottle",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56126,
    "drug": {
      "current_status": "MARKETED",
      "id": 17484,
      "drug_code": 78527,
      "updated_date": "2025-05-15T02:32:00-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256163,
          "ingredient": {
            "id": 3424,
            "ingredient_code": 16030,
            "en_name": "NELARABINE",
            "fr_name": "Nélarabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02299925",
      "brand_name": "ATRIANCE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152299001"
    },
    "created_date": "2018-07-20T14:45:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02299925",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "L01BB07",
    "atc_description": "ANTIMETABOLITES",
    "anticipated_start_date": "2018-08-31T00:00:00-04:00",
    "estimated_end_date": "2018-09-04T00:00:00-04:00",
    "actual_end_date": "2018-08-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-08-28T17:34:29-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "ATRIANCE",
    "en_drug_common_name": "ATRIANCE INJ 5MG/ML 50ML X 6",
    "fr_drug_brand_name": "ATRIANCE",
    "fr_drug_common_name": "ATRIANCE INJ 5MG/ML 50ML X 6",
    "en_ingredients": "NELARABINE",
    "fr_ingredients": "Nélarabine",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "50ML X 6",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56141,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9182,
      "drug_code": 62045,
      "updated_date": "2025-05-15T03:57:44-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8326682,
          "ingredient": {
            "id": 2604,
            "ingredient_code": 11789,
            "en_name": "NELFINAVIR",
            "fr_name": "Nelfinavir (Mésylate de nelfinavir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02238617",
      "brand_name": "VIRACEPT -250MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134340001"
    },
    "created_date": "2018-07-20T16:27:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238617",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "J05AE04",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "actual_start_date": "2018-07-17T00:00:00-04:00",
    "actual_end_date": "2018-09-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-09-10T15:28:12-04:00",
    "status": "resolved",
    "en_comments": "Distributed by ViiV Healthcare.",
    "fr_comments": "Distribué par ViiV Heathcare.",
    "en_drug_brand_name": "VIRACEPT -250MG",
    "en_drug_common_name": "Viracept",
    "fr_drug_brand_name": "VIRACEPT -250MG",
    "fr_drug_common_name": "VIRACEPT",
    "en_ingredients": "NELFINAVIR",
    "fr_ingredients": "NELFINAVIR",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 x 300's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56184,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 5774,
      "drug_code": 3819,
      "updated_date": "2025-05-15T03:26:40-04:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8275412,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00470953",
      "brand_name": "DEXTROSE INJECTION USP",
      "brand_name_fr": "DEXTROSE INJECTABLE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "55612",
      "number_of_ais": "1",
      "ai_group_no": "0102181016"
    },
    "created_date": "2018-07-23T12:19:58-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00470953",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "B05BA03",
    "atc_description": "I.V. SOLUTIONS",
    "discontinuation_date": "2018-07-17T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-17T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-24T12:10:36-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "DEXTROSE INJECTION USP",
    "en_drug_common_name": "Dextrose 40% Injection USP",
    "fr_drug_brand_name": "ICU MEDICAL",
    "fr_drug_common_name": "40 % dextrose injectables USP",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "400MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "500ml in 1000ml",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56191,
    "drug": {
      "current_status": "MARKETED",
      "id": 7052,
      "drug_code": 47865,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8253221,
          "ingredient": {
            "id": 1652,
            "ingredient_code": 348,
            "en_name": "HEPATITIS A VACCINE, INACTIVATED",
            "fr_name": "Vaccin contre l'hépatite a, inactivé"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02229702",
      "brand_name": "VAQTA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126318003"
    },
    "created_date": "2018-07-23T13:05:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02229702",
    "company_name": "MERCK CANADA INC",
    "atc_number": "J07BC02",
    "atc_description": "VIRAL VACCINES",
    "anticipated_start_date": "2018-07-30T00:00:00-04:00",
    "estimated_end_date": "2019-12-31T00:00:00-05:00",
    "actual_start_date": "2018-07-27T00:00:00-04:00",
    "actual_end_date": "2019-10-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-10-21T15:30:38-04:00",
    "status": "resolved",
    "en_comments": "Remaining doses are reserved for the public immunization program. /Les doses restantes sont réservées au programme public de vaccination.",
    "fr_comments": "Remaining doses are reserved for the public immunization program. /Les doses restantes sont réservées au programme public de vaccination.",
    "en_drug_brand_name": "VAQTA",
    "en_drug_common_name": "hepatitis A vaccine, purified inactivated Suspension for injection",
    "fr_drug_brand_name": "VAQTA",
    "fr_drug_common_name": "vaccin purifié inactivé contre l’hépatite A Suspension Injectable",
    "en_ingredients": "HEPATITIS A VACCINE, INACTIVATED",
    "fr_ingredients": "Vaccin contre l'hépatite a, inactivé",
    "drug_strength": "50UNIT",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "50U/1ML 1DOSE VIAL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56198,
    "drug": {
      "current_status": "MARKETED",
      "id": 13766,
      "drug_code": 73640,
      "updated_date": "2025-05-15T02:31:36-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8254955,
          "ingredient": {
            "id": 76,
            "ingredient_code": 626,
            "en_name": "CHLORHEXIDINE GLUCONATE",
            "fr_name": "Gluconate de chlorhexidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8254954,
          "ingredient": {
            "id": 716,
            "ingredient_code": 8881,
            "en_name": "ISOPROPYL ALCOHOL",
            "fr_name": "Alcool isopropylique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02251477",
      "brand_name": "BAXEDIN 2% - 70%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0213979006"
    },
    "created_date": "2018-07-23T13:42:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02251477",
    "company_name": "OMEGA LABORATORIES LTD",
    "atc_number": "D08AC52",
    "atc_description": "ANTISEPTICS AND DISINFECTANTS",
    "estimated_end_date": "2018-09-15T00:00:00-04:00",
    "actual_start_date": "2018-07-18T00:00:00-04:00",
    "actual_end_date": "2018-09-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-18T14:40:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BAXEDIN 2% - 70%",
    "en_drug_common_name": "Chlorhexidine Gluconate 2% w/v with Isopropyl Alcohol 70% (tinted solution)",
    "fr_drug_brand_name": "Baxedin 2% - 70%",
    "fr_drug_common_name": "Gluconate de chlorhexidine 0,5% p/v avec 70% v/v d'alcool isopropylique (solution colorée)",
    "en_ingredients": "CHLORHEXIDINE GLUCONATE\r\nISOPROPYL ALCOHOL",
    "fr_ingredients": "Gluconate de chlorhexidine\r\nAlcool isopropylique",
    "drug_strength": "2%\r\n70%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "20 x 110mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56228,
    "drug": {
      "current_status": "MARKETED",
      "id": 5712,
      "drug_code": 37574,
      "updated_date": "2025-05-15T02:31:01-04:00",
      "company": {
        "id": 604,
        "created_date": "2017-03-09T13:22:58-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 6996,
        "mfr_code": "BEW08",
        "name": "BRACCO IMAGING CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11065 BOUL. L-H LAFONTAINE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "VILLE D'ANJOU",
        "postal_code": "H1J 2Z4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252922,
          "ingredient": {
            "id": 2048,
            "ingredient_code": 2111,
            "en_name": "SINCALIDE",
            "fr_name": "Sincalide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02228602",
      "brand_name": "KINEVAC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H5116",
      "number_of_ais": "1",
      "ai_group_no": "0113162001"
    },
    "created_date": "2018-07-23T17:52:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02228602",
    "company_name": "BRACCO IMAGING CANADA",
    "atc_number": "V04CC03",
    "atc_description": "OTHER DIAGNOSTIC AGENTS",
    "anticipated_start_date": "2018-06-25T00:00:00-04:00",
    "estimated_end_date": "2018-09-03T00:00:00-04:00",
    "actual_start_date": "2018-06-25T00:00:00-04:00",
    "actual_end_date": "2018-09-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-08-03T14:03:37-04:00",
    "status": "resolved",
    "en_comments": "Supply chain issue with 3rd party supplier to be resolved by end of august / early Septemeber",
    "en_drug_brand_name": "KINEVAC (SINCALIDE) FOR INJECTION 5MCG/VIAL",
    "en_drug_common_name": "Sincalide",
    "fr_drug_brand_name": "Kinevac",
    "fr_drug_common_name": "Kinevac Sincalide for Injection",
    "en_ingredients": "SINCALIDE",
    "fr_ingredients": "Sincalide",
    "drug_strength": "5MCG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 vials pr box",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56235,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 526,
      "drug_code": 11103,
      "updated_date": "2025-05-15T03:37:32-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8287517,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00839418",
      "brand_name": "PRINIVIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71370",
      "number_of_ais": "1",
      "ai_group_no": "0121550002"
    },
    "created_date": "2018-07-23T19:47:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00839418",
    "company_name": "MERCK CANADA INC",
    "atc_number": "C09AA03",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2018-08-10T00:00:00-04:00",
    "estimated_end_date": "2018-08-24T00:00:00-04:00",
    "actual_start_date": "2018-08-10T00:00:00-04:00",
    "actual_end_date": "2018-08-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-08-21T15:46:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PRINIVIL",
    "en_drug_common_name": "lisinopril tablets",
    "fr_drug_brand_name": "PRINIVIL",
    "fr_drug_common_name": "comprimés de lisinopril",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28TAB",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56238,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9818,
      "drug_code": 63892,
      "updated_date": "2025-05-15T03:59:38-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8329433,
          "ingredient": {
            "id": 2702,
            "ingredient_code": 11891,
            "en_name": "EPTIFIBATIDE",
            "fr_name": "Eptifibatide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02240351",
      "brand_name": "INTEGRILIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137621001"
    },
    "created_date": "2018-07-23T19:57:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240351",
    "company_name": "MERCK CANADA INC",
    "atc_number": "B01AC16",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2018-07-30T00:00:00-04:00",
    "estimated_end_date": "2018-08-24T00:00:00-04:00",
    "actual_start_date": "2018-07-27T00:00:00-04:00",
    "actual_end_date": "2018-08-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-08-17T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Limited quantity available",
    "fr_comments": "Quantité limitée disponible",
    "en_drug_brand_name": "INTEGRILIN",
    "en_drug_common_name": "Eptifibatide Injection",
    "fr_drug_brand_name": "INTEGRILIN",
    "fr_drug_common_name": "eptifibatide injectable",
    "en_ingredients": "EPTIFIBATIDE",
    "fr_ingredients": "Eptifibatide",
    "drug_strength": "0.75MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "100ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56257,
    "drug": {
      "current_status": "MARKETED",
      "id": 22706,
      "drug_code": 85244,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258184,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02367602",
      "brand_name": "PRAMIPEXOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169001"
    },
    "created_date": "2018-07-24T11:50:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02367602",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N04BC05",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2018-08-13T00:00:00-04:00",
    "estimated_end_date": "2019-03-26T00:00:00-04:00",
    "actual_start_date": "2018-08-07T00:00:00-04:00",
    "actual_end_date": "2019-03-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-03-27T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Business decision made to discontinue product. See Discontinuation Report # 79465",
    "fr_comments": "Décision commerciale. Rapport de cessation #79465",
    "en_drug_brand_name": "PRAMIPEXOLE",
    "en_drug_common_name": "PRAMIPEXOLE TAB",
    "fr_drug_brand_name": "PRAMIPEXOLE",
    "fr_drug_common_name": "PRAMIPEXOLE COMPRIME",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56260,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 5386,
      "drug_code": 3537,
      "updated_date": "2025-05-15T03:26:26-04:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8275051,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.3",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8275050,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.298",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8275049,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.3",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00472077",
      "brand_name": "POTASSIUM CHLORIDE 40 MEQ IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE",
      "brand_name_fr": "CHLORURE DE POTASSIUM 40 MEQ DANS DU DEXTROSE À 3,3% ET DU CHLORURE DE SODIUM À 0,3%",
      "descriptor": "SINGLE USE",
      "pediatric_flag": false,
      "accession_number": "54639",
      "number_of_ais": "3",
      "ai_group_no": "0300097028"
    },
    "created_date": "2018-07-24T12:08:11-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00472077",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "B05BB02",
    "atc_description": "I.V. SOLUTIONS",
    "discontinuation_date": "2018-07-18T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-18T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-24T12:12:52-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "POTASSIUM CHLORIDE 40 MEQ IN 3.3% DEXTROSE WITH 0.3% SODIUM CHLORIDE",
    "en_drug_common_name": "40 (mEq) mmol/L Potassium Chloride in 3.3% Dextrose and 0.3% Sodium Chloride Injection USP",
    "fr_drug_brand_name": "Chlorure de potassium dans 3,3 % Dextrose et chlorure de sodium à 0,3 % injectables USP",
    "fr_drug_common_name": "Chlorure de potassium dans 3,3 % Dextrose et chlorure de sodium à 0,3 % injectables USP",
    "en_ingredients": "DEXTROSE\r\nPOTASSIUM CHLORIDE\r\nSODIUM CHLORIDE",
    "fr_ingredients": "Dextrose\r\nChlorure de potassium\r\nChlorure de sodium",
    "drug_strength": "33.3MG\r\n2.98MG\r\n3.00MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1000ML",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56322,
    "drug": {
      "current_status": "DORMANT",
      "id": 31474,
      "drug_code": 93800,
      "updated_date": "2025-05-15T06:55:56-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369362,
          "ingredient": {
            "id": 2956,
            "ingredient_code": 12253,
            "en_name": "FONDAPARINUX SODIUM",
            "fr_name": "Fondaparinux sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.4",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02451700",
      "brand_name": "ARIXTRA",
      "brand_name_fr": "ARIXTRA",
      "descriptor": "0.4ML SINGLE USE PRE-FILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0146781002"
    },
    "created_date": "2018-07-24T19:57:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02451700",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "B01AX05",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "actual_start_date": "2014-01-01T00:00:00-05:00",
    "actual_end_date": "2014-01-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-04-29T15:11:33-04:00",
    "status": "resolved",
    "en_comments": "n/a",
    "fr_comments": "n/a",
    "en_drug_brand_name": "ARIXTRA",
    "en_drug_common_name": "Arixtra 0.4 mL single use pre-filled syringe",
    "fr_drug_brand_name": "Arixtra",
    "fr_drug_common_name": "Arixtra 0.4ML Seringue pré-remplie à usage unique",
    "en_ingredients": "FONDAPARINUX SODIUM",
    "fr_ingredients": "Fondaparinux sodique",
    "drug_strength": "12.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56325,
    "drug": {
      "current_status": "DORMANT",
      "id": 31476,
      "drug_code": 93801,
      "updated_date": "2025-05-15T06:55:56-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369363,
          "ingredient": {
            "id": 2956,
            "ingredient_code": 12253,
            "en_name": "FONDAPARINUX SODIUM",
            "fr_name": "Fondaparinux sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.8",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02451719",
      "brand_name": "ARIXTRA",
      "brand_name_fr": "ARIXTRA",
      "descriptor": "0.8ML SINGLE USE PRE-FILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0146781002"
    },
    "created_date": "2018-07-24T19:59:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02451719",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "B01AX05",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "actual_start_date": "2014-01-01T00:00:00-05:00",
    "actual_end_date": "2014-01-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-04-29T15:10:12-04:00",
    "status": "resolved",
    "en_comments": "n/a",
    "fr_comments": "n/a",
    "en_drug_brand_name": "ARIXTRA",
    "en_drug_common_name": "Arixtra 0.8 mL single use pre-filled syringe",
    "fr_drug_brand_name": "Arixtra",
    "fr_drug_common_name": "Arixtra 0.8ML Seringue pré-remplie à usage unique",
    "en_ingredients": "FONDAPARINUX SODIUM",
    "fr_ingredients": "Fondaparinux sodique",
    "drug_strength": "12.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56328,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 5552,
      "drug_code": 36949,
      "updated_date": "2025-05-15T03:47:42-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8309397,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02213230",
      "brand_name": "ELTROXIN",
      "brand_name_fr": "ELTROXIN",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H4375",
      "number_of_ais": "1",
      "ai_group_no": "0107794002"
    },
    "created_date": "2018-07-24T20:00:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02213230",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "H03AA01",
    "atc_description": "THYROID PREPARATIONS",
    "actual_start_date": "2010-01-01T00:00:00-05:00",
    "actual_end_date": "2018-07-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-07-28T15:16:32-04:00",
    "status": "resolved",
    "en_comments": "DISCONTINUED",
    "fr_comments": "DISCONTINUED",
    "en_drug_brand_name": "ELTROXIN",
    "en_drug_common_name": "Eltroxin 300 mcg",
    "fr_drug_brand_name": "Eltroxin",
    "fr_drug_common_name": "Eltroxin 300 mcg",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "300MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 tablets",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56331,
    "drug": {
      "current_status": "DORMANT",
      "id": 31382,
      "drug_code": 93677,
      "updated_date": "2025-05-15T06:55:56-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369353,
          "ingredient": {
            "id": 2536,
            "ingredient_code": 11714,
            "en_name": "NADROPARIN CALCIUM",
            "fr_name": "Nadroparine calcique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9500",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02450615",
      "brand_name": "FRAXIPARINE",
      "brand_name_fr": "",
      "descriptor": "0.2 ML (1900 IU) PREFILLED SYRINGE - YELLOW",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131662001"
    },
    "created_date": "2018-07-24T20:02:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02450615",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "B01AB06",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "actual_start_date": "2014-01-01T00:00:00-05:00",
    "actual_end_date": "2014-01-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-04-29T15:08:53-04:00",
    "status": "resolved",
    "en_comments": "n/a",
    "en_drug_brand_name": "FRAXIPARINE",
    "en_drug_common_name": "Fraxiparine 0.2 mL (1900 IU) pre-filled syringes",
    "fr_drug_brand_name": "Fraxiparine",
    "fr_drug_common_name": "Fraxiparine 0.2 mL (1900 IU) syringes pré-remplies",
    "en_ingredients": "NADROPARIN CALCIUM",
    "fr_ingredients": "Nadroparine calcique",
    "drug_strength": "9500UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56336,
    "drug": {
      "current_status": "MARKETED",
      "id": 26714,
      "drug_code": 89000,
      "updated_date": "2025-05-15T02:33:55-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8259634,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02405180",
      "brand_name": "AURO-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415005"
    },
    "created_date": "2018-07-24T21:08:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02405180",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C10AA01",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2018-07-27T00:00:00-04:00",
    "actual_start_date": "2018-07-25T00:00:00-04:00",
    "actual_end_date": "2018-07-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-08-01T16:19:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-SIMVASTATIN",
    "en_drug_common_name": "SIMVASTATIN",
    "fr_drug_brand_name": "AURO-SIMVASTATIN",
    "fr_drug_common_name": "simvastatine",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 & 100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56339,
    "drug": {
      "current_status": "MARKETED",
      "id": 28442,
      "drug_code": 90564,
      "updated_date": "2025-05-15T02:34:15-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8260312,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8260311,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "32",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02421054",
      "brand_name": "AURO-CANDESARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0244181003"
    },
    "created_date": "2018-07-24T21:13:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02421054",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C09DA06",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "actual_start_date": "2018-07-25T00:00:00-04:00",
    "actual_end_date": "2018-08-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-08-30T15:06:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-CANDESARTAN HCT",
    "en_drug_common_name": "hydrochlorothiazide; candesartan cilexetil",
    "fr_drug_brand_name": "AURO-CANDESARTAN HCT",
    "fr_drug_common_name": "Hydrochlorothiazide Candésartan cilexétil",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nCANDESARTAN CILEXETIL",
    "fr_ingredients": "Hydrochlorothiazide\r\nCandésartan cilexétil",
    "drug_strength": "25MG\r\n32MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56343,
    "drug": {
      "current_status": "MARKETED",
      "id": 31232,
      "drug_code": 93444,
      "updated_date": "2025-05-15T02:35:09-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8261578,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02448726",
      "brand_name": "AURO-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783003"
    },
    "created_date": "2018-07-24T21:16:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02448726",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2022-01-30T00:00:00-05:00",
    "actual_start_date": "2018-07-25T00:00:00-04:00",
    "actual_end_date": "2022-01-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-01T21:13:59-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "AURO-OLANZAPINE ODT",
    "fr_drug_common_name": "Olanzapine",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3X10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56346,
    "drug": {
      "current_status": "MARKETED",
      "id": 31234,
      "drug_code": 93445,
      "updated_date": "2025-05-15T02:35:09-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8261579,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02448734",
      "brand_name": "AURO-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783002"
    },
    "created_date": "2018-07-24T21:20:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02448734",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2022-02-10T00:00:00-05:00",
    "actual_start_date": "2018-07-25T00:00:00-04:00",
    "actual_end_date": "2022-01-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-09T20:47:25-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "AURO-OLANZAPINE ODT",
    "fr_drug_common_name": "Olanzapine",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3X10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56349,
    "drug": {
      "current_status": "MARKETED",
      "id": 31236,
      "drug_code": 93446,
      "updated_date": "2025-05-15T02:35:09-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8261580,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02448742",
      "brand_name": "AURO-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783005"
    },
    "created_date": "2018-07-24T21:21:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02448742",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2022-02-10T00:00:00-05:00",
    "actual_start_date": "2018-07-25T00:00:00-04:00",
    "actual_end_date": "2022-01-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-09T20:47:58-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "AURO-OLANZAPINE ODT",
    "fr_drug_common_name": "Olanzapine",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3X10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56352,
    "drug": {
      "current_status": "MARKETED",
      "id": 31238,
      "drug_code": 93447,
      "updated_date": "2025-05-15T02:35:09-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8261581,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02448750",
      "brand_name": "AURO-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783006"
    },
    "created_date": "2018-07-24T21:22:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02448750",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2022-02-10T00:00:00-05:00",
    "actual_start_date": "2018-07-25T00:00:00-04:00",
    "actual_end_date": "2022-01-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-09T20:48:21-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "AURO-OLANZAPINE ODT",
    "fr_drug_common_name": "Olanzapine",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3X10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56355,
    "drug": {
      "current_status": "MARKETED",
      "id": 56300,
      "drug_code": 93538,
      "updated_date": "2025-05-15T02:35:10-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8261629,
          "ingredient": {
            "id": 3408,
            "ingredient_code": 11753,
            "en_name": "ZIPRASIDONE",
            "fr_name": "Ziprasidone (Chlorhydrate de ziprasidone monohydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02449552",
      "brand_name": "AURO-ZIPRASIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152272002"
    },
    "created_date": "2018-07-24T21:24:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02449552",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N05AE04",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2018-07-25T00:00:00-04:00",
    "actual_end_date": "2018-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-10-03T16:33:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-ZIPRASIDONE",
    "en_drug_common_name": "Ziprasidone Hydrochloride Monohydrate",
    "fr_drug_brand_name": "AURO-ZIPRASIDONE",
    "fr_drug_common_name": "monohydrate de chlorhydrate de ziprasidone",
    "en_ingredients": "ZIPRASIDONE",
    "fr_ingredients": "ZIprasidone",
    "drug_strength": "40MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60 & 100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56358,
    "drug": {
      "current_status": "MARKETED",
      "id": 29788,
      "drug_code": 91826,
      "updated_date": "2025-05-15T02:34:35-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8260799,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02433877",
      "brand_name": "AURO-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121002"
    },
    "created_date": "2018-07-24T21:27:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02433877",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N03AX16",
    "atc_description": "ANTIEPILEPTICS",
    "actual_start_date": "2018-07-25T00:00:00-04:00",
    "actual_end_date": "2018-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-08-01T18:09:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-PREGABALIN",
    "en_drug_common_name": "Pregabalin",
    "fr_drug_brand_name": "AURO-PREGABALIN",
    "fr_drug_common_name": "Prégabaline",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56361,
    "drug": {
      "current_status": "MARKETED",
      "id": 28710,
      "drug_code": 90835,
      "updated_date": "2025-05-15T02:34:17-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8260415,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8260414,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02423642",
      "brand_name": "AURO-LOSARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168001"
    },
    "created_date": "2018-07-24T21:30:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423642",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C09DA01",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2018-08-07T00:00:00-04:00",
    "actual_start_date": "2018-07-25T00:00:00-04:00",
    "actual_end_date": "2018-08-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-08-08T20:59:55-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-LOSARTAN HCT",
    "en_drug_common_name": "Hydrochlorothiazide; Losartan Potassium",
    "fr_drug_brand_name": "AURO-LOSARTAN HCT",
    "fr_drug_common_name": "hydrochlorothiazide; losartan potassique",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "12.5MG\r\n50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 & 100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56364,
    "drug": {
      "current_status": "MARKETED",
      "id": 28714,
      "drug_code": 90837,
      "updated_date": "2025-05-15T02:34:17-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8260419,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8260418,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02423669",
      "brand_name": "AURO-LOSARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168002"
    },
    "created_date": "2018-07-24T21:32:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423669",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C09DA01",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2018-08-08T00:00:00-04:00",
    "actual_start_date": "2018-07-25T00:00:00-04:00",
    "actual_end_date": "2018-08-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-08-08T21:00:26-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-LOSARTAN HCT",
    "en_drug_common_name": "Hydrochlorothiazide; Losartan Potassium",
    "fr_drug_brand_name": "AURO-LOSARTAN HCT",
    "fr_drug_common_name": "hydrochlorothiazide; losartan potassique",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "25MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 & 100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56369,
    "drug": {
      "current_status": "MARKETED",
      "id": 27666,
      "drug_code": 89890,
      "updated_date": "2025-05-15T02:34:04-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8260014,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "320",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02414244",
      "brand_name": "AURO-VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885004"
    },
    "created_date": "2018-07-24T21:35:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02414244",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2018-07-25T00:00:00-04:00",
    "actual_end_date": "2018-12-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-12-19T16:06:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-VALSARTAN",
    "en_drug_common_name": "Valsartan",
    "fr_drug_brand_name": "AURO-VALSARTAN",
    "fr_drug_common_name": "Valsartan",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "320MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 & 100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56413,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7188,
      "drug_code": 48885,
      "updated_date": "2025-05-15T03:50:41-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8314742,
          "ingredient": {
            "id": 1596,
            "ingredient_code": 8541,
            "en_name": "VANCOMYCIN",
            "fr_name": "Vancomycine (Chlorhydrate de vancomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02230192",
      "brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
      "brand_name_fr": "CHLORHYDRATE DE VANCOMYCINE POUR INJECTION, USP",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131315009"
    },
    "created_date": "2018-07-25T14:10:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230192",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "J01XA01",
    "atc_description": "OTHER ANTIBACTERIALS",
    "actual_start_date": "2018-10-12T00:00:00-04:00",
    "actual_end_date": "2019-06-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-06-27T13:37:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "en_drug_common_name": "VANCOMYCIN",
    "fr_drug_brand_name": "VANCOMYCIN HYDROCHLORIDE POUR INJECTION, USP",
    "fr_drug_common_name": "VANCOMYCIN",
    "en_ingredients": "VANCOMYCIN",
    "fr_ingredients": "VANCOMYCIN",
    "drug_strength": "1000MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 x 20mL PVL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56416,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21210,
      "drug_code": 83599,
      "updated_date": "2025-05-15T04:16:59-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348852,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02350785",
      "brand_name": "NAPROXEN EC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109634001"
    },
    "created_date": "2018-07-25T14:16:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02350785",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "M01AE02",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "anticipated_start_date": "2018-07-26T00:00:00-04:00",
    "estimated_end_date": "2018-11-30T00:00:00-05:00",
    "actual_start_date": "2018-07-26T00:00:00-04:00",
    "actual_end_date": "2018-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-12-11T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "NAPROXEN EC",
    "en_drug_common_name": "NAPROXEN EC TAB",
    "fr_drug_brand_name": "NAPROXEN EC",
    "fr_drug_common_name": "NAPROXEN EC COMPRIME",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56467,
    "drug": {
      "current_status": "MARKETED",
      "id": 31534,
      "drug_code": 93854,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261785,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452111",
      "brand_name": "TARO-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485002"
    },
    "created_date": "2018-07-25T16:51:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452111",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "G04BE08",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2018-06-30T00:00:00-04:00",
    "estimated_end_date": "2018-08-06T00:00:00-04:00",
    "actual_start_date": "2018-06-30T00:00:00-04:00",
    "actual_end_date": "2018-08-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-01T21:51:20-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-TADALAFIL",
    "en_drug_common_name": "RAN-TADALAFIL",
    "fr_drug_brand_name": "RAN-TADALAFIL",
    "fr_drug_common_name": "RAN-TADALAFIL",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56507,
    "drug": {
      "current_status": "MARKETED",
      "id": 25960,
      "drug_code": 88339,
      "updated_date": "2025-05-15T02:33:44-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8259362,
          "ingredient": {
            "id": 3074,
            "ingredient_code": 13247,
            "en_name": "ALMOTRIPTAN",
            "fr_name": "Almotriptan (Malate d'almotriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02398435",
      "brand_name": "MYLAN-ALMOTRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149521001"
    },
    "created_date": "2018-07-25T17:35:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02398435",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N02CC05",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "anticipated_start_date": "2018-10-03T00:00:00-04:00",
    "estimated_end_date": "2019-02-15T00:00:00-05:00",
    "actual_start_date": "2018-10-03T00:00:00-04:00",
    "actual_end_date": "2019-02-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-02-16T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-ALMOTRIPTAN",
    "en_drug_common_name": "ALMOTRIPTAN",
    "fr_drug_brand_name": "MYLAN-ALMOTRIPTAN",
    "fr_drug_common_name": "ALMOTRIPTAN",
    "en_ingredients": "ALMOTRIPTAN",
    "fr_ingredients": "ALMOTRIPTAN",
    "drug_strength": "6.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6BL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56518,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10390,
      "drug_code": 65589,
      "updated_date": "2025-12-03T01:19:14-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8332003,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02241919",
      "brand_name": "MARCAINE",
      "brand_name_fr": "",
      "descriptor": "PRESERVATIVE-FREE, SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108896004"
    },
    "created_date": "2018-07-25T17:51:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241919",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "N01BB01",
    "atc_description": "ANESTHETICS, LOCAL",
    "actual_start_date": "2019-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-01-10T14:11:23-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MARCAINE",
    "en_drug_common_name": "MARCAINE",
    "fr_drug_brand_name": "MARCAINE",
    "fr_drug_common_name": "MARCAINE",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne",
    "drug_strength": "5.0MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nEPIDURAL",
    "drug_route_fr": "Bloc/Infiltration\r\nÉpidurale",
    "drug_package_quantity": "10 x 20mL GVL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56521,
    "drug": {
      "current_status": "MARKETED",
      "id": 30752,
      "drug_code": 92801,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 16877,
        "created_date": "2020-06-16T21:30:06-04:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 17770,
        "mfr_code": "",
        "name": "JUNO PHARMACEUTICALS CORP.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "402",
        "street_name": "2233 ARGENTIA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 2X7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261320,
          "ingredient": {
            "id": 814,
            "ingredient_code": 1241,
            "en_name": "KETOROLAC TROMETHAMINE",
            "fr_name": "Kétorolac trométhamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02443376",
      "brand_name": "KETOROLAC TROMETHAMINE INJECTION, USP",
      "brand_name_fr": "KÉTOROLAC TROMÉTHAMINE INJECTABLE, USP",
      "descriptor": "1ML SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121995002"
    },
    "created_date": "2018-07-25T18:29:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443376",
    "company_name": "MDA INC.",
    "atc_number": "M01AB15",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "anticipated_start_date": "2018-07-20T00:00:00-04:00",
    "estimated_end_date": "2018-10-29T00:00:00-04:00",
    "actual_start_date": "2018-07-25T00:00:00-04:00",
    "actual_end_date": "2018-10-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-11-05T14:21:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "KETOROLAC TROMETHAMINE INJECTION, USP",
    "en_drug_common_name": "Ketorolac",
    "fr_drug_brand_name": "Ketorolac",
    "fr_drug_common_name": "Ketorolac",
    "en_ingredients": "KETOROLAC TROMETHAMINE",
    "fr_ingredients": "Kétorolac trométhamine",
    "drug_strength": "30MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "1 ml Vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56538,
    "drug": {
      "current_status": "MARKETED",
      "id": 51711,
      "drug_code": 93838,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261771,
          "ingredient": {
            "id": 3020,
            "ingredient_code": 12251,
            "en_name": "TENOFOVIR DISOPROXIL FUMARATE",
            "fr_name": "Fumarate de ténofovir disoproxil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02451980",
      "brand_name": "APO-TENOFOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152569001"
    },
    "created_date": "2018-07-26T02:14:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02451980",
    "company_name": "APOTEX INC",
    "atc_number": "J05AF07",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2018-10-15T00:00:00-04:00",
    "actual_start_date": "2018-07-23T00:00:00-04:00",
    "actual_end_date": "2018-08-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-04T14:16:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TENOFOVIR",
    "en_drug_common_name": "TENOFOVIR",
    "fr_drug_brand_name": "APO-TENOFOVIR",
    "fr_drug_common_name": "TENOFOVIR",
    "en_ingredients": "TENOFOVIR DISOPROXIL FUMARATE",
    "fr_ingredients": "Fumarate de ténofovir disoproxil",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56541,
    "drug": {
      "current_status": "MARKETED",
      "id": 20168,
      "drug_code": 81611,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257152,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "54",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02330377",
      "brand_name": "APO-METHYLPHENIDATE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548006"
    },
    "created_date": "2018-07-26T02:16:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330377",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA04",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2018-10-25T00:00:00-04:00",
    "actual_start_date": "2018-07-23T00:00:00-04:00",
    "actual_end_date": "2018-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-25T19:33:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "en_drug_common_name": "METHYLPHENIDATE",
    "fr_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "fr_drug_common_name": "METHYLPHENIDATE",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "54MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56578,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22478,
      "drug_code": 84910,
      "updated_date": "2025-05-15T04:18:12-04:00",
      "company": {
        "id": 58,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 8481,
        "mfr_code": "PIA08",
        "name": "PALADIN PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 BLVD ALEXIS-NIHON, SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": "",
        "contact_information": "1-866-340-1112\r\npaladincs@endo.com"
      },
      "drug_ingredients": [
        {
          "id": 8349945,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02364174",
      "brand_name": "ABSTRAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302012"
    },
    "created_date": "2018-07-26T13:54:47-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02364174",
    "company_name": "PALADIN LABS INC",
    "atc_number": "N02AB03",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2018-07-24T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-24T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-26T18:38:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ABSTRAL",
    "en_drug_common_name": "FENTANYL",
    "fr_drug_brand_name": "ABSTRAL",
    "fr_drug_common_name": "FENTANYL",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "100MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "SUBLINGUAL",
    "drug_route_fr": "Sublinguale",
    "drug_package_quantity": "10 Tabs",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56588,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17660,
      "drug_code": 78724,
      "updated_date": "2025-05-15T04:13:11-04:00",
      "company": {
        "id": 58,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 8481,
        "mfr_code": "PIA08",
        "name": "PALADIN PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 BLVD ALEXIS-NIHON, SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": "",
        "contact_information": "1-866-340-1112\r\npaladincs@endo.com"
      },
      "drug_ingredients": [
        {
          "id": 8344736,
          "ingredient": {
            "id": 1742,
            "ingredient_code": 4924,
            "en_name": "VITAMIN D2",
            "fr_name": "Vitamine D2"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02301911",
      "brand_name": "OSTO-D2",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108517001"
    },
    "created_date": "2018-07-26T14:29:32-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02301911",
    "company_name": "PALADIN LABS INC",
    "atc_number": "A11CC01",
    "atc_description": "VIT A AND D, INCL COMBINATIONS OF THE TWO",
    "discontinuation_date": "2018-07-23T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-26T15:20:21-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "OSTO-D2",
    "en_drug_common_name": "OSTO-D2",
    "fr_drug_brand_name": "Osto D-2",
    "fr_drug_common_name": "Osto D-2",
    "en_ingredients": "VITAMIN D2",
    "fr_ingredients": "Vitamine D2",
    "drug_strength": "50000UNIT",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56591,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23268,
      "drug_code": 85846,
      "updated_date": "2025-05-15T04:19:25-04:00",
      "company": {
        "id": 58,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 8481,
        "mfr_code": "PIA08",
        "name": "PALADIN PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 BLVD ALEXIS-NIHON, SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": "",
        "contact_information": "1-866-340-1112\r\npaladincs@endo.com"
      },
      "drug_ingredients": [
        {
          "id": 8350715,
          "ingredient": {
            "id": 144,
            "ingredient_code": 182,
            "en_name": "DIPHENHYDRAMINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diphénhydramine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02373300",
      "brand_name": "UNISOM SLEEP GELS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102639002"
    },
    "created_date": "2018-07-26T14:31:35-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02373300",
    "company_name": "PALADIN LABS INC",
    "atc_number": "R06AA02",
    "atc_description": "ANTIHISTAMINES FOR SYSTEMIC USE",
    "discontinuation_date": "2018-07-23T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-26T14:32:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "UNISOM SLEEP GELS",
    "en_drug_common_name": "UNISOM",
    "fr_drug_brand_name": "UNISOM 25MG",
    "fr_drug_common_name": "UNISOM 25MG",
    "en_ingredients": "DIPHENHYDRAMINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diphénhydramine",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "20",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56596,
    "drug": {
      "current_status": "MARKETED",
      "id": 24194,
      "drug_code": 86821,
      "updated_date": "2025-05-15T02:33:19-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8258707,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02382350",
      "brand_name": "MIDAZOLAM INJECTION USP",
      "brand_name_fr": "MIDOZOLAM INJECTABLE US",
      "descriptor": "PRESERVATIVE-FREE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935001"
    },
    "created_date": "2018-07-26T15:19:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382350",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "N05CD08",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "actual_start_date": "2018-10-15T00:00:00-04:00",
    "actual_end_date": "2018-11-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-11-03T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MIDAZOLAM INJECTION USP",
    "en_drug_common_name": "MIDAZOLAM",
    "fr_drug_brand_name": "MIDAZOLAM INJECTION USP",
    "fr_drug_common_name": "MIDAZOLAM",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "10 x 1mL PVL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56601,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 942,
      "drug_code": 12220,
      "updated_date": "2025-05-15T03:38:40-04:00",
      "company": {
        "id": 58,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 8481,
        "mfr_code": "PIA08",
        "name": "PALADIN PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 BLVD ALEXIS-NIHON, SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": "",
        "contact_information": "1-866-340-1112\r\npaladincs@endo.com"
      },
      "drug_ingredients": [
        {
          "id": 8289479,
          "ingredient": {
            "id": 62,
            "ingredient_code": 9412,
            "en_name": "NITROGLYCERIN",
            "fr_name": "Nitroglycérine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01926454",
      "brand_name": "NITROL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73269",
      "number_of_ais": "1",
      "ai_group_no": "0103615018"
    },
    "created_date": "2018-07-26T15:21:50-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "01926454",
    "company_name": "PALADIN LABS INC",
    "atc_number": "C01DA02",
    "atc_description": "VASODILATORS USED IN CARDIAC DISEASES",
    "discontinuation_date": "2018-07-23T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-26T15:22:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "NITROL",
    "en_drug_common_name": "NITROL",
    "fr_drug_brand_name": "NITROL",
    "fr_drug_common_name": "NITROL",
    "en_ingredients": "NITROGLYCERIN",
    "fr_ingredients": "Nitroglycérine",
    "drug_strength": "2%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "60GR",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56615,
    "drug": {
      "current_status": "MARKETED",
      "id": 694,
      "drug_code": 115,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250114,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037818",
      "brand_name": "BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP",
      "brand_name_fr": "CHLORURE DE SODIUM AVEC BACTÉRIOSTATIQUE INJECTABLE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "03696",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2018-07-26T15:51:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00037818",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "B05CB01",
    "atc_description": "IRRIGATING SOLUTIONS",
    "actual_start_date": "2018-08-27T00:00:00-04:00",
    "actual_end_date": "2018-10-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-29T14:47:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP",
    "en_drug_common_name": "BACTERIOSTATIC SODIUM CHLORIDE",
    "fr_drug_brand_name": "Chlorure de sodium bactériostatique injectable USP",
    "fr_drug_common_name": "Chlorure de sodium bactériostatique",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "9MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "25 X 20mL PVL MD",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56618,
    "drug": {
      "current_status": "MARKETED",
      "id": 11186,
      "drug_code": 67514,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8254203,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02243596",
      "brand_name": "ASMANEX TWISTHALER",
      "brand_name_fr": "",
      "descriptor": "FOR ORAL INHALATION ONLY",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121732004"
    },
    "created_date": "2018-07-26T16:11:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243596",
    "company_name": "MERCK CANADA INC",
    "atc_number": "R03BA07",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "anticipated_start_date": "2018-08-24T00:00:00-04:00",
    "estimated_end_date": "2018-09-10T00:00:00-04:00",
    "actual_start_date": "2018-08-24T00:00:00-04:00",
    "actual_end_date": "2018-08-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-08-31T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Available in 30 dose format / Disponible en format de 30 doses",
    "fr_comments": "Available in 30dose format / Disponible en format de 30 dose",
    "en_drug_brand_name": "ASMANEX TWISTHALER",
    "en_drug_common_name": "mometasone furoate dry powder inhaler",
    "fr_drug_brand_name": "ASMANEX TWISTHALER",
    "fr_drug_common_name": "furoate de mométasone inhalateur de poudre sèche",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "400MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "60DOSE",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56623,
    "drug": {
      "current_status": "MARKETED",
      "id": 25342,
      "drug_code": 87817,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259186,
          "ingredient": {
            "id": 934,
            "ingredient_code": 11130,
            "en_name": "FLUOXETINE",
            "fr_name": "Fluoxétine (Chlorhydrate de fluoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392909",
      "brand_name": "MAR-FLUOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116847003"
    },
    "created_date": "2018-07-26T17:56:48-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02392909",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "discontinuation_date": "2018-07-26T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-26T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-27T05:00:08-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-FLUOXETINE",
    "en_drug_common_name": "MAR-Fluoxetine",
    "fr_drug_brand_name": "MAR-Fluoxetine",
    "fr_drug_common_name": "MAR-Fluoxetine",
    "en_ingredients": "FLUOXETINE",
    "fr_ingredients": "Fluoxetine",
    "drug_strength": "10MG",
    "drug_dosage_form_fr": "Tablets",
    "drug_route_fr": "Oral",
    "drug_package_quantity": "100 Tabs",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56626,
    "drug": {
      "current_status": "MARKETED",
      "id": 25344,
      "drug_code": 87818,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259187,
          "ingredient": {
            "id": 934,
            "ingredient_code": 11130,
            "en_name": "FLUOXETINE",
            "fr_name": "Fluoxétine (Chlorhydrate de fluoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392917",
      "brand_name": "MAR-FLUOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116847001"
    },
    "created_date": "2018-07-26T17:58:00-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02392917",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "discontinuation_date": "2018-07-26T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-26T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-27T05:00:08-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-FLUOXETINE",
    "en_drug_common_name": "MAR-Fluoxetine",
    "fr_drug_brand_name": "MAR-Fluoxetine",
    "fr_drug_common_name": "MAR-Fluoxetine",
    "en_ingredients": "FLUOXETINE",
    "fr_ingredients": "Fluoxetine",
    "drug_strength": "20MG",
    "drug_dosage_form_fr": "Tablets",
    "drug_route_fr": "Oral",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56629,
    "drug": {
      "current_status": "MARKETED",
      "id": 25344,
      "drug_code": 87818,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259187,
          "ingredient": {
            "id": 934,
            "ingredient_code": 11130,
            "en_name": "FLUOXETINE",
            "fr_name": "Fluoxétine (Chlorhydrate de fluoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392917",
      "brand_name": "MAR-FLUOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116847001"
    },
    "created_date": "2018-07-26T17:58:53-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02392917",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "discontinuation_date": "2018-07-26T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-26T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-27T05:00:08-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-FLUOXETINE",
    "en_drug_common_name": "MAR-Fluoxetine",
    "fr_drug_brand_name": "MAR-Fluoxetine",
    "fr_drug_common_name": "MAR-Fluoxetine",
    "en_ingredients": "FLUOXETINE",
    "fr_ingredients": "Fluoxetine",
    "drug_strength": "20MG",
    "drug_dosage_form_fr": "Tablet",
    "drug_route_fr": "Oral",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56632,
    "drug": {
      "current_status": "MARKETED",
      "id": 31652,
      "drug_code": 940,
      "updated_date": "2025-12-03T00:30:19-05:00",
      "company": {
        "id": 510,
        "created_date": "2017-03-09T13:22:50-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16647,
        "mfr_code": "",
        "name": "SEARCHLIGHT PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1600 RUE NOTRE DAME OUEST, SUITE 312",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3J 1M1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250219,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "00155357",
      "brand_name": "ADRENALIN",
      "brand_name_fr": "",
      "descriptor": "PRESERVATIVE-FREE (AMPOULES)",
      "pediatric_flag": false,
      "accession_number": "32787",
      "number_of_ais": "1",
      "ai_group_no": "0104871002"
    },
    "created_date": "2018-07-26T18:22:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00155357",
    "company_name": "ERFA CANADA 2012 INC",
    "atc_number": "C01CA24",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "anticipated_start_date": "2018-07-20T00:00:00-04:00",
    "actual_start_date": "2018-07-23T00:00:00-04:00",
    "actual_end_date": "2018-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2018-12-11T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ADRENALIN CHLORIDE SOL 1:1000 AMP",
    "en_drug_common_name": "ADRENALIN",
    "fr_drug_brand_name": "ADRENALIN CHLORIDE SOL 1:1000 AMP",
    "fr_drug_common_name": "ADRENALIN",
    "en_ingredients": "EPINEPHRINE",
    "fr_ingredients": "Épinéphrine",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "10 X 1ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56638,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22480,
      "drug_code": 84911,
      "updated_date": "2025-05-15T04:18:12-04:00",
      "company": {
        "id": 58,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 8481,
        "mfr_code": "PIA08",
        "name": "PALADIN PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 BLVD ALEXIS-NIHON, SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": "",
        "contact_information": "1-866-340-1112\r\npaladincs@endo.com"
      },
      "drug_ingredients": [
        {
          "id": 8349946,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02364182",
      "brand_name": "ABSTRAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302017"
    },
    "created_date": "2018-07-26T18:34:18-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02364182",
    "company_name": "PALADIN LABS INC",
    "atc_number": "N02AB03",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2018-07-24T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-24T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-26T18:37:23-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ABSTRAL",
    "en_drug_common_name": "FENTANYL",
    "fr_drug_brand_name": "ABSTRAL",
    "fr_drug_common_name": "FENTANYL",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "200MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "SUBLINGUAL",
    "drug_route_fr": "Sublinguale",
    "drug_package_quantity": "10 Tabs",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56643,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22482,
      "drug_code": 84912,
      "updated_date": "2025-05-15T04:18:12-04:00",
      "company": {
        "id": 58,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 8481,
        "mfr_code": "PIA08",
        "name": "PALADIN PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 BLVD ALEXIS-NIHON, SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": "",
        "contact_information": "1-866-340-1112\r\npaladincs@endo.com"
      },
      "drug_ingredients": [
        {
          "id": 8349947,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02364190",
      "brand_name": "ABSTRAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302022"
    },
    "created_date": "2018-07-26T19:01:08-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02364190",
    "company_name": "PALADIN LABS INC",
    "atc_number": "N02AB03",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2018-07-24T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-24T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-26T19:01:32-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ABSTRAL",
    "en_drug_common_name": "FENTANYL",
    "fr_drug_brand_name": "ABSTRAL",
    "fr_drug_common_name": "FENTANYL",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "300MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "SUBLINGUAL",
    "drug_route_fr": "Sublinguale",
    "drug_package_quantity": "10 TABS",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56646,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22484,
      "drug_code": 84913,
      "updated_date": "2025-05-15T04:18:12-04:00",
      "company": {
        "id": 58,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 8481,
        "mfr_code": "PIA08",
        "name": "PALADIN PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 BLVD ALEXIS-NIHON, SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": "",
        "contact_information": "1-866-340-1112\r\npaladincs@endo.com"
      },
      "drug_ingredients": [
        {
          "id": 8349948,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02364204",
      "brand_name": "ABSTRAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302018"
    },
    "created_date": "2018-07-26T19:02:27-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02364204",
    "company_name": "PALADIN LABS INC",
    "atc_number": "N02AB03",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2018-07-24T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-24T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-26T19:02:47-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ABSTRAL",
    "en_drug_common_name": "FENTANYL",
    "fr_drug_brand_name": "ABSTRAL",
    "fr_drug_common_name": "FENTANYL",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "400MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "SUBLINGUAL",
    "drug_route_fr": "Sublinguale",
    "drug_package_quantity": "10 TABS",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56649,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22486,
      "drug_code": 84914,
      "updated_date": "2025-05-15T04:18:12-04:00",
      "company": {
        "id": 58,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 8481,
        "mfr_code": "PIA08",
        "name": "PALADIN PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 BLVD ALEXIS-NIHON, SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": "",
        "contact_information": "1-866-340-1112\r\npaladincs@endo.com"
      },
      "drug_ingredients": [
        {
          "id": 8349949,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02364212",
      "brand_name": "ABSTRAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302019"
    },
    "created_date": "2018-07-26T19:03:18-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02364212",
    "company_name": "PALADIN LABS INC",
    "atc_number": "N02AB03",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2018-07-24T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-24T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-26T19:03:40-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ABSTRAL",
    "en_drug_common_name": "FENTANYL",
    "fr_drug_brand_name": "ABSTRAL",
    "fr_drug_common_name": "FENTANYL",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "600MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "SUBLINGUAL",
    "drug_route_fr": "Sublinguale",
    "drug_package_quantity": "10 TABS",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56652,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22488,
      "drug_code": 84915,
      "updated_date": "2025-05-15T04:18:12-04:00",
      "company": {
        "id": 58,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 8481,
        "mfr_code": "PIA08",
        "name": "PALADIN PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 BLVD ALEXIS-NIHON, SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": "",
        "contact_information": "1-866-340-1112\r\npaladincs@endo.com"
      },
      "drug_ingredients": [
        {
          "id": 8349950,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "800",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02364220",
      "brand_name": "ABSTRAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302020"
    },
    "created_date": "2018-07-26T19:04:48-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02364220",
    "company_name": "PALADIN LABS INC",
    "atc_number": "N02AB03",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2018-07-24T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-07-24T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-26T19:05:09-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ABSTRAL",
    "en_drug_common_name": "FENTANYL",
    "fr_drug_brand_name": "ABSTRAL",
    "fr_drug_common_name": "FENTANYL",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "800MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "SUBLINGUAL",
    "drug_route_fr": "Sublinguale",
    "drug_package_quantity": "10 TABS",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56667,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18536,
      "drug_code": 79820,
      "updated_date": "2025-05-15T04:13:55-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8345683,
          "ingredient": {
            "id": 2160,
            "ingredient_code": 1290,
            "en_name": "LOVASTATIN",
            "fr_name": "Lovastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02312670",
      "brand_name": "PRO-LOVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0120669002"
    },
    "created_date": "2018-07-26T21:26:25-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02312670",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C10AA02",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2018-07-26T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-27T05:00:09-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PRO-LOVASTATIN",
    "en_drug_common_name": "LOVASTATIN",
    "fr_drug_brand_name": "PRO-LOVASTATIN",
    "fr_drug_common_name": "LOVASTATIN",
    "en_ingredients": "LOVASTATIN",
    "fr_ingredients": "Lovastatine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30-100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56670,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18538,
      "drug_code": 79821,
      "updated_date": "2025-05-15T04:13:55-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8345684,
          "ingredient": {
            "id": 2160,
            "ingredient_code": 1290,
            "en_name": "LOVASTATIN",
            "fr_name": "Lovastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02312689",
      "brand_name": "PRO-LOVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0120669001"
    },
    "created_date": "2018-07-26T21:27:47-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02312689",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C10AA02",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2018-07-26T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-27T05:00:09-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PRO-LOVASTATIN",
    "en_drug_common_name": "LOVASTATIN",
    "fr_drug_brand_name": "PRO-LOVASTATIN",
    "fr_drug_common_name": "LOVASTATIN",
    "en_ingredients": "LOVASTATIN",
    "fr_ingredients": "Lovastatine",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30-100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56681,
    "drug": {
      "current_status": "MARKETED",
      "id": 2930,
      "drug_code": 17199,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8252189,
          "ingredient": {
            "id": 40,
            "ingredient_code": 2037,
            "en_name": "NAPROXEN SODIUM",
            "fr_name": "Naproxène sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "275",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00887056",
      "brand_name": "NAPROXEN-NA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79350",
      "number_of_ais": "1",
      "ai_group_no": "0113934001"
    },
    "created_date": "2018-07-26T21:33:11-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00887056",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "M01AE02",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "decision_reversal": true,
    "en_discontinuation_comments": "This product has been re-introduced into the market.",
    "fr_discontinuation_comments": "Ce produit a été réintroduit sur le marché.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-06-25T15:37:25-04:00",
    "status": "reversed",
    "en_drug_brand_name": "NAPROXEN-NA",
    "en_drug_common_name": "NAPROXEN",
    "fr_drug_brand_name": "NAPROXEN-NA",
    "fr_drug_common_name": "NAPROXEN",
    "en_ingredients": "NAPROXEN SODIUM",
    "fr_ingredients": "Naproxène sodique",
    "drug_strength": "275MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56686,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18540,
      "drug_code": 79822,
      "updated_date": "2025-05-15T04:13:55-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8345685,
          "ingredient": {
            "id": 38,
            "ingredient_code": 10110,
            "en_name": "VERAPAMIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de vérapamil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "240",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02312697",
      "brand_name": "PRO-VERAPAMIL SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113846003"
    },
    "created_date": "2018-07-26T21:36:13-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02312697",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C08DA01",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "discontinuation_date": "2018-07-26T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-27T05:00:09-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PRO-VERAPAMIL SR",
    "en_drug_common_name": "VERAPAMIL",
    "fr_drug_brand_name": "PRO-VERAPAMIL-SR",
    "fr_drug_common_name": "VERAPAMIL",
    "en_ingredients": "VERAPAMIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de vérapamil",
    "drug_strength": "240MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56699,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27852,
      "drug_code": 90051,
      "updated_date": "2025-05-15T04:21:52-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8353949,
          "ingredient": {
            "id": 584,
            "ingredient_code": 11161,
            "en_name": "QUINAPRIL",
            "fr_name": "Quinapril (Chlorhydrate de quinapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02415917",
      "brand_name": "QUINAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123206001"
    },
    "created_date": "2018-07-26T21:44:48-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02415917",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09AA06",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2018-07-26T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-27T05:00:10-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "QUINAPRIL",
    "en_drug_common_name": "QUINAPRIL",
    "fr_drug_brand_name": "QUINAPRIL",
    "fr_drug_common_name": "QUINAPRIL",
    "en_ingredients": "QUINAPRIL",
    "fr_ingredients": "QUINAPRIL",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56702,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27854,
      "drug_code": 90052,
      "updated_date": "2025-05-15T04:21:52-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8353950,
          "ingredient": {
            "id": 584,
            "ingredient_code": 11161,
            "en_name": "QUINAPRIL",
            "fr_name": "Quinapril (Chlorhydrate de quinapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02415925",
      "brand_name": "QUINAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123206002"
    },
    "created_date": "2018-07-26T21:46:23-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02415925",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09AA06",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2018-07-26T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-27T05:00:10-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "QUINAPRIL",
    "en_drug_common_name": "QUINAPRIL",
    "fr_drug_brand_name": "QUINAPRIL",
    "fr_drug_common_name": "QUINAPRIL",
    "en_ingredients": "QUINAPRIL",
    "fr_ingredients": "QUINAPRIL",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56705,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27856,
      "drug_code": 90053,
      "updated_date": "2025-05-15T04:21:52-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8353951,
          "ingredient": {
            "id": 584,
            "ingredient_code": 11161,
            "en_name": "QUINAPRIL",
            "fr_name": "Quinapril (Chlorhydrate de quinapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02415933",
      "brand_name": "QUINAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123206003"
    },
    "created_date": "2018-07-26T21:47:38-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02415933",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09AA06",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2018-07-26T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-27T05:00:10-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "QUINAPRIL",
    "en_drug_common_name": "QUINAPRIL",
    "fr_drug_brand_name": "QUINAPRIL",
    "fr_drug_common_name": "QUINAPRIL",
    "en_ingredients": "QUINAPRIL",
    "fr_ingredients": "QUINAPRIL",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56708,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27858,
      "drug_code": 90054,
      "updated_date": "2025-05-15T04:21:52-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8353952,
          "ingredient": {
            "id": 584,
            "ingredient_code": 11161,
            "en_name": "QUINAPRIL",
            "fr_name": "Quinapril (Chlorhydrate de quinapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02415941",
      "brand_name": "QUINAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123206004"
    },
    "created_date": "2018-07-26T21:48:47-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02415941",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09AA06",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2018-07-26T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-27T19:03:56-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "QUINAPRIL",
    "en_drug_common_name": "QUINAPRIL",
    "fr_drug_brand_name": "QUINAPRIL",
    "fr_drug_common_name": "QUINAPRIL",
    "en_ingredients": "QUINAPRIL",
    "fr_ingredients": "QUINAPRIL",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56742,
    "drug": {
      "current_status": "MARKETED",
      "id": 19942,
      "drug_code": 81253,
      "updated_date": "2025-05-15T02:32:25-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8256972,
          "ingredient": {
            "id": 1592,
            "ingredient_code": 5900,
            "en_name": "METHOTREXATE",
            "fr_name": "Méthotrexate (Méthotrexate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02327236",
      "brand_name": "METHOTREXATE INJECTION BP",
      "brand_name_fr": "METHOTREXATE INJECTABLE BP",
      "descriptor": "WITHOUT PRESERVATIVE (2 ML SINGLE-USE VIALS)",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107545002"
    },
    "created_date": "2018-07-27T13:20:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327236",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "L01BA01",
    "atc_description": "ANTIMETABOLITES",
    "anticipated_start_date": "2018-07-17T00:00:00-04:00",
    "estimated_end_date": "2018-08-11T00:00:00-04:00",
    "actual_start_date": "2018-07-17T00:00:00-04:00",
    "actual_end_date": "2018-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-02T13:38:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "METHOTREXATE INJECTION BP",
    "en_drug_common_name": "METHOTREXATE",
    "fr_drug_brand_name": "METHOTREXATE",
    "fr_drug_common_name": "METHOTREXATE",
    "en_ingredients": "METHOTREXATE",
    "fr_ingredients": "Méthotrexate",
    "drug_strength": "25MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRA-ARTERIAL\r\nINTRAMUSCULAR\r\nINTRATHECAL\r\nINTRAVENOUS\r\nINTRAVENTRICULAR",
    "drug_route_fr": "Intra-artérielle\r\nIntramusculaire\r\nIntrathécale\r\nIntraveineuse\r\nIntraventriculaire",
    "drug_package_quantity": "1 VIAL OF 40 ML  | 1 FIOLE DE 40 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56785,
    "drug": {
      "current_status": "MARKETED",
      "id": 5426,
      "drug_code": 35783,
      "updated_date": "2025-05-15T02:31:00-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252835,
          "ingredient": {
            "id": 502,
            "ingredient_code": 7588,
            "en_name": "TRIAMCINOLONE ACETONIDE",
            "fr_name": "Acétonide  de triamcinolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02194031",
      "brand_name": "ARISTOCORT R",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H3070",
      "number_of_ais": "1",
      "ai_group_no": "0106310002"
    },
    "created_date": "2018-07-27T15:38:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02194031",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "D07AB09",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "actual_start_date": "2018-07-20T00:00:00-04:00",
    "actual_end_date": "2018-10-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-10-05T14:18:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ARISTOCORT R",
    "en_drug_common_name": "ARISTOCORT R",
    "fr_drug_brand_name": "ARISTOCORT R",
    "fr_drug_common_name": "ARISTOCORT R",
    "en_ingredients": "TRIAMCINOLONE ACETONIDE",
    "fr_ingredients": "Acétonide  de triamcinolone",
    "drug_strength": "0.1%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "30g tube",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56792,
    "drug": {
      "current_status": "MARKETED",
      "id": 1138,
      "drug_code": 12645,
      "updated_date": "2025-12-03T00:30:30-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8251648,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00884154",
      "brand_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "WITH PRESERVATIVE",
      "pediatric_flag": false,
      "accession_number": "73810",
      "number_of_ais": "1",
      "ai_group_no": "0101280004"
    },
    "created_date": "2018-07-27T17:01:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00884154",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N01BB02",
    "atc_description": "ANESTHETICS, LOCAL",
    "actual_start_date": "2018-10-24T00:00:00-04:00",
    "actual_end_date": "2019-03-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-03-28T14:09:46-04:00",
    "status": "resolved",
    "en_comments": "Product is discontinued",
    "fr_comments": "Produit est discontinué",
    "en_drug_brand_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP 1%",
    "en_drug_common_name": "LIDOCAINE HYDROCHLORIDE",
    "fr_drug_brand_name": "Chlorhydrate de lidocaïne injectable USP",
    "fr_drug_common_name": "Chlorhydrate de lidocaïne",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de lidocaïne",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration",
    "drug_package_quantity": "25 x 20 mL PVL MD",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56803,
    "drug": {
      "current_status": "MARKETED",
      "id": 30290,
      "drug_code": 92351,
      "updated_date": "2025-12-03T00:32:46-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261063,
          "ingredient": {
            "id": 4068,
            "ingredient_code": 22591,
            "en_name": "BROMFENAC",
            "fr_name": "Bromfénac (Bromfénac sodique sesquihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.07",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02439123",
      "brand_name": "PROLENSA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0156750001"
    },
    "created_date": "2018-07-27T17:33:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439123",
    "company_name": "BAUSCH & LOMB INC",
    "atc_number": "S01BC11",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "estimated_end_date": "2018-08-14T00:00:00-04:00",
    "actual_start_date": "2018-07-26T00:00:00-04:00",
    "actual_end_date": "2018-08-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-08-22T17:22:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PROLENSA",
    "en_drug_common_name": "PROLENSA",
    "fr_drug_brand_name": "PROLENSA",
    "fr_drug_common_name": "PROLENSA",
    "en_ingredients": "Bromfenac",
    "fr_ingredients": "bromfenac",
    "drug_strength": "0.07%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "3ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56807,
    "drug": {
      "current_status": "MARKETED",
      "id": 29954,
      "drug_code": 92020,
      "updated_date": "2025-12-03T00:32:42-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260886,
          "ingredient": {
            "id": 3518,
            "ingredient_code": 20429,
            "en_name": "LOTEPREDNOL ETABONATE",
            "fr_name": "Étabonate de lotéprednol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02435853",
      "brand_name": "LOTEMAX GEL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152508002"
    },
    "created_date": "2018-07-27T17:36:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02435853",
    "company_name": "BAUSCH & LOMB INC",
    "atc_number": "S01BA14",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "actual_start_date": "2018-09-05T00:00:00-04:00",
    "actual_end_date": "2018-09-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-09-27T19:48:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LOTEMAX GEL",
    "en_drug_common_name": "LOTEMAX GEL",
    "fr_drug_brand_name": "LOTEMAX GEL",
    "fr_drug_common_name": "LOTEMAX GEL",
    "en_ingredients": "LOTEPREDNOL ETABONATE",
    "fr_ingredients": "Étabonate de lotéprednol",
    "drug_strength": "0.5%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "5gm",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56810,
    "drug": {
      "current_status": "MARKETED",
      "id": 6398,
      "drug_code": 43308,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253062,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02221829",
      "brand_name": "ALTACE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9639",
      "number_of_ais": "1",
      "ai_group_no": "0122858001"
    },
    "created_date": "2018-07-27T17:38:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02221829",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "C09AA05",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "actual_start_date": "2018-08-08T00:00:00-04:00",
    "actual_end_date": "2018-08-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-08-31T18:04:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ALTACE",
    "en_drug_common_name": "ALTACE",
    "fr_drug_brand_name": "ALTACE",
    "fr_drug_common_name": "ALTACE",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "1.25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 caps",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56829,
    "drug": {
      "current_status": "MARKETED",
      "id": 2040,
      "drug_code": 14318,
      "updated_date": "2025-12-03T00:30:31-05:00",
      "company": {
        "id": 52,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15353,
        "mfr_code": "",
        "name": "ABBVIE CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "8401 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4S 1Z1",
        "post_office_box": "",
        "contact_information": "Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270."
      },
      "drug_ingredients": [
        {
          "id": 8251942,
          "ingredient": {
            "id": 1062,
            "ingredient_code": 738,
            "en_name": "BERACTANT",
            "fr_name": "Béractant"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02016109",
      "brand_name": "SURVANTA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75894",
      "number_of_ais": "1",
      "ai_group_no": "0124200001"
    },
    "created_date": "2018-07-27T18:13:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02016109",
    "company_name": "ABBVIE CORPORATION",
    "atc_number": "R07AA02",
    "atc_description": "OTHER RESPIRATORY SYSTEM PRODUCTS",
    "estimated_end_date": "2018-09-04T00:00:00-04:00",
    "actual_start_date": "2018-07-24T00:00:00-04:00",
    "actual_end_date": "2018-08-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-08-30T18:11:00-04:00",
    "status": "resolved",
    "en_comments": "We are currently monitoring our inventory of Survanta 4mL due to an unexpected increase in market demand.  We have normal inventory levels of Survanta 8mL. During that period, orders will be processed to prioritize patient needs.",
    "fr_comments": "Nous surveillons actuellement notre inventaire de Survanta 4mL en raison d'une augmentation inattendue de la demande du marché. Nous avons des niveaux d'inventaire normaux de Survanta 8mL. Pendant cette période, les commandes seront traitées afin de prioriser les besoins des patients.",
    "en_drug_brand_name": "SURVANTA",
    "en_drug_common_name": "SURVANTA VIAL, 4mL",
    "fr_drug_brand_name": "SURVANTA",
    "fr_drug_common_name": "SURVANTA VIAL, 4mL",
    "en_ingredients": "BERACTANT",
    "fr_ingredients": "Béractant",
    "drug_strength": "25MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRATRACHEAL",
    "drug_route_fr": "Intratrachéale",
    "drug_package_quantity": "4mL vial",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56848,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 4448,
      "drug_code": 2170,
      "updated_date": "2025-05-15T03:25:04-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8272971,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00341975",
      "brand_name": "HYDROCHLOROTHIAZIDE TAB 25MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "47908",
      "number_of_ais": "1",
      "ai_group_no": "0101048002"
    },
    "created_date": "2018-07-27T20:46:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00341975",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C03AA03",
    "atc_description": "LOW-CEILING DIURETICS, THIAZIDES",
    "actual_start_date": "2018-07-27T00:00:00-04:00",
    "actual_end_date": "2018-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-08-01T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Discontinued",
    "fr_comments": "Cessation de vente",
    "en_drug_brand_name": "HYDROCHLOROTHIAZIDE TAB 25MG",
    "en_drug_common_name": "HYDROCHLOROTHIAZIDE",
    "fr_drug_brand_name": "HYDROCHLOROTHIAZIDE TAB 25MG",
    "fr_drug_common_name": "HYDROCHLOROTHIAZIDE",
    "en_ingredients": "HYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56881,
    "drug": {
      "current_status": "MARKETED",
      "id": 2856,
      "drug_code": 16902,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8252171,
          "ingredient": {
            "id": 26,
            "ingredient_code": 10146,
            "en_name": "HALOPERIDOL",
            "fr_name": "Halopéridol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02130300",
      "brand_name": "HALOPERIDOL LA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78972",
      "number_of_ais": "1",
      "ai_group_no": "0101774008"
    },
    "created_date": "2018-07-30T15:44:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02130300",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N05AD01",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2018-10-05T00:00:00-04:00",
    "estimated_end_date": "2018-12-19T00:00:00-05:00",
    "actual_start_date": "2018-10-02T00:00:00-04:00",
    "actual_end_date": "2018-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2018-12-17T19:55:43-05:00",
    "status": "resolved",
    "en_drug_brand_name": "HALOPERIDOL LA",
    "en_drug_common_name": "HALOPERIDOL",
    "fr_drug_brand_name": "HALOPERIDOL",
    "fr_drug_common_name": "HALOPERIDOL",
    "en_ingredients": "HALOPERIDOL",
    "fr_ingredients": "Halopéridol",
    "drug_strength": "100MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "SINGLE 5ML VIAL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56891,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 16982,
      "drug_code": 77992,
      "updated_date": "2025-12-03T01:24:56-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8344083,
          "ingredient": {
            "id": 2870,
            "ingredient_code": 1893,
            "en_name": "PROPAFENONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propafénone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02294575",
      "brand_name": "PMS-PROPAFENONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116258002"
    },
    "created_date": "2018-07-30T17:36:56-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02294575",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C01BC03",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "discontinuation_date": "2017-12-29T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Sku deactivated - in process for deactivation",
    "fr_discontinuation_comments": "Produit desactivé - en processus de discontinuation",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-30T17:38:31-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-PROPAFENONE",
    "en_drug_common_name": "PROPAFENONE",
    "fr_drug_brand_name": "PMS-PROPAFENONE",
    "fr_drug_common_name": "PROPAFENONE",
    "en_ingredients": "PROPAFENONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propafénone",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56906,
    "drug": {
      "current_status": "MARKETED",
      "id": 11202,
      "drug_code": 6755,
      "updated_date": "2025-12-03T00:30:23-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250938,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00594652",
      "brand_name": "STATEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63972",
      "number_of_ais": "1",
      "ai_group_no": "0104545003"
    },
    "created_date": "2018-07-30T18:58:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00594652",
    "company_name": "PALADIN LABS INC",
    "atc_number": "N02AA01",
    "atc_description": "OPIOIDS",
    "actual_start_date": "2018-07-30T00:00:00-04:00",
    "actual_end_date": "2018-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-03T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "STATEX TAB 5MG",
    "en_drug_common_name": "Statex",
    "fr_drug_brand_name": "Statex 5mg tabs",
    "fr_drug_common_name": "Statex",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56909,
    "drug": {
      "current_status": "MARKETED",
      "id": 200,
      "drug_code": 10511,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251349,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00060348",
      "brand_name": "5% DEXTROSE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70437",
      "number_of_ais": "1",
      "ai_group_no": "0102181006"
    },
    "created_date": "2018-07-30T19:00:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00060348",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA03",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2018-07-30T00:00:00-04:00",
    "estimated_end_date": "2018-10-09T00:00:00-04:00",
    "actual_start_date": "2018-07-30T00:00:00-04:00",
    "actual_end_date": "2018-10-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-10T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DEXTROSE 5% INJ 5GM/100ML USP",
    "en_drug_common_name": "5% Dextrose Injection",
    "fr_drug_brand_name": "5% Dextrose Injection",
    "fr_drug_common_name": "5% Dextrose Injection",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "5G",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "100mL Mini-Bag Plus",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56912,
    "drug": {
      "current_status": "MARKETED",
      "id": 200,
      "drug_code": 10511,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251349,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00060348",
      "brand_name": "5% DEXTROSE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70437",
      "number_of_ais": "1",
      "ai_group_no": "0102181006"
    },
    "created_date": "2018-07-30T19:01:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00060348",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA03",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2018-07-30T00:00:00-04:00",
    "estimated_end_date": "2018-10-09T00:00:00-04:00",
    "actual_start_date": "2018-07-30T00:00:00-04:00",
    "actual_end_date": "2018-10-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-10T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DEXTROSE 5% INJ 5GM/100ML USP",
    "en_drug_common_name": "5% Dextrose Injection",
    "fr_drug_brand_name": "5% Dextrose Injection",
    "fr_drug_common_name": "5% Dextrose Injection",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "5G",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "50mL Mini-Bag Plus",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56915,
    "drug": {
      "current_status": "MARKETED",
      "id": 34,
      "drug_code": 10040,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251278,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "900",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00060208",
      "brand_name": "0.9% SODIUM CHLORIDE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69686",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2018-07-30T19:02:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00060208",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05XA03",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2018-07-30T00:00:00-04:00",
    "estimated_end_date": "2018-10-09T00:00:00-04:00",
    "actual_start_date": "2018-07-30T00:00:00-04:00",
    "actual_end_date": "2018-10-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-10T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SODIUM CHLORIDE 0.9% INJ 900MG/100ML USP",
    "en_drug_common_name": "0.9% Sodium Chloride Injection",
    "fr_drug_brand_name": "0.9% Sodium Chloride Injection",
    "fr_drug_common_name": "0.9% Sodium Chloride Injection",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "900MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "100mL Mini-Bag Plus",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56918,
    "drug": {
      "current_status": "MARKETED",
      "id": 34,
      "drug_code": 10040,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251278,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "900",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00060208",
      "brand_name": "0.9% SODIUM CHLORIDE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69686",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2018-07-30T19:03:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00060208",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05XA03",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2018-07-30T00:00:00-04:00",
    "estimated_end_date": "2018-10-09T00:00:00-04:00",
    "actual_start_date": "2018-07-30T00:00:00-04:00",
    "actual_end_date": "2018-10-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-10T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SODIUM CHLORIDE 0.9% INJ 900MG/100ML USP",
    "en_drug_common_name": "0.9% Sodium Chloride Injection",
    "fr_drug_brand_name": "0.9% Sodium Chloride Injection",
    "fr_drug_common_name": "0.9% Sodium Chloride Injection",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "900MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "50mL Mini-Bag Plus",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56945,
    "drug": {
      "current_status": "MARKETED",
      "id": 28786,
      "drug_code": 90903,
      "updated_date": "2025-05-15T02:34:19-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8260446,
          "ingredient": {
            "id": 2670,
            "ingredient_code": 11854,
            "en_name": "SILDENAFIL",
            "fr_name": "Sildénafil (Citrate de sildénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02424320",
      "brand_name": "SILDENAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136261003"
    },
    "created_date": "2018-07-30T21:04:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02424320",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "G04BE03",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "actual_start_date": "2018-07-30T00:00:00-04:00",
    "actual_end_date": "2019-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-01-18T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SILDENAFIL",
    "en_drug_common_name": "SILDENAFIL",
    "fr_drug_brand_name": "SILDENAFIL",
    "fr_drug_common_name": "SILDENAFIL",
    "en_ingredients": "SILDENAFIL",
    "fr_ingredients": "SILDENAFIL",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56983,
    "drug": {
      "current_status": "MARKETED",
      "id": 4930,
      "drug_code": 2798,
      "updated_date": "2025-05-15T02:30:28-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250448,
          "ingredient": {
            "id": 564,
            "ingredient_code": 10091,
            "en_name": "FUROSEMIDE",
            "fr_name": "Furosémide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00396788",
      "brand_name": "APO-FUROSEMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "51365",
      "number_of_ais": "1",
      "ai_group_no": "0101944002"
    },
    "created_date": "2018-07-31T12:15:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00396788",
    "company_name": "APOTEX INC",
    "atc_number": "C03CA01",
    "atc_description": "HIGH-CEILING DIURETICS",
    "estimated_end_date": "2018-10-31T00:00:00-04:00",
    "actual_start_date": "2018-07-30T00:00:00-04:00",
    "actual_end_date": "2018-10-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-11T20:26:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO FUROSEMIDE TAB 20MG",
    "en_drug_common_name": "FUROSEMIDE",
    "fr_drug_brand_name": "APO FUROSEMIDE TAB 20MG",
    "fr_drug_common_name": "FUROSEMIDE",
    "en_ingredients": "FUROSEMIDE",
    "fr_ingredients": "Furosémide",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56986,
    "drug": {
      "current_status": "MARKETED",
      "id": 21678,
      "drug_code": 84059,
      "updated_date": "2025-05-15T02:32:47-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257744,
          "ingredient": {
            "id": 3134,
            "ingredient_code": 12429,
            "en_name": "IMATINIB",
            "fr_name": "Imatinib (Mésylate d'imatinib)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02355345",
      "brand_name": "APO-IMATINIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145503003"
    },
    "created_date": "2018-07-31T12:17:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02355345",
    "company_name": "APOTEX INC",
    "atc_number": "L01XE01",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "estimated_end_date": "2018-11-15T00:00:00-05:00",
    "actual_start_date": "2018-07-30T00:00:00-04:00",
    "actual_end_date": "2018-11-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-11-16T02:02:50-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-IMATINIB",
    "en_drug_common_name": "IMATINIB",
    "fr_drug_brand_name": "APO-IMATINIB",
    "fr_drug_common_name": "IMATINIB",
    "en_ingredients": "IMATINIB",
    "fr_ingredients": "IMATINIB",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 56989,
    "drug": {
      "current_status": "DORMANT",
      "id": 18672,
      "drug_code": 79946,
      "updated_date": "2025-05-15T06:55:37-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368177,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313944",
      "brand_name": "APO-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858005"
    },
    "created_date": "2018-07-31T12:20:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313944",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH04",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-10-19T00:00:00-04:00",
    "actual_start_date": "2018-07-30T00:00:00-04:00",
    "actual_end_date": "2018-09-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-28T15:03:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "APO-QUETIAPINE",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 57003,
    "drug": {
      "current_status": "MARKETED",
      "id": 14866,
      "drug_code": 75263,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 678,
        "created_date": "2017-03-09T13:23:04-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 14108,
        "mfr_code": "",
        "name": "TAKEDA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "3800",
        "street_name": "22 ADELAIDE STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5H 4E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255325,
          "ingredient": {
            "id": 2294,
            "ingredient_code": 11086,
            "en_name": "PANTOPRAZOLE",
            "fr_name": "Pantoprazole (Pantoprazole sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02267233",
      "brand_name": "TECTA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133229001"
    },
    "created_date": "2018-07-31T14:18:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02267233",
    "company_name": "TAKEDA CANADA INC",
    "atc_number": "A02BC02",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "anticipated_start_date": "2018-07-31T00:00:00-04:00",
    "estimated_end_date": "2018-09-17T00:00:00-04:00",
    "actual_start_date": "2018-07-31T00:00:00-04:00",
    "actual_end_date": "2018-09-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-21T05:00:05-04:00",
    "status": "resolved",
    "en_comments": "Resolved.",
    "fr_comments": "Résolu.",
    "en_drug_brand_name": "TECTA",
    "en_drug_common_name": "Pantoprazole Magnesium",
    "fr_drug_brand_name": "TECTA",
    "fr_drug_common_name": "pantoprazole magnésien",
    "en_ingredients": "PANTOPRAZOLE",
    "fr_ingredients": "pantoprazole magnésien",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "Blisters - 30 ct.",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 57012,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 4448,
      "drug_code": 2170,
      "updated_date": "2025-05-15T03:25:04-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8272971,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00341975",
      "brand_name": "HYDROCHLOROTHIAZIDE TAB 25MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "47908",
      "number_of_ais": "1",
      "ai_group_no": "0101048002"
    },
    "created_date": "2018-07-31T14:32:18-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00341975",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C03AA03",
    "atc_description": "LOW-CEILING DIURETICS, THIAZIDES",
    "discontinuation_date": "2018-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-08-01T05:00:07-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "HYDROCHLOROTHIAZIDE TAB 25MG",
    "en_drug_common_name": "HYDROCHLOROTHIAZIDE",
    "fr_drug_brand_name": "HYDROCHLOROTHIAZIDE TAB 25MG",
    "fr_drug_common_name": "HYDROCHLOROTHIAZIDE",
    "en_ingredients": "HYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1000",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 57023,
    "drug": {
      "current_status": "MARKETED",
      "id": 25348,
      "drug_code": 87820,
      "updated_date": "2025-12-03T00:32:06-05:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8259189,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392933",
      "brand_name": "MYLAN-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055001"
    },
    "created_date": "2018-07-31T14:49:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392933",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10AA05",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2018-10-11T00:00:00-04:00",
    "estimated_end_date": "2018-10-19T00:00:00-04:00",
    "actual_end_date": "2018-10-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-10-09T18:55:30-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "MYLAN-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "MYLAN-ATORVASTATIN",
    "fr_drug_common_name": "ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90 BT, 500 BT",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 57055,
    "drug": {
      "current_status": "MARKETED",
      "id": 28702,
      "drug_code": 90828,
      "updated_date": "2025-05-15T02:34:17-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260412,
          "ingredient": {
            "id": 786,
            "ingredient_code": 93,
            "en_name": "CIPROFLOXACIN",
            "fr_name": "Ciprofloxacine (Chlorhydrate de ciprofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02423561",
      "brand_name": "MINT-CIPROFLOX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123207001"
    },
    "created_date": "2018-07-31T15:48:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423561",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "J01MA02",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "estimated_end_date": "2020-04-30T00:00:00-04:00",
    "actual_start_date": "2018-07-31T00:00:00-04:00",
    "actual_end_date": "2020-03-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-03-21T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-CIPROFLOX",
    "en_drug_common_name": "Ciprofloxacin",
    "fr_drug_brand_name": "Mint- Ciprofloxacin",
    "fr_drug_common_name": "Ciprofloxacin",
    "en_ingredients": "CIPROFLOXACIN",
    "fr_ingredients": "Ciprofloxacine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 57064,
    "drug": {
      "current_status": "MARKETED",
      "id": 23990,
      "drug_code": 86635,
      "updated_date": "2025-05-15T02:33:13-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258633,
          "ingredient": {
            "id": 934,
            "ingredient_code": 11130,
            "en_name": "FLUOXETINE",
            "fr_name": "Fluoxétine (Chlorhydrate de fluoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02380560",
      "brand_name": "MINT-FLUOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116847003"
    },
    "created_date": "2018-07-31T15:55:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02380560",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "N06AB03",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-04-30T00:00:00-04:00",
    "actual_start_date": "2018-07-31T00:00:00-04:00",
    "actual_end_date": "2020-12-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-01-11T17:16:43-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-FLUOXETINE",
    "en_drug_common_name": "Fluoxetine",
    "fr_drug_brand_name": "Mint- Fluoxetine",
    "fr_drug_common_name": "Fluoxetine",
    "en_ingredients": "FLUOXETINE",
    "fr_ingredients": "Fluoxetine",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 57069,
    "drug": {
      "current_status": "MARKETED",
      "id": 23992,
      "drug_code": 86636,
      "updated_date": "2025-05-15T02:33:13-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258634,
          "ingredient": {
            "id": 934,
            "ingredient_code": 11130,
            "en_name": "FLUOXETINE",
            "fr_name": "Fluoxétine (Chlorhydrate de fluoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02380579",
      "brand_name": "MINT-FLUOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116847001"
    },
    "created_date": "2018-07-31T15:56:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02380579",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "N06AB03",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-04-30T00:00:00-04:00",
    "actual_start_date": "2018-07-31T00:00:00-04:00",
    "actual_end_date": "2020-12-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-01-11T17:17:45-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-FLUOXETINE",
    "en_drug_common_name": "Fluoxetine",
    "fr_drug_brand_name": "Mint- Fluoxetine",
    "fr_drug_common_name": "Fluoxetine",
    "en_ingredients": "FLUOXETINE",
    "fr_ingredients": "Fluoxetine",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 57126,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 5850,
      "drug_code": 4008,
      "updated_date": "2025-05-15T03:26:51-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8275800,
          "ingredient": {
            "id": 450,
            "ingredient_code": 2370,
            "en_name": "CARBIDOPA",
            "fr_name": "Carbidopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8275799,
          "ingredient": {
            "id": 452,
            "ingredient_code": 4068,
            "en_name": "LEVODOPA",
            "fr_name": "Lévodopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00513997",
      "brand_name": "SINEMET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "56348",
      "number_of_ais": "2",
      "ai_group_no": "0210315003"
    },
    "created_date": "2018-07-31T18:52:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00513997",
    "company_name": "MERCK CANADA INC",
    "atc_number": "N04BA02",
    "atc_description": "DOPAMINERGIC AGENTS",
    "hc_updated_date": "2022-07-28T17:01:47-04:00",
    "anticipated_start_date": "2018-11-16T00:00:00-05:00",
    "estimated_end_date": "2022-08-31T00:00:00-04:00",
    "actual_start_date": "2018-11-08T00:00:00-05:00",
    "actual_end_date": "2022-07-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-28T17:01:50-04:00",
    "status": "resolved",
    "en_comments": "Discontinued / Discontinué",
    "fr_comments": "Discontinued / Discontinué",
    "en_drug_brand_name": "SINEMET 100/25",
    "en_drug_common_name": "levodopa and carbidopa tablets",
    "fr_drug_brand_name": "Sinemet",
    "fr_drug_common_name": "comprimés de levodopa and carbidopa",
    "en_ingredients": "CARBIDOPA\r\nLEVODOPA",
    "fr_ingredients": "Carbidopa\r\nLévodopa",
    "drug_strength": "25MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100TAB",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 57129,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 4420,
      "drug_code": 2142,
      "updated_date": "2025-05-15T03:25:04-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8272927,
          "ingredient": {
            "id": 450,
            "ingredient_code": 2370,
            "en_name": "CARBIDOPA",
            "fr_name": "Carbidopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8272926,
          "ingredient": {
            "id": 452,
            "ingredient_code": 4068,
            "en_name": "LEVODOPA",
            "fr_name": "Lévodopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00328219",
      "brand_name": "SINEMET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "47755",
      "number_of_ais": "2",
      "ai_group_no": "0210315001"
    },
    "created_date": "2018-07-31T18:57:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00328219",
    "company_name": "MERCK CANADA INC",
    "atc_number": "N04BA02",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2018-10-15T00:00:00-04:00",
    "estimated_end_date": "2019-02-08T00:00:00-05:00",
    "actual_start_date": "2018-10-15T00:00:00-04:00",
    "actual_end_date": "2019-02-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-06T17:44:38-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SINEMET 250/25",
    "en_drug_common_name": "levodopa and carbidopa tablets",
    "fr_drug_brand_name": "Sinemet",
    "fr_drug_common_name": "comprimés de levodopa and carbidopa",
    "en_ingredients": "CARBIDOPA\r\nLEVODOPA",
    "fr_ingredients": "Carbidopa\r\nLévodopa",
    "drug_strength": "25MG\r\n250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100TAB",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 57132,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 686,
      "drug_code": 11481,
      "updated_date": "2025-05-15T03:38:06-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8288209,
          "ingredient": {
            "id": 450,
            "ingredient_code": 2370,
            "en_name": "CARBIDOPA",
            "fr_name": "Carbidopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8288208,
          "ingredient": {
            "id": 452,
            "ingredient_code": 4068,
            "en_name": "LEVODOPA",
            "fr_name": "Lévodopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00870935",
      "brand_name": "SINEMET CR 200/50",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72185",
      "number_of_ais": "2",
      "ai_group_no": "0210315004"
    },
    "created_date": "2018-07-31T19:00:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00870935",
    "company_name": "MERCK CANADA INC",
    "atc_number": "N04BA02",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2019-02-15T00:00:00-05:00",
    "estimated_end_date": "2019-04-01T00:00:00-04:00",
    "actual_start_date": "2019-02-11T00:00:00-05:00",
    "actual_end_date": "2019-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-04-03T20:12:48-04:00",
    "status": "resolved",
    "en_comments": "This drug has been discontinued.  Please refer to discontinuation report for more details.",
    "fr_comments": "Ce médicament a été discontinué.  Svp veuillez vous référer au rapport de discontinuation pour de plus amples informations.",
    "en_drug_brand_name": "SINEMET CR 200/50",
    "en_drug_common_name": "levodopa and carbidopa controlledrelease tablets",
    "fr_drug_brand_name": "SINEMET CR",
    "fr_drug_common_name": "comprimés de lévodopa et de carbidopa à libération prolongée",
    "en_ingredients": "CARBIDOPA\r\nLEVODOPA",
    "fr_ingredients": "Carbidopa\r\nLévodopa",
    "drug_strength": "50MG\r\n200MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100TAB",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  }
]